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ABSTRACT
C hira lity  Is universally accepted as a paramount feature that governs 
the biological ac tiv ity  of organic molecules. I t  therefore has major 
significance In relation to Investigations of the receptors with which 
pharmacologically active ligands Interact and to the design of novel 
medicinal agents.
Although histamine Its e lf  Is an achiral molecule, many Hj 
receptor antagonists of histamine are either chiral or geometrically 
Isomeric. A review of the stereochemical studies of 
antihistamines 1s given 1n this thesis to Illu s tra te  the marked 
stereospeclflty of the receptors with respect to antagonists.
The thesis studies differences In antlhlstamlnlc potency of 
enantiomeric pairs of chiral antihistamines at both peripheral and 
central sites by 1n v itro  (binding and guinea pig Ileum) and 1n vivo 
(mice and humans) methods and also of novel Z and Z pairs of 
amlnopropene-type compounds In v itro  and correlates these results with 
structural and configurational requirements at the H recep to r.
The need to resolve a variety of chiral antihistamines, with a high 
level of optical purity, prior to pharmacological study Is emphasized 
In the work. Work 1s presented on novel methods of chiral analysis of 
antihistamines Involving *H NMR and/or HPLC techniques with cyclodextrlns 
or a-acld glycoprotein since the most commonly employed methods eg optical 
rotation do not provide an 'absolute' measure of optical purity.
From the human study data the results Indicate that the sedative side 
effects associated with H1 antagonists are due to blockade of central 
Hj receptors. Correlation of the structural requirements for 
antagonistic a c tiv ity  at histamine receptors highlights configurational 
s im ila rities  between the semi rig id  amlnopropenes and the more flex ib le  
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C hira lity  Is universally accepted as a paramount feature that 
governs the biological a c tiv ity  of organic molecules. I t ,  
therefore, has major significance In relation to Investigations 
of the receptors with which pharmacologically active ligands 
In teract. The main reasons for studying the stereochemistry of 
drug molecules 1s the Information that such data can provide with 
respect to the nature of drug-receptor Interactions and receptor 
characteristics. Prior to reaching the receptor s ite , the drug 
molecule 1s subjected to a variety of physiological processes 
such as absorption, d istribution , metabolism, uptake at storage 
sites and excretion. Many of these processes may be 
stereoselective (eg enzyme reactions) to varying degrees 
resulting In d iffering  Isomeric concentrations at the receptor 
sites; In these cases the Isomeric potency ratios may be due to 
concentration effects rather than drug-receptor Interactions.
Sterlc effects are lik e ly  to Influence penetration of 
membranes by drugs 1f active transport mechanisms are Involved. 
The stereospeclf1c1ty of amino acid and carbohydrate uptake by 
the small Intestine and by bacteria has been studied and results 
show the R amino acids to be absorbed much more rapidly than the 
corresponding S-enant1omer.
Catecholamines provide good examples of differences In the 
uptake and binding of enantlomers. Levo Isomers of octopamlne, 
m-octopam1ne and norepinephrine are preferentially retained by 
the heart.
Nonsteroidal anti-inflammatory agents such as Ibuprofen and 
naproxen also show differences 1n potency and metabolism between 
th e ir Isomeric forms.
2In these cases, the S Isomers are the active forms -  the Inactive 
R enantlowers are activated In the body by th e ir  conversion Into
S enantlowers (Walner and Doyle, 1984).
Examples of enantiomeric pairs In which each Isomer shows 
considerable differences In Its  biological effects have long been 
known. The f i r s t  recorded case was due to an observation of 
Louis Pasteur. In 1858 Pasteur reported that when the mould 
Penlclllum olaucum fed on a mixture of enantiomeric ta rta ric  
acids I t  consumed only the dextro (+) enantloner and le f t  the
levo ( - )  ta rta ric  acid behind.
Since this time, there have been many reported cases of 
enantiomeric differences In pharmacological a c tiv ity  (Williams 
and Lee, 1985; Casy, 1970).
The example of thalidomide, where the (+) enantlomer provides 
the desired hypnotic effects and the ( - )  Isomer Is responsible 
for the well known teratogenic effects of the racemlc agent. 
(Karnes and Sarkar, 1987), highlights the need for chiral 
resolution of drug compounds -  discussed la te r  In the thesis.
This thesis looks 1n more detail at antagonists of the 
receptor of histamine and studies the stereochemical aspects 
associated with a selection of these compounds.
Since histamine has many well defined effects I t  may be 
assumed that the biological response 1s via a receptor or 
receptors.
The effects of histamine are considered to be mediated by at 
least three sets of receptors 1e. H ,^ H? and H^ .
Those effects mediated by the receptor Include contraction 
of smooth muscle and the d ilata tion  and Increased permeability of 
the cap illa ries . The effects of histamine on vascular smooth 
muscle are mediated by H2 as well as H, receptors.
3Other effects which are mediated by H? receptors Include 
cardiac accelerating effects and the stimulating action of 
histamine on the secretion of gastric acid. Two examples of 
H2 antagonists are clmetldlne and ran itid ine, both of which 
are achiral. The third subclass of histamine receptors appear 
to be Involved in the feedback control of histamine synthesis 
and release In the brain (Arrang et a l,  1983). This thesis does 
not discuss these la tte r  types of histamine receptors or 
antagonists In any d e ta il.
1.2 Introduction to Antihistamines
Histamine Is an achiral molecule (la ) which exists under 
physiological conditions as the monocation (lb ) In equilibrium  
with Its  N*H tautomer (GanelUn, 1982).
A variety of chiral analogues produced by Introduction of a 
methyl group Into the ethylamlno side chain have been tested as 
Hj and H? agonists but a ll proved to be of much lower 
potency than that of the parent compound (Ganellln, 1982).
♦
( la ) (lb )
4At the H3 receptor, however, one analogue le 
R-a-methylhlstarolne (lc ) was shown to be IS tiroes more potent 
than histamine Its e lf  and 100 tiroes more potent than Its S Isomer 
(Arrang et a l, 1988).
Stereoselectivity has also been reported for compounds acting at 
receptor sites ( Elz and Schunack, 1988; Arrang et a l,
1985). By replacing the homohlstamlne side chain of the potent 
achiral H2 agonist Iropronldlne (2a) with a-methy) histamine 
yields soproroldlne (2b) and Its  S enantloroer
Sopromldlne acts as a highly potent H? agonist (7 times that 
of histamine) whereas Its S enantlomer acts as an H? 
antagonist. In contrast, at the H3 receptor both compounds 
act as an antagonists having apparent dissociation constants very 
similar to Impromldlne. These results show that the H3 
receptors are chemically stereoselective, with structural 
requirements d ifferen t from those of Hj and H? receptors.
(2a)
/= ^ C H 2CH NHCNHCH2CH2SCH2p = ^
V  NH
CH,
Host compounds that are effective at low dose levels In 
antagonizing histamine at receptor sites (Ash ♦ Schlld,
1966) may be described by the general structure (3) where Ar Is 
aryl (phenyl, substituted phenyl or heteroaryl) and Ar1 Is a 
second aryl group or Ar-CH  ^ group.
Ar
X -  C -  C -  N 
A r * /  ,_________ .
B-amlnoethyl side chain 
(3)
3
The unit X may be nitrogen, saturated (sp ) carbon-oxygen 
(ether linkages) or a saturated carbon linked d irectly  to the
0-am1noethy1 side chain. X-C may also be replaced by a pair of
2alkenlc (sp ) carbon atoms 1e. a C=C double bond. The terminal 
nitrogen Is part of a te rtia ry  acyclic or a llcyc llc  basic group eg. 
dlmethylamlno (-NMe?) or l-pyrrol1d1no (-N ^J ) .  Tricyclic  
derivatives In which the two aromatic rings are bridged are also 
encountered and these do not d if fe r  essentially from the general 
structure. Overall, ^-antagonists have structures comprising a 
double -  aromatic unit linked by a two or three atom chain to a 
te rtia ry  amino basic group. Histamine, Its e lf  d iffers  from Its  
antagonists 1n possessing only a single aromatic (Imidazole) feature 
and having a primary (NH )^ basic feature.
In presenting the stereochemical features of non-symmetrlc 
analogues of (3) I t  1s convenient to c las lfy  them Into d is tin c t 
groups.
1e. 1. Chiral and
2. Geometrically Isomeric antlhlstamlnlc groups.
1.3 Chiral Antlhlstamlnlc Agents
1.3.1 Early Examples and Ethylenedlawlnes
I t  Is Interesting that the f ir s t  compound reported capable of 
antagonising some of the effects of histamine In animals was the 
chiral 1-4 benzodloxane (4) (Fourneau and Bovet, 1933). I t  had
only weak a c tiv ity  and was examined solely as the racemate. 
These early leads led to the development of phenbenzamlne (5) 





(5) Ar -  Ph
Ar1 -  Ph
(6) Ar * 2-Py
Ar’ * 4-MeO-CcHo 4
No chiral analogues of phenbenzamlne have been described.
71.3.2 Tertiary Awlno Alkyl Ethers
During the 1940's, medicinal chemists in the USA investigated 
antihistamines in which the alkylamino nitrogen of phenbenzamlne 
(5) was replaced by oxygen to give a series of basic ethers.
This led to the introduction of the prototype member of this 
group, diphenhydramine (7 ) , several ch iral variants of which have 
been examined. The simplest, obtained by oara methyl substitution
Ph 7) R -  Ph
V  8) R .  ]>HePh
of one of the phenyl rings, is the potent racemate (8) marketed 
as neobenodine.
Jarrousse and Regnler (1951) f i r s t  reported the antipodal 
forms, a fte r resolution of the carbinol intermediates as 
phthalate esters with quinine. The re la tive  potencies of these 
enantiomers in antihistamine tests were as follows (Table 1 .1 ).
Test (♦ ) ( - )  RS
Inhibition of histamine- 
induced contractions of 
guinea-pig ileum 1 0.37 0.75
Protection of guinea-pig 
against histamine induced 
bronchospasm 1 0.25 0.5
Protection of guinea-pigs 
against a lethal i .v .  dose 
of histamine 1 0.11 0.79
Table 1.1 Relative potencies of the isomers of neobenodine in 
three antihistamine tests.
8Later work (Rekker et al 1971 and 1972), using optical Isomers
•  •
of specific rotations R *13.0 and S -10.3 In ethanol (S te lt et 
a l,  1969) reported that the R(+) form (pA? 8.7) was 65 times 
more potent than the S(-) form (pAj 6.9) In antagonizing guinea 
pig Ileum sites. The R and RS forms unexpectedly displayed equal 
potencies. These results show higher potency ratios than those 
obtained In the French work, probably due to the poor optical purity 
of the dextro Isomer used o rig ina lly .
The compound (8) Is used c lin ic a lly  as the racemate. Antipodal 
forms of para-ethyl and methylamlno analogues of (8) d iffe r  
sim ilarly in th e ir antlhlstamlnlc potencies In the guinea pig Ileum 
assay (Nauta and Rekker, 1978). The ortho methyl analogue, 
orphenadrlne. Is only l/10th as active as (8) and Its  antipodes are 
equ1-act1ve ( i t  Is used as an anticholinergic agent).




and 1n this case 2-pyrldyl and 4-chlorophenyl are the two 
non-identical aryl groups.
Antipodal forms obtained by resolution with d and 1 ta r ta r ic  
acids di ffered s ign if icant ly  In a c t iv i ty  (Roszkowski and Govier, 
1959) -  as shown in Table 1.2.
Table 1.2 : Relative potencies of RS carblnoxamlne and the 
individual enantlomers
Relative Potencies
Isomer Test 1 Test 2
<-) 29 (ED5q 0.26yg/100ml) 34 (ED50 50vg/kg)
<♦) 1 1
<±> 15 19 (ED50 90vg/kg)
Footnotes for Table 1.2.
Test 1. Inhibition of supramaximal histamine > Induced 
contractions of guinea pig Ileum.
Test 2. Protection of guinea pigs against lethal 1.v.
histamine (3mg/kg) given 20 mlns a fte r 1.p. carblnoxamlne.
10
Barough et al (1971) showed the more active levo Isomer of (9) to have 
the S-conflguratlon and to be superlmposable on the more active dextro 
enantlomers of the phenlramlnes (17, 17b and 17c) (Shafl'ee and H ite , 
1969).
Doxylamlne (10) and mebrophenhydramlne (11) are chiral analogues of 
carblnoxamlne -  both having a methyl substituent on the benzyl1c carbon 
atom.
(10) (11)
Neither of these racemates have been reported to have been resolved. 
Doxylamlne Is used c lin ic a lly  as the racemate (HartIndale, 1982) but 
mebrophenydramlne was not marketed (Novak and Protlva, 1959) due to toxic 
side effects.
11
Clemastine (12) 1s similar 1n structure,to mebrophenhydramlne
(11 ), d ifferin g  only 1n the halogen substituent on the aromatic 
ring and also the amlnoalkyl side chain terminating 1n an 
a11cycl1c basic group.
( 12)
The compound (12) possesses two chiral centres -  one at the 
benzyllc carbon and the other at C-2 of the pyrrolidine ring. 
Clemastine, therefore exists 1n four optically active forms, a ll 
of which have been separated and tested for pharmacological 
a c tiv ity . The absolute configurations were
established by degradation to R and S l-methyl-2-pyrrol1d1noethanol 
and by X-ray analysis of the most active Isomer (Ebnother and 
Weber, 1976). The pharmacological data are given 1n Table 1.3.
12








Histamine Spasm3 pA2 4
RR (clemastine) 0.04 ca. *7 9.45
SS 5.0 ca. -1 .5 7.99
SR 11.0 ca. -6 8.57
RS 0.28 ca. +5 9.40
Footnotes:
1. Configuration of benzyl 1c centre followed by that of C-2 of 
the pyrrolidine ring.
2. Dose which protects 50% of a population of guinea pigs from
the lethal effects of a 20mg/kg s.c. dose of histamine given
3h a fter receipt of the test substance. Animals surviving 
12h were regarded as protected.
3. Potency re la tive  to that of the standard drug thenalldlne 
(*1) 1n the guinea pig Ileum tes t. Spasms Induced by
5 X 10“® g/ml histamine HC1 applied 5 m1n a fter addition of 
test substance.
4. Guinea pig Ileum data obtained by Nauta and Rekker, (1978).
13
From Table 1.3, I t  Is clear that the chiral centre at the 
benzyl 1c carbon Is of greater Importance with respect to 
pharmacological a c tiv ity  since the RR and RS Isomers are the most 
active. Many other pharmacological and c lin ica l studies of 
clemastine have been carried out but none of these provide 
comparative data upon Its  Isomers.
Several antlhlstamlnlc piperazines (cycllzlnes) possessing a 
chiral substituted benzyl 1c feature are known. (P'An et a l ,
These Include meclizine (13), bucllzlne (14), hydroxyzine (15) 
and ce tlr lz ln e  (16). Two compounds (13) and (14) are well known 
c lin ic a l agents but a l l  reports on these compounds relate to the 
racemlc mixtures only. C etlrlz lne (16) has recently been launched 
as a non-sedating antlhlstamlnlc agent .
1954).
R





1.3.3 3-Am1no-1-arvl-l-(2-pyr1dy1) orooanes (Phenlramlnes)
This group provides three compounds In c lin ica l use, 1e. 
phenlramlne Its e lf  (17), brompheniramine (17b) and 
chlorpheniramine (17c). The halogen derivatives are d is tin ctly  
more potent than phenlramlne I ts e l f .  The structural resemblence 
of the group to the ?-pyr1dy1 congeners of diphenhydramine (7) Is 
clear, and the compounds are also saturated analogues of 
tr lp ro lld ln e  (23) and related amino propenes.
Resolution of a l l  three compounds as dlastereomerlc salts of 
phenylsucclnlc acid has been reported (Patent, 1960). The patent 
claims that the (♦) isomers have enhanced antlhlstamlnlc ac tiv ity  
substantially free from untoward side effects - while the ( - )  
Isomers have local anaesthetic and psychotherapeutic uses.
X
X .  H (17)
X -  Br (17b)
X -  Cl (17c)
Several reports relate to the comparative pharmacology of (♦) 
and ( - )  chlorpheniramine (17c). An 1n v itro  study (Roth and 
Govler, 1958) showed the dextro Isomer to have an antlhlstamlnlc 
potency of approximately twice that of the racemate and 200 times 
that of the levo Isomer (guinea pig Ileum test, dose of maleate 
required to produce 50% Inhibition of muscle spasm Induced with 
histamine -  0.2yg/ml; (+) 0.8pg/ml; RS 1.7yg/l; ( - )  190yg/l).
In an 1n vivo test (protection against 1.v. or aerosolized 
histamine le th a H H ty ) the dextro Isomer had 2-3 times the potency 
of the racemate and 100 times that of the levo. The central 
nervous system effects of a ll  three forms of chlorpheniramine 1n 
mice and cats were sim ilar -  a l l  producing general stimulation 
while no signs of sedation were observed.
B rittain  et al (1959) found a more modest potency ratio  between 
chlorpheniramine enantlomers at guinea pig Ileum sites and 
reported pA2 values (+) 8.47, RS 8.10, ( - )  7.81 measured after  
a 2 minute contact time. More recent pA2 values of 
chlorpheniramine enantlomers determined at guinea pig Ileum sites 
are listed 1n Table 1.4 (Nauta and Rekker, 1978). These Indicate 
that the potency ra tio  of B ritta in  et a l,  (1959), 1s too low -  
possibly because of the contact time used.
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Table 1.4 : In Vitro pA^  values of chlorpheniramine 
Isomers obtained on guinea pig Ileum
Enantlomer pA2 1 pA2 2
(+) chlorpheniramine 9.3 9.3
(-*) chlorpheniramine 7.8 7.5
Footnotes:
1. Data from Jansenn Pharmaceutlca, 1n Rekker et a1f 1971 
and 1972.
2. Data from G1st-Brocades 1n Rekker et a l.  1971 and 1972.
Subsequently Roth (1961) provided data on the three forms of 
phenlramlne (17) and Its  bromo analogue (17b) (Table 1 .5 ).
Table 1.5 : In v itro  antlhlstamlnlc potency of RS, (+) and ( - )  










Phenlramlne (17) RS 9.0 1.0 7.8
(♦> 5.5 1.6 7.5 (7.96)
( - ) 170.0 0.05 6.0 (6.74)
Brompheniramine (17b) RS 1.4 1.0 -
(♦) 0.56 2.5 -
( - ) 88.0 0.016 -
In oral tests 1n guinea pigs the therapeutic Indexes 
(LD^/protectlve dose^) of the (♦ ) Isomers of (17c) and 
(17b) were about twice that of th e ir corresponding racemate and 
many times that of the levo isomer eg. chlorpheniramine, (17c),
RS 1430, (+) 3380, ( - )  25. Although c lin ica l use of the more 
potent phenlramlnes has not demonstrated a significant separation 
of sedative a c tiv ity  from an effective antlhlstamlnlc response -  
the reduced dose of these Isomers, re lative to the racemlc dose, 
results 1n a corresponding reduction of sedative slde-effects. 
Dexchlorphenlramlne and dextro-bromphen1ram1ne have both been 
marketed for c lin ic a l use 1n the USA.
The configuration of the dextrorotatory phenlramlnes has been 
shown to be S by chemical methods (Shafl'ee and H ite, 1969) and 
confirmed by X-ray crystallography (James and Williams, 1974).
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1.3.4 Phenoth1az1ne Derivatives
A number of antlhlstamlnlc agents have been discovered as a 
result of bridging the terminal d iaryl unit of phenbenzamlne (5) 
and diphenhydramine (7) across the ortho positions of the 
aromatic rings. The best known examples of antihistamines so 
derived are phenothlazlne derivatives (18), where the bridging
group 1s sulphur and the nitrogen of the ring system 1s
substituted with an alkylamlno chain (R) similar to that found 1n other
classes of antihistamines. Promethazine (18, R * CI^ CHMeNMe^ )
and Its  1-aza analogue 1soth1pendy1 (19) both contain a chiral side






Enantlomers of promethazine (18) have sim ilar antlhlstamlnlc 
and pharmacological properties (Toldy et a l ,  1959). Results with 
antipodes of Isothlpendyl produced unexpected results since both 
(+) and ( - )  forms were less potent than the racemate In an In 
vivo test. The levo Isomer, however, was about one half as 
potent as the dextro form (Table 1 .6 ). In the In v itro  Ileum 
te s t, the antipodal forms had sim ilar ac tiv itie s  that were 
marginally greater than that of the racemate.
Table 1.6 : Antlhlstamlnlc potencies of RS, (♦) and 
( - )  Isothlpendyl (19) In the guinea pig
Protective Relative In Vitro test
dose^ against 
l .v .  histamine3
Potency (Ileum)*1
Form No. of Effective conc.
Animals mg/kg (RS~1.0) 50yg/l
RS 30 0.86 (0.54-1.37) 1.0 0.76
29 0.90 (0 .5-1 .62) - -
(♦) 30 1.2 (0.81-1.77) 0.7 0.7
( - ) 29 2.3 (1 .15-4 .6 ) 0.37 0.68
Footnotes:
a. l.lmg/kg histamine 2HC1
b. Four tests carried out
95% confidence lim its  are given 1n parentheses
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I t  1s Important to note here that the chiral centres of these 
two phenothlazines are much further away from the aromatic 
centres than the chiral carbons In the diphenhydramines or 
phenlramlnes. This factor appears to be very Important for 
receptor sensitiv ity  to ligand stereochemistry. The results 
quoted previously (Table 1.3) for clemastine (12) support this  
view.
1.3.5 Indene Derivatives
There are two Indene derivatives that are Important as 
ant1h1stam1n1cs 1e. dlmethlndene (20) and phenlndamlne (21 ). The
f ir s t  of these, dlmethlndene (20) has been resolved as the
tartra te  salts and the pharmacological ac tiv ity  found to be 
greatest 1n the levo 1somert which 1s about four times more




Borchard et al (1985) obtained the following data from Isolated
o
guinea pig organs, suspended 1n an organ bath at 31 C (Table
1.7).
Table 1.7 : In v itro  antlhlstamlnlc potencies of the 






(♦ > /( - )  
Potency ratio
Left atr1ab 9.4 6.3 1600
Trachea 9.3 7.0 200
Aorta 9.9 7.3 400
Ileum 9.1 7.8 20
Footnotes:
a. Preparations stimulated with histamine or
2-pyr1dylethylam1ne (trachea only),
b. E lec trica lly  driven at 1 Hz.
A 90 minute washout of levo dlmethlndene led to a small 
reduction In receptor blockade 1n the Ileum and aorta whereas 
there was nearly no change 1n the le f t  a tria  and trachea. The 
antagonistic action of the dextro Isomer was almost completely 
reversed In the aorta and Ileum by the same treatment, but only 
to a small extent 1n the le f t  a tria  and trachea. Amongst these 
tissues, Ileum sites appear to be the least stereoselective 
(d iffe rin g  equilibrium rates may contribute, however, to 
variations 1n the antipodal potency ratios).
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Although the second chiral Indene derivative phenindamlne (21) 
Is used c lin ica lly  as the ta rtra te  sa lt (Theohorlnl. the material 
1s a dlastereomerlc mixture (60:40 approx) (Kern, private comm.) 





The freshly synthesized base 1s a mixture of 4a-9a (21a) and 
9a-9-ene (21b) positional Isomers from which the more active 
4a-9a>ene may be separated as a ta rtra te  salt (most other salts  
are 9-9a enes). These structural relationships have been 
established by high fie ld  NNR ( ' h, 13C) Investigation 
(Hussain, 1987; Branch et a l,  1988).
Dihydroanalogues of phenindamlne are less active than the 
parent and the more potent of the two reported probably has the 





1.4 Geometrically Isomeric Antlhlstamlnlc Agents
1.4.1 1.1-01a ry1-3-Amino-orooenes
Antlhlstamlnlc agents of this type are used c lin ic a lly  as 
single Isomeric forms. Since geometrical Isomers usually d iffe r  
1n th e ir physical properties they may be separated re la tive ly  
easily without the need for use of chiral agents.
The best known amlnopropene 1s tr1pro11dine (23), 
E -l-(2 -pyr1dy l)-3 -(l-pyrro l1d1no)-l-(4 -to ly l)p rop-l-ene (Adamson 
et a l ,  1951 and 1957).
Me
No c lin ica l comparisons of trip ro lid ln e  (23) and Its  
corresponding Z-1somer appear to have been carried out; this 1s 
not surprising 1n view of the large potency difference between 
the two Isomers found 1n animal tests.
E/Z pairs of these compounds may be separated from binary 
mixtures by fractional crysta lliza tion  of hydrogen oxalate or 
hydrochloride salts. I t  was later found that the ratio  of 
Isomeric propenes was dependent on their equilibration rates. In 
the case of the trip ro lid ln e  pair, equilibration in acid yields 
the desired E-1somer almost exclusively (Ison and Casy, 1971).
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Adamson et al (1951) reported differences in antihistaminic 
a c tiv ity  for geometrical isomers but specific examples were 
lim ited to the 4-chloro analogue (24) and its  isomer.
Cl
In the usual guinea pig ileum test the E isomer was 80 times 
more active than the Z form. Further pharmacological studies 
(Ison et a l ,  1973) confirmed the high ac tiv ity  of trip ro lid ine  
(23) (log K. 9.95) and the superiority of E over the
D
corresponding 2 isomer as antihistaminic agents. In four such 
pairs the E-isomer had about 10 times the a ffin ity  of its  Z 
partner for histamine sites (Table 1 .8 ).
(24)
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Table 1.8 : Comparative a ff in it ie s  of 3-am1noprop-l-ene Isomers
C=CHCH2X
R ' /
R R1 X a log Kb Ratio of
a f f in it ie s
(E/Z)
2-pyr1dyl B-tolyl NC4H8 3.07 1170 (23)a
2-pyr1dyl phenyl NC4H8 0.97 9.3
2-pyr1dyl 2-C1.C H 6 4 NC4H8 0.83 6.8a (24)
2-pyr1dyl phenyl NMe2 1.2 16
phenyl fi-Cl.C H 6 4 nc4h8 1.1 13
Footnote:
a. E arlier potency ratio  quoted as 80 (Adamson et a l, 1951).
The a f f in ity  ratio  for trip ro lid lne  and Its  Isomer (1170) 
was remarkably higher than those of other pairs.
Taking the diphenyl compound (25) as the standard 1t 1s seen 
(Scheme 1) that replacement of phenyl by 2-pyr1dyl raises the 
a ff in ity  constant when E-to-the pyrrolldlno group but lowers 1t 
when Z to the same group. In contrast, the effect of 
substitution of phenyl by £ -to ly l are opposite; 1n the position 
trans to the pyrrolldlno group 1t reduces ac tiv ity  and 1n the cjj. 





















Scheme 1: Log values for tripro lid lne and Its  analogues 
(Ison et a l, 1973)
In the case of phenyl and p-chlorophenyl the effects are much 
less.
One of the causes of the large a ff in ity  ratio  observed for 
tr ip ro lid ln e  (23) and Its  Z-1somer must therefore be due to the 
combination of both 2-pyr1dyl and j)-to ly l groups being 1n 
favourable positions relative to the amino group 1n the active 
E-1somer and unfavourable positions 1s the less active Z compound.
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This view that a coplanar aromatic-double bond system In 1,1, 
diaryl-3-am1nopropenes Is Important for antlhlstamlnlc a c tiv ity  
(Casy and Ison, 1970) was supported by the fact that a 2-methyl 
analogue (26) of trip ro lid lne  (23) In which a coplanar 
conformation, as described previously. Is unfavoured, has a very 
low a f f in ity  for histamine H. receptors (Ison et a l,  1973).
Zlmeldlne (27) and Its  corresponding E-Isomer are 3-pyrldyl 
analogues of tr ip ro lid ln e . Stereoselectivity for the histamine 
receptor 1s unaltered by this variation, the E Isomer of (27) 1s 
11 times more potent than zlmeldlne at guinea pig Ileum sites 
(th is  Isomer Is , however, a re la tive ly  feeble antlhlstamlnlc -  15 
to 20 times less active than brompheniramine). Zlmeldlne (27) Is 





The c lin ic a lly  Important member of this group 1s pyrrobutamlne 
(28) diphosphate, which 1s one of the four dehydration products 
produced from the te rtia ry  alcohol (29).
A problem arises with respect to the structure of butenes
derived from this alcohol (29) -  since 1t may lose water 1n
either two directions giving but-1-ene or but-2-ene mixtures,
each of which may exist as an E/Z mixture.
The position of the double bond and the configuration of
pyrrobutamlne remained doubtful for some years. The accurate
characterization was made possible by the application of
*H-NMR and UV spectroscopy (Casy and Ison, 1970) and
established 1t as E-but-2-ene (28). Pyrrobutamlne (28)
dlsphcsphate 1s one of the most potent antihistamines known (log
Kb 10.34 at equilibrium guinea pig Ileum sites) and
significantly  more active than Its Z-but-2-ene and but-1-ene
analogjes (Ison et a l ,  1973). The but-1-enes are s t i l l ,  however,
reasonably potent antlhlstamlnlc agents with log It values ofb
8.12 (£) and 8.65 (Z Isomer).
(28) (29)
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The pyrrolldlno basic group of pyrrobutamlne and its  isomers 
makes an Important contribution to the potency as shown 1n 
Table 1.9 (Ison et a1t 1973) as compared with the previously 
discussed propenes.
Table 1.9 : Potency data for some analogues of pyrobutamlne








Potency data on a variety of but-2-enes (related to (28)) and 
but-1-enes confirm once again the superiority of the E-1somer 
geometry 1n blocking histamine receptor sites of the guinea pig 











1.5 Sedation and Antihistamines (Reinhardt and Borchard, 1982; 
Nicholson, 1983; Levander et a l,  1985)
Sedation Is the most prominent side effect of antihistamines, 
although the extent may vary from patient to patient as much as 
with drug to drug. The question of mechanism and especially 
whether these side effects are due to blockade of histamine 
receptors In the central nervous system Is s t i l l  unclear. Uzan 
et al (1979) reported that mequltazlne (a phenothlazlne 
derivative with a low level of side effects) showed less binding 
for central H1 receptors and therefore suggested that the 
sedative effects of antihistamines may be associated with 
receptor blockade
The majority of 'o lder' H1 receptor antagonists appear to 
display sedative effects because of their a b ility  to cross the 
blood-braln barrier. Two recently Introduced antihistamines I.e .  
terfenadine and astemlzole appear to be non-sedating (Nicholson 
and Stone, 1982) due to th e ir reduced a b ility  to cross the 
blood-braln barrier.
There have been many studies to assess the sedative effects of 
a number of antihistamines In humans. The method Involves 
comparison of a placebo with at least two antlhlstamlnlc agents 
e.g. terfenadine /  chlorpheniramine (Kulrestha et a l,  1978); 
brompheniramine /  tr ip ro lid ln e  (Nicholson, 1979); tr ip ro lid ln e  /  
clemastine (Peck et a l ,  1978); hydroxyzine /  clemastine /  
azatadlne (Levander et a l ,  1985). Assessment of the side effects  
Involves a number of performance tests and evaluation of 
subjective drowsiness. The reported data clearly Indicates the
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drug to drug variation of re lative hlstanlnlc blockade and 
sedation a c tiv it ie s .
A reduction of these drug related sedative effects has already 
been achieved by chemical modification of the antagonist 
structure I .e .  terfenadine, astemlzole and ce tlrlz lne . The 
reduced a b ility  to cross the blood-braln barrier Is due to 
metabolic changes 1n their structure (e .g . formation of COOH 
group) rendering them more hydrophilic. In the case of racemlc 
antihistamines I t  may be possible that administration of one 
enantlomer may combine active antlhlstamlnerglc properties with 
the absence of sedation. On the other hand, the active 
antagonistic enantlomer may also Induce sedation while the less 
active enantlomer does not. A result of this kind would lend 
support to the view that sedation 1s linked to histamine 
stimulation of central receptors. A study of this kind,
1n which Individual Isomers of enantiomeric pairs w ill be 
administered 1n an In vivo study and any central sedative effects  
quantified, form one of the alms of this thesis.
1.6 Aims and Objectives of the Work
The alms and objectives of this work are to re-evaluate and 
extend the knowledge of potency differences between Isomeric 
pairs of Hj antlhlstamlnlc agents with special reference to 
the following points:
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-  The study of differences In pharmacological potency of 
enantiomeric pairs at both central and peripheral receptor 
sites by In vitro  (guinea pig Ileum assay and binding 
studies) and In vivo methods (In  animals and possibly 
humans).
-  The absolute configurational requirements of 
^antagonists at the receptor s ite , correlating the data 
for existing compounds and also evaluating data of novel 
cases.
-  To study semi-rigid antihistamines of the amlnopropene 
type (e .g . tr ip ro lid ln e ). To Identify configurational 
requirements and correlate these with the phenlramlnes and 
related chiral agents e.g diphenhydramines. To attempt 
additional S.A.R. studies by the sythesls of novel 
amlno-propene type antihistamines with d ifferin g  pyrldyl 
substituents e.g. replacing the 2-pyr1dyl with 3- or 
4-pyrldyl and/or varying the aryl substituent.
In order to carry out this work I t  was necessary to resolve a 
variety of chiral antihistamines on a scale that provided enough 
material for a range of pharmacological assays Including binding 
studies and 1n vivo work. In previous work on Isomers of this 
kind no special attempts were made to establish the Isomeric 
purity of the materials examined. I t  was Important, therefore, 
to f ir s t ly  examine c r it ic a lly  the method usually employed for the 
assessment of optical purity I .e .  optical rotation. Since this 
method Is not an 'absolute* method I t  led to the study of chiral 
analysis by NNR and HPLC.
Chapter 2
Chiral Resolution by Fractional Crysta111zat1
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2.1 Introduction
A chiral molecule 1s one which contains an element of 
dissymmetry such that the molecule may exist 1n two forms related 
as object to mirror Image. A commonly encountered dissymmetric 
element 1s an asymmetric carbon atom I .e .  a carbon atom with four 
d ifferen t substituents attached (F1g 2 .1 ).
I .e .  Ax
F1g 2.1
A chiral molecule exists 1n two forms which bear an 
object-mlrror Image relationship and are termed enantlomers, 
enantlomorphs or optical antipodes. These Isomers are optically  
active 1n the sense that when a beam of plane-polarized light 
passes through a solution of one enantlomer, the plane of 
polarization 1s rotated. Moreover, separate enantlomers rotate the 
plane of plane-polarized light 1n equal amounts but 1n opposite 
directions.
The number of degrees that the plane of polarization 1s rotated 
as 1t passes through a solution of an enantlomer depends on the 
number of chiral molecules that 1t encounters. This depends on the 
length of the polarlmeter tube and the concentration of the 
enantlomer.
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Specific rotation [a] Is defined as the rotation produced by 1 g 
of substance 1n 1 ml of liquid In a 1 da polarlmeter tube.
Thus [a] * 100a
c . l .
[a] * specific rotation
a * observed rotation
c = sample concentration (In  g/100 ml)
1 * polarlmeter cell-length 1n decimetres
The specific rotation depends on:
( I )  the temperature
( I I )  the wavelength of the plane-polarized light
( I I I )  the solvent
(1v) the concentration.
Specific rotations are therefore reported to Include these 
particulars.
Hence to ]®  -  ♦ 33.7* (c. 1.0, NeOH) 
means using the sodium D-11ne ( \  * 589 nm), at a temperature of 
25°C, the specific rotation of a sample containing 1 g per 100 ml 
of the optically active substance dissolved In methanol, In a 
sample tube of 1 decimetre length, produces a rotation of 33.7* 1n 
a clockwise direction.
The value of the observed rotation 1s measured with a 
polarlmeter. This consists of a lig h t source (h is to rica lly  a 
sodium lamp), a polarizing (Nlcol) prism, a sample tube, an 
analyser prism with a circular scale and a detector (usually the 
eye). In principle the measurements can be made by f ir s t  adjusting 
the two prisms to a crossed position to yield a minimum light 
Intensity 1n the presence of pure solvent.
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With an optically active sample 1n place, rotation of the beam 
causes an Increase in lig h t intensity which can be offset by 
rotation of the analyser prism. This angular change necessary to 
minimize the intensity again, corresponds to the rotatory power of 
the sample. Unfortunately the position of minimum intensity cannot 
be determined accurately with the eye and so polarimeters are 
equipped with a half-shadow device. This consists of a small Nicol 
prism that intercepts half of the beam emerging from the 
polarizer. Thus in the presence of pure solvent, with this Nicol 
prism at 90° with respect to the polarizer, a s p lit  light/dark  
fie ld  is observed. The lig h t prism corresponds to that half of the 
beam that has been rotated by the small prism and the dark part 
corresponds to the unobstructed beam. In the presence of an 
optically active sample the analyser is rotated until the same 
balance is obtained, so that the two halves of the fie ld  are 
equally illuminated. A clockwise rotation corresponds to a 
dextrorotatory substance (a is positive) and an anti-clockwise 
rotation to a laevorotatory substance (a is negative).
The polarlmeter used in the following experiments was an Optical 
Activity AA-10 polarlmeter. Although the principle is the same as 
that employed in visually-balanced polarimeters, there are a number 
of factors which make this instrument especially useful and easy to 
use.
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This polarlmeter has a d ig ita l display which gives sample 
rotation d irectly in degrees. I t  also has a fan-cooled mercury arc 
lamp, (instead of a sodium lamp) coupled to a series of five  
interference f i l te rs  mounted on a tu rret with means for wavelength 
't i l t - tu n in g '.  The light from the mercury arc is projected into 
the polarlmeter where an adjustable plane mirror brings the beam 
into alignment with the optical path.
The five f i l te rs  enable a values to be recorded at 589, 578,
546, 436 and 365 nm. The use of five  wavelength measurements and 
not just one (589 nm) increases the va lid ity  of the results and 
enables greater scope for reproducibility. In general, the extent 
of rotation increases as the wavelength of observation decreases, 
hence sensitiv ity 1s enhanced by having access to wavelengths 
shorter than 589 nm.
Although specific rotational values aid the monitoring of 
resolution of chiral compounds i t  is not an absolute indication of 
optical purity. For instance, i f  (+)A is contaminated with a 
certain proportion of (-)A  and vice versa, the rotation values w ill 
be identical except for sign. I f  recrystallization does not a lte r  
this proportion, one might assume two pure enantiomers are 
present. I t  is important, therefore, to develop methods where the 
proportions of each enantiomer can be visualised (Chapter 3 ).
Since the physical properties of enantiomers are identical, they 
cannot be separated by commonly employed methods e.g. not by 
fractional d is t illa t io n , because their boiling points are 
identical, not by fractional crys ta lliza tio n , because their 
so lub ilities  in a given solvent are identical (unless the solvent 
is optically active), not by chromatography, because they are held 
equally strongly on a given adsorbent (unless i t  is optically  
active).
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The resolution of a racemlc compound therefore requires a 
special kind of approach.
The most widely used method Is conversion of a racenlc mixture, 
by an optically  active reagent. Into a mixture of dlastereomers 
which can, 1n principle, be separated because antipodal 
relationships no longer hold.
For example, a racemlc base (±)B can be converted Into a 
dlastereomerlc mixture of salts , [(-)BH* (-)A~] and 
[(♦)BH+ (-)A ~ ], using enantlomerlcally pure acid (-)HA. These 
dlastereomerlc salts have non-1dent1cal physical properties 
Including so lu b ilities  1n a given solvent. They can therefore be 
separated by fractional crys ta lliza tio n . Once the two salts are 
separated, optically  active base can be recovered from each salt by 
the addition of a stronger base (assuming there 1s no danger of 
racemlzatlon).
Naturally occurring optically active amine alkaloids such as 
(-)-qu ln ln e , (-)-strychnlne and (-)-bruclne are often employed as 
resolving agents for racemlc acids using the same method as 
mentioned above.
Examples of the acids used for resolving racemlc bases, such as 
those used 1n this work Include (+)-L-natural or (-)-D-unnatural 
ta rta ric  acids and their derivatives.
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The assignment of the configuration of (+)tartar1c acid (natural 
ta rta ric  acid) has h isto rica lly  met with d iff ic u lt ie s , because this 
add has two asymmetric carbon centres. Prior to 1951, 1t was 
necessary to assign an arbitrary configuration to a molecule 
correlating 1t to another similar structure. In many cases 
(t)-glyceraldehyde was the compound of comparison, this a rb itra r ily  
being assigned the D- configuration.
F1g 2.2 Fischer projection of (*)-glyceraldehyde.
In the case of ta rta ric  ad d , having two asymmetric centres, 1t 
1s d if f ic u lt  to decide whether the natural (+)tartar1c acid should 
be assigned the L-conflguratlon using the bottom asymmetric carbon 









F1g 2.3 (*)Tartar1c Add
39
In 1951, Bijvoet et al (Bijvoet et a l,  1951) successfully 
analysed the sodium rubidium salt of natural ta rta ric  acid by X-ray 
crystallography to show i t  as the (.-configuration i .e .  the hydroxyl 
group is on the le f t  hand side of the lower asymmetric carbon atom.
CO3Rb
CO3Na
F1g 2.4 Sodium rubidium sa lt of (+)tartar1c *c1d
Tartaric acid is a clear example where an unambiguous system for 
the specification of absolute configuration is necessary. In 1956, 
Cahn, Ingold and Prelog (Cahn, Ingold and Prelog, 1956) proposed 
such a system. Taking each asymmetric centre in turn, the four 
groups attached to the asymmetric carbon are arranged in a p rio rity  
sequence, based on decreasing atomic number and other c r ite r ia .
The molecule is then viewed with the group of lowest priority  
pointing away from the viewer. I f  the remaining three groups trace 
a clockwise p rio rity  order, the configuration about that carbon is 






R1 H ------- OH•1






For the ta rtar ic  acid salt ( F1g 2.5) ,  looking at the lower 
asymmetric carbon, the pr iori ty  order, with the hydrogen atom 
pointing away, w i l l  be OH> C02Na > R' I . e .  R configuration. 
Similarly at the second asymmetric centre, the same pattern 1s 
observed I . e .  the R configuration. Therefore a non-amb1guous way 
to describe the configuration of L - ( ♦ ) tartaric  acid 1s 
R,R,(* )tartar1c add.
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2. Results and Discussion
2.2 Chlorpheniramine
The resolution of chlorpheniramine (17c) was f ir s t  reported by 
Roth & Govler (1958.) using phenylsucdnic acids as the resolving 
agents. The details (Scherlco Patent, 1960) of the resolution 
Involved the use of a molar equivalent of RS base and either (+) or 
( - )  phenylsucdnic add dissolved 1n ethanol. Resolution of 
phenylsucdnic add (Wren and Williams, 1916) by fractional 
crysta lliza tion  of the brucine salts from ethanollc solution was 
therefore undertaken, the (-)b rudne salt of the (+)ac1d being the 
more sparingly soluble. After many weeks of purification, small 
samples of each of the antipodal phenylsucdnic adds were obtained 
(2 .7 .5 ).
Trials of the resolution of chlorpheniramine using the (♦) and 
(-)phenylsucdnlc add proved unsatisfactory. After six months an 
o il but no crystalline solid had formed. Use of another optically  
active acid was deemed necessary.
References to the use of four other adds 1n the resolution of 
chlorpheniramine were found. These Included tartran111c add  
(Yosh1tom1, 1975), p-n1tro-tartranH1c add (Kongo Yakukln, 1976), 
N-tosylaspart1c add (Yosh1tom1, 1973) and D1-p-toluoyltartar1c 
add (abbreviated to d1-f>TTA) (Hunt, 1961). For the f ir s t  three 
adds lis ted  above, no details were available and thus d1-j>TTA was 
the next t r ia l  add to be employed.
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B ritta in , O'Arcy and Hunt (1959) reported the resolution of 
chlorpheniramine using d1-pTTA 1n ethanol but stated that only 
afte r 1 year was any crysta llization  seen. Our attempts using RS 
chlorphen1ram1ne:d1-i>TTA (1:1 ra tio ) yielded only a green o i l .
Hunt (1961), reported an Improvement of this method "by the 
substitution of HC1 for half an equivalent of the active acid*. In 
this way an equilibrium was established between the salts of RS 
base(B) -  HC1 and (+) or (-)base with the d1-pTTA. When the less 
soluble dlastereomerlc salt crysta llizes this shifts the 
equilibrium to the right, thus Increasing the formation of the 
d1-|>-toluoyltartrate sa lt.




Communication with Dr Hunt (now sadly deceased) Indicated an 18 
month time lag was necessary before any crystallization occurred. 
Fortunately some seed crystals were available and kindly donated, 
and th e ir use successfully Induced the f i r s t  crystallization  which 
was complete within one month.
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In it ia l ly  the two enantiomers of chlorpheniramine were obtained 
by treating RS chlorpheniramine with either (♦) or (-)d1-j>TTA.
Since, however, the laevorotatory d1-&-to1uoy1 derivative of 
natural L -(*)ta rta r1c  acid Is more readily available (and less 
expensive) further resolutions Involved recovery of the (-)base 
from the mother liquors of the reaction of RS chlorpheniramine and 
(-)d1-|>TTA, these being enriched In the (-)lsomer of 
chlorpheniramine. The ( - ) Isomer was then treated with the 
dextrorotatory dl-gTTA, obtained from unnatural D -(-)-ta rta r1 c  acid. 
RecrystalHzatIon of both of these dlastereomerlc salts was 
continued until a constant rotation value was obtained and by 
comparison to lite ra tu re  values (Hunt, 1961). The salt obtained 
using (-)d1-j>TTA had an overall (-)ro ta tlo n  ([<*]^ -  60.7,
c. 1.19, 95% EtOH) which on baslflcatlon gave (+)chlorphen1ram1ne 
base ( [ « ]»  ♦ 25.6, c. 1.44, 95% EtOH).
The two antipodal bases of chlorpheniramine were converted to
th e ir  maleate salts for pharmacological testing (Chapter 6 ). The
malelc acid had no effect on the sign of rotation I .e .
(+)ch1orphen1ram1ne base as a maleate salt carried a (+ )rotation In
water and DHF ([<»]“  ♦ 23.3, c. 1 .2, H O 
25and [a ]Q ♦ 41.1, c. 1 .0 , DMF). Comparison of these maleate 
rotation results to the lite ra tu re  Indicates a good correlation  




The resolution of dimethindene (20) had been reported (Huebner, 
et a l,  1960) using ta rta ric  acid as the resolving agent, but no 
details were Included. Our attempts using a molar equivalent of 
ta rta ric  acid to dimethindene base 1 n ethanollc solution led to 
crystalline salts and the f i r s t  recrystalHzatlon was complete 1n 
24 hours. After four such recrystal11zat1ons from absolute ethanol 
a constant rotation value had been reached. These dlastereomerlc 
salts were suitable for pharmacological testing since the ta rtra te  
anion 1s In ert 1n this sense (Chapter 6 ) .
Again 1t was the (-)base that gave the less soluble 
dlastereomerlc sa lt with the (+)ac1 d -  although 1 n this case the 
salt had an overall (-)ro ta tlo n  ([o]q -  146.1, c. 1.07, 
methanol). The derived o ily  base had a high negative rotation 
( [a ]^  -  144, c. 1.01, methanol) suffic ient to counteract 
the positive contribution from the L -(+ )-ta rta r 1 c add  
([<*]^ ♦ 1 2 . 0 , c. 2 0 , water).
Conversion of this salt to Its  maleate derivative followed, for 
direct comparison with the marketed racemlc maleate (Fenostll,Zyma). 
The sa lt of (-)-dlmethlndene and malelc add , as expected had a 
(-)ro ta tlo n , although higher than that of the original (-)base. 
([ajp 4  -  206.6, c. 1.00, methanol). Similarly 
(+)d1 meth1 ndene maleate had a rotation value of the same order 
I .e .  [a ]^  ♦ 197.8 (c . 1.02, methanol).
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2.4 Carbinoxamine
Resolution of carbinoxamine (9) has been reported without
details (Roszkowskl and Gov1erf 1959) using ta rta ric  acid as the
resolving agent 1n ethanol1c solution. After six months of tr ia ls
at Bath, using a variety of solvent mixtures e.g. methanol,
ethanol, ethanol/ethyl acetate -  only o ily  residues formed. Some
seed crystals were then obtained from McNeill Laboratories.
Seeding an absolute ethanol mixture of L(+)-tartar1c acid and RS
carbinoxamine base, with carb1noxam1ne-L-tartrate and leaving at
room temperature for two weeks successfully Induced
crysta llization . Collection and recrystalHzatlon followed to
yield the dlastereomerlc sa lts . Again the least soluble sa lt was
that of (-)base (+)ac1d. The resolved carbinoxamine bases have
very small rotation values I .e .  [<*]^ ♦ 6  and - 8
respectively and therefore their ta rtra te  salts take on the sign of
the add used I .e .  the salt of (-)carblnoxamlne and (+ )ta r ta r 1 c
add had a constant rotation [a]p + 45.8 (c. 1.07, HeOH),
the other salt having an [ * ] ^  -  46.0 (c. 1.00, MeOH).
Carbinoxamine does not follow the same pattern as the two
previous examples a fte r conversion to the maleate. When the
maleate salt of carbinoxamine was made the sign of rotation was
opposite that of the base used. Thus the maleate s a lt, formed
25from (-)carblnoxamlne base, [a ]D -  8.0 (c . 0.96, absolute
2c
ethanol) and malelc acid, had a rotation [a ]Q + 40.8
25
(c. 1.01, MeOH). S im ilarly (+)carb1noxam1ne base, [a]p ♦
25
6.0 (c . 1.00, abs EtOH) formed a maleate salt with [a ] .  -  
47.8 (c . 0.98 in HeOH).
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Although the maleates were found to d iffe r  in the magnitude of 
their rotation [«]q + 40.8 and -  47.8 (1n methanol) 
respectively, such a difference was not seen 1 n the ta rtra te  salts, 
these two salts having similar magnitudes of constant rotation 1 n 
methanol of ♦ 45.8 and - 46.0 respectively. I t  1s unlikely that 
any racemlzatlon has occurred during the transfer of ta rtra te  to 
maleate s a lt. Another possible explanation was the association of 
differing  quantities of solvent of c rys ta lliza tio n  with the two 
dlastereomerlc salts. This possib ility  was eliminated by 
ra1 cro-ana1 ys1 s results which show no solvent of crystallization to 
be present (2 .7 .3 ).
I t  would appear, therefore, that the difference 1n magnitude of 
the two maleate dlastereomers 1s due to the malelc acid. The 
rotation value of another salt was necessary for comparison. The 
new salt chosen was that of a hydrochloride. Addition of a few 
drops of N-HC1 to a polarlmeter ce ll containing the respective 
maleate s a lt, changed the rotation dramatically.
N HC1
I 0




[a ] 2 5  Carbinoxamine Maleate
nm (♦) Base ( - )  Base
HeOH MeOH + HC1 MeOH MeOH + HC1
589 -  47.8 -  135.2 + 40.8 ♦ 130.2
578 -  48.8 -  140.2 ♦ 44.7 ♦ 138.2
546 -  56.9 -  163.6 ♦ 49.7 + 160.0
436 -  1 0 2 . 6 -  320.1 ♦ 97.4 ♦ 314.1
365 -  189.0 - ♦ 182.0 -
Table 2.1 The change 1n rotation of carbinoxamine maleates on 
addition of n HC1.
Changing the sa1tf from maleate to hydrochloride has a drastic 
effect on the rotation. As hydrochlorides the differences 1n the 
rotations was only = 3% whereas as maleates a 14% difference 1n the 
two values was seen. This suggests that the maleate counter 1on 
d iffe re n tia lly  Influences the rotational magnitudes of the 
optically active ( - )  and (+) cations. A similar phenomenon was 
observed 1n regard to the 'h NHR features of the maleate salt 




The resolution of mebrophenhydramine (11) has not previously 
been reported. Trials using tartaric  acid, d1-j>TTA, 
d-1 0 -camphorsulphonic acid, as 1 : 1  molar equivalents were therefore 
carried out. Only an o ily  product was formed with ta rta ric  acid 
(95% EtOH) and di-gTTA (95% EtOH) and there was no success either 
with d-10 CSA (95% EtOH). The use of di-|>TTA (abs EtOH) proved 
more successful and a fter four weeks at room temperature the 
crystals which formed were collected.
The crystals collected from reaction of RS base with (-)di-|>TTA, 
having an overall (-)ro ta tio n  [<*]^ -  89.4 (c . 0.928, HeOH) 
were in fact the salt formed between (-)mebrophenhydramine base 
[o]“  -  32.1 (c . 5.02, HeOH) and (-)d1-&TTA -  the opposite 
of the three previous examples. Recovery of the (+)ant1pode 
enriched base from the mother liquors was followed by formation of 
(*)d1-i>-toluoyl ta rtra te  [<*]^ ♦ 91.2 (c . 0.95, HeOH). As 
no lite ra tu re  values were available i t  was essential to ensure 
constant rotation had been reached.
Formation of the maleate sa lt, highlighted the effect of the 
maleate counter ion, on this type of structure. Again the two 
maleates had very d ifferen t [a] values. The salt of 
(-)mebrophenhydramine and maleic add had a rotation value of 
[a ]^  -  20.9 (c . 1.00, HeOH) and sim ilarly the maleate salt
25
of the (+)base bad a rotation value of [a ]D ♦ 5.06 (c. 1.0,
HeOH).
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In this case the difference 1s even more pronounced than that 
seen for the antipodal maleates of carbinoxamine. As d1-j>TTA salts 
the rotation for the two dlastereomers are closely comparable, 
results which suggest that resolution 1s complete. As maleates, 
however, one would question that the two salts are fu lly  resolved. 
As 1n the case of carbinoxamine racemlzatlon or the presence of 
solvent of crystallization (from m1cro-analys1s results -  2 .7 .4 ) 
can be eliminated as an explanation for this phenomenon.
Again, addition of N-HC1, to the respective maleates, to form 
hydrochlorides, alters the rotation although not as much as 1 n the 
previous case.
[a ] 2 5  mebrophenhydramlne maleate
(nm)
(♦)base
MeOH MeOH ♦ HC1
589 ♦ 5.06 ♦ 8 . 1 0
578 ♦ 7.08 ♦ 9.11
546 ♦ 8 . 1 0 ♦1 0 . 1 2
436 ♦18.22 ♦19.23
365 ♦30.36 -
These results emphasize the need for measurement of optical 
purity by absolute methods, which are less ambiguous and more 
re liab le  -  see later discussions using circular dlchrolsm (CD), 
HPLC and ’h NHR.
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Other attempted resolutions included that of RS doxylamine with 
d-10 CSA (EtOH, MeOH) and d1-fcTTA (Et0H) but no crystalline solid 
formed.
In addition, the resolution of meclozlne and hydroxyzine was 
undertaken. These compounds, having two basic nitrogens, required 
a 1:2 molar ra tio  of base:ac1d. Trials using d-j>TTA (EtOH), d-10 
CSA (EtOH) and ta rta r ic  acid (95% EtOH, abs EtOH) were set up. 
After 12 months a crysta lline  solid began to form with ta rta ric  
acid (abs EtOH). This was collected but unfortunately there was 
Insuffic ient time for further recrystallizations to be completed.
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2.6 Circular D1chro1sm (CD)
2.6.1 Introduction
Circular dlchrolsm (CD), lik e  optical rotary dispersion (0RD)v 
1s an aspect of the feature of optical ac tiv ity  known as the Cotton 
e ffe c t. I t  1s a consequence of the fact that when a beam of plane 
polarized lig h t (PPL) Is passed through a solution of an optically  
active substance which also exhibits specific absorption. In the 
region of the absorption band the two circular polarized beams.
Into which the Incident plane polarized beam Is s p lit , are absorbed 
to d ifferen t extents. This gives rise to a rotated e ll lp t lc a lly  
polarized beam, the origin of which 1 s readily visualized 1 n 
F1 g. 2 . 6 .
Plane polarized light may be regarded as made up of right and 
le f t  handed c ircu larly  polarized lig h t. The two components travel 
through an optically active medium at d ifferent speeds (producing 
rotation of the plane of polarized lig h t) and suffer d ifferent 
degrees of absorption 1 f the medium Includes an appropriate 
chromophore. The rotation a 1s the angle between the major axis of 
the e llipse and the plane of the Incident beam. The e lU p tlc lty  1s 
defined as the angle ( ^ )  whose tangent 1 s given by the ratio  of 
minor and major axes. CD 1s the result of this d iffe ren tia l 
absorption and can be measured 1 n terms either of the absorption 
difference or e lU p tlc lty  to which 1t gives r1se.(Crabbe, 1965 ; 
Drake, 19861 ; Velluz et a l, 1965). H istorically CD was 
detected through this change 1 n polarisation (linear to e l l ip t ic a l) .
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F1g 2.6 Basis of e l l ip t ic a l  polarization and circular dlchrolsm 
Plane of Incident polarization 1s rotated to the right or le f t  
according to whether the le f t  circular vector rotates slower or 
faster than the right circular vector. I f  there 1s d iffe ren tia l  
absorption of the two beams then the resultant amplitude vector 
w il l  trace out an e ll ipse .
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Modern Instrumentation however Is able to effectively generate 
Individual alternate pulses of le f t  and right c ircu larly polarized 
light using an electro-optic modulator. The polarisation modulated 
light beam passing through an optically active solution In the 
region of an absorption band fa lls  onto a photomultiplier where I t  
generates an out-of-balance signal that can be used to provide an 
accurate measure of d iffe ren tia l absorption ( A c ) .
CO spectra are presented as plots of wavelength against Ac where 
Ac 1s the d iffe re n tia l molar absorptivity of le f t  and right 
c ircu larly  polarized lig h t,
I .e .  Ac = (c l-cr) = ( A l - A r )  c . 1.
Ac 1s related to the molar e lU p tlc lty  ( ^ )  (the traditional 
unit) and Is e ither positive or negative. When positive I .e .
A^  > Ar  1t gives rise to a Cotton Effect band of positive
sign and vice versa. The special stereochemical value of CO spectra
rests on the fact that the sign of the CD band 1s related to the
absolute configuration of a chiral centre close to the UV
chromophore.
Thus a group of optical antipodes of related ch ira lity  and with 
similar chromophores give rise to CD effects of Identical sign.
This Is the basis of the use of this technique for configurational 
assignments. (Crabbe, 1965 ; Drake, 19862) .  To employ this  
technique, ch ira l centres of similar chemical structure must be 
present 1 n the test compounds.
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2.6 .2 Results and Discussion
All the molecules analysed by this method contain aromatic 
chromophores close to the chiral centres.
2.6 .3 Phenlramlne type
The CO spectra of (+) and (-)chlorphenlramlne (17c) are related 
as object to mirror Image (F1g 2 .7 ). That of (♦)bromphen1ram1ne 
(17b) closely resembled that of (+)ch1orphen1ram1nef both known to 
be the more active antipodes of S configuration (ShafVee and H1te 
1969), 1n both sign and fine structure as shown by F1g 2.7. These 
results emphasize the closely related CO features of phenlramlne 
derivatives of Identical configuration and the object to mirror 
Image relationship of R-CD and S-CO curves.
H -C -C H 2CH2N(CH3)2 X = H (17)
X * Br (17b)




^  (♦) chlorpheniramine maleate
^ ' ( - )  chlorpheniramine maleate *****(♦) brompheniramine maleate
F1 g 2.7a CO spectra for some phenlramlne Isomers 1n H^ O.
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The CO features of both ( - )  chlorpheniramine and (♦) 
brompheniramine were sensitive to pH (F1g 2.7b)
PH X max/m1 n Ae
( - )  chlorpheniramine 4.7-6.1 264 -0.43
2 . 2 265 ♦0.74
( 4-) brompheniramine 5.3, 6 . 8 264 ♦0.48
3.4 266 -0.53
The sign of the CD band 1s progressively reversed when a rise 1n 
the population of dlprotonated species occurs (pyrldyl nitrogen 







F1g 2.7b CD spectra for ( - )  chlorpheniramine showing the effect 
of pH on the sign of the band
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In the region of 240-270 nmv the CO features of (+)neobenod1ne 
HC1 ( 8 ) (the more potent antipode) resemble those of 
(+)ch1 orphen1 ram1 ne and (♦ )brompheniramine -  although at lower 
wavelength the pattern 1s d ifferen t (F1g 2 .8 ). This 1s evidence 
that («•) neobenodlne 1 s related 1 n configuration to the 
(+)phen1 ramines a relationship established on chemical grounds 
(Barough et a l ,  1971).
The CD features of antipodal forms of carbinoxamine (9) show a 
broad maximum 1n the region of 230-280 nm. Both ( - )  carbinoxamine 
and (+) neobenodlne show maxima of positive sign 1 n this region 1 n 
accord with th e ir chemically related configuration. The fact that 
their maxima d iffe r  1 n fine structure 1 s not unexpected 1 n view of 
the fact the neobenodlne contains two homoaryl sustltuents while 
carbinoxamine 1 s a homo/heteroaryl derivative.
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neobenodlne HC1 
neobenodlne HC1 / < - > carblnoxamlne maleate
F1g 2.8 CO spectra for (♦) and ( - )  neobenodlne hydrochloride 
and ( - )  carblnoxamlne maleate 1n H20
Clemastine (12) 1s another example of this type of compound, 
although 1 t  has two chiral centres, one at the benzyllc s ite  and 
the other 1 n the pyrrolldino ring.
The four possible Isomers are a ll  of known configuration I .e .  
RR1, RS\ SR* and SS1 (Ebnother and Weber, 1976). Study of the CO 





SS' *  SR'
F1g 2.9 CO spectra for clemastine fumarate Isomers 1n water
F1g 2.9 shows that the Isomers RR' and RS‘ have similar CO 
features as do SS' and SR' but that the la tte r  are mirror Images of 
the former. This Indicates that the CO bands are l i t t l e  Influenced 
by the c h ira li ty  of the pyrrolldlno chiral centre possibly because 
this 1s too far removed from the chromophore.
The CO features of the RR and SS Isomers are remarkably similar 
to those of (♦) and ( - )  neobenodlne respectively and the data 
provides further proof of the configurational assignments made to 
these enantlomers. The CO features of chiral molecules of this kind 
are not s ignificantly  altered when hydrogen attached to the chiral 
centre (as In (17) and (8)) 1s replaced by methyl (as 1n (12) ).
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Clemastine 1s a good model for mebrophenhydramlne (11) a 
compound for which no evidence of the antipodal configuration has 
been reported.
The fact that the CO features of the most active (-)antlpode of 
mebrophenhydramlne correspond clearly with those of clemastine 
(RR') and Its RS‘ dlastereomer, provide good evidence of the tr io  





mebrophenhydramlne maleate ( - )  mebrophenhydramlne maleate
F1g 2.10 CO spectra for (♦) and ( - )  Isomers of 
mebrophenhydramlne maleate 1n H^ O
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At pH 3 .0 , 3.5 and 4.3 , three bands are seen 
positive band max, 275nm
negative band max, 250nm Ac +0.07
positive band max, 245nm
At pH 5.8, 5.5, one band 1s visible  
negative band m1n, 260nm Ac -0.68
At pH 8.5 Ac -0 .8
These data again demonstrate the Influence of the protonation 
state of the molecule upon Its  CD characteristics. The signs of the 
CO bands cannot be used as configurational evidence because the 
chiral centre of dlmethlndene d iffers radically from the other 
compounds examined 1 n these experiments.
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2.7 Experimental Details
2.7.1 Resolution of RS Chlorpheniramine by D1-p-to1uov1 ta rta ric  acids 
RS chlorpheniramine base (liberated from RS chlorpheniramine 
maleate) (24 g, 0.09 H) and (-)-d1-|)-to luoyl-L -tartar1c  acid 
monohydrate (16.7 g, 0.041 H) were dissolved 1n warm ethanol 
(60 m1)f and water (80 ml) containing n HC1 (43.1 ml, 0.043 mol) 
was added. The solution was cooled slowly un til clouding 
commenced, then seeded with a sample of the d1-|>-toluoyl L -tartrate  
provided by Or J Hunt and allowed to cool overnight to room 
temperature. After 1 week the crystals which formed were f ilte re d , 
washed with 30% aqueous EtOH (50 ml) and dried. Three 
recrystal 11zatlons from 50% aqueous EtOH gave an L-j)-toluoyl 
ta rtra te  of constant rotation, mp 135*C [<*]" -  60.7 
(c . 1.19, 95% aq. EtOH) (Hunt (1961) [o]?° -  57.8 (c . 1.7,
EtOH).)
Evidence for constant rotation
Crystallization 589 578 546
[a ]2 S nm 
436 365 WT (g)
1 st crop -55.3 -58.3 -70.2 -141.3 -286.6 21.85
1 . -56.4 -60.3 -69.1 -142.0 -287.9 17.32
2 . -60.8 -64.4 -74.2 -156.5 -316.6 13.62
3. -60.7 -65.0 -74.2 -157.2 -319.8 12.30
The above salt (12.3 g) was suspended 1n water (44 ml) and baslfled 
with N-NaOH (44 m l). An ethereal extract of the base was dried 
(MgS04) and evaporated under reduced pressure to a yellow o il 
(+)ch1orphen1ram1ne base (4.7 g)
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nm 589 578 546 436 365
[«]2S +25.6 *26.3 >31.9 >60.9 >129.5
c. 1,44 In 95X EtOH
Hunt (1959) M ? 1 ' 5  > 31.6 (c . 1 .8 , EtOH)
The maleate sa lt was prepared by adding a solution of maleic 
acid (1.86 g) 1n Isopropyl acetate (34 ml) to a solution of the 
above base (4 .4  g) in Isopropyl acetate (10 ml). The s a lt, which 
crystallized on cooling, was recrystallized three times from 
Isopropyl acetate to give (>)ch1orpheniramine maleate, mp 113-115*,
t o ] 24 > 2 3 . 2  (c . 1 . 2 ,  H20) •
C rystallisation
589 578 546




1st crop > 2 0 .5 >22.1 >22 .9 >46 .6 >95.7 1 . 2 2 , H20
1.  > 2 1 .8 >2 3 .8 > 31 .8 >52 .6 >103 .2 1 . 0 1 , h2o
> 3 9 .0 >42.9 >49 .5 >102 .9 >223 .8 1 . 0 5 , DHF
2.  > 2 3 . 2 >25 .0 >26 .8 >51 .8 >103 .6 1 . 1 2 , h2o
> 4 1 .0 >43 .8 > 5 3 .2 >103 .5 >224 .8 1 . 0 7 , DHF
3.  > 2 3 .2 >25 .2 > 2 7 .0 > 5 1 .6 >104 .0 1 . 2 0 , H20
>41.1 >44.1 >57.1 >10 3 .8 >225 .3 1 . 0 0 , DHF
Hunt, ( 1 9 6 1 )  [ a ] * 4 > 23.1 ( C .  1 . 2 , h2o )
Scherlco Patent, (1 9 6 0 )  [ a ] 25 > 4 4 .3  (c. 1 . 0 0 ,  DHF) 
(Found: C, 6 1 . 4 9 ;  H, 5 . 7 7 ;  N, 7 .2 1  calculated for
C20H23C1 N2°4 : C’ 61-46;> H* 5-93: N* 7-17* )
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In a similar way the RS base (fresh or enriched 1n one Isomer) 
and (♦ )d 1 -B -to luoyl-0 - ta r ta r 1 c acid monohydrate gave the 
0 1 - 2 -toluoyl ta rtra te  of constant rotation, mp 135*C,
[o ]?  ♦ 62.3 (c . 1.01, 95X EtOH), [Hunt, (1961)
[a ] * 4  ♦ 57.4* ( C .  1.1, EtOH)].
C rystallization
589 578
[ a ] "  nm 
546 436 365
concn 1 n 
95% EtOH
1 st crop ♦62 - 7 ♦65.7 ♦74.5 ♦154.9 ♦312.7 1 . 0 2
2 nd crop ♦61.1 ♦65.1 ♦78.2 ♦152.3 ♦312.6 0.99
3rd crop ♦62.3 ♦65.6 ♦79.1 ♦153.3 ♦312.8 1 . 0 1
By baslfylng the sa lt, 
was obtained,
(-)chlorphenlramlne as an unpurified
nm 589 578 546 436 365
M 2 5 19.8 -■20.7 -24.0 -50.4 -106.6
c. 1 . 2 1  1n 95X EtOH 
Hunt, (1961) [a f t 1 - 5  -  31.6* (c . 1 .8 , EtOH)
The maleate s a lt, a fte r two crystallizations had mp 112-114*0, 








1 . -22.4 -23.3 -26.1 -55.0 -107.3 1.07, H20
-40.6 -42.5 -50.9 -107.6 -234.9 1.63, DHF
2 . -23.9 -24.9 -28.5 -57.1 -112.3 1.08, H20
-42.6 -44.6 -54.3 -110.5 -238.4 1.03, 0HF
3. -24.1 -24.9 -28.7 -57.6 -113.4 1.04, H20
-42.8 -44.7 -54.8 -113.2 -239.0 1.10, DHF
Hunt, (1961) [a[jj -  23.1 (c . 1 .2, HjO) and 
Sherlco Patent, (1960) [a ]“  -  44.1 (c . 1 .0, DHF).
2.7 .2 Resolution of RS dlmethlndene by ta rta ric  acids
RS dlmethlndene (14.8 g, 0.05 M) and L -(*)-ta rtar1c  acid (7.61 
g, 0.05 H) were dissolved 1n warm absolute EtOH (30 ml). The 
solution was allowed to cool overnight to room temperature. The 
crystals which separated were filte re d  and following four 
recrystalHzatlons from absolute EtOH gave the L-tartrate of 
constant rotation.
6 8
C rysta lliza tion  589
[ a ] 25 nm 
578 546 436 365 concn 
1n MeOH
1 .  - 1 0 3 . 4 - 1 0 8 . 2 - 1 2 5 . 2 -2 3 9 .1 - 4 5 9 . 2 1 .0 5 4
2 .  - 1 2 9 . 7 - 1 3 7 .1 - 1 5 7 . 2 - 3 0 2 . 7 - 5 6 9 . 6 0 . 9 4 8
3 .  - 1 4 6 . 5 - 1 5 4 . 5 - 1 7 5 . 2 - 3 3 0 . 7 - 6 2 2 . 5 1.01
4 .  - 1 4 6 . 1 - 1 5 3 . 6 - 1 7 7 . 0 - 3 3 4 . 3 - 6 2 8 . 3 1 . 0 6 8
The above sa lt (3 g) was suspended 1n water (20 ml) and baslfled 
with NH3 -H2 0. The ethereal extract of the base was dried 
(MgS04) and evaporated to an o il,  (-)dlmethlndene.
nm 589 578 546 436 365
[ a ] 24 - 1 4 4  -1 53  -1 7 2  -322  -581
c. 1.01 1n MeOH
Bas1f1cat1on of the mother liquors followed by ethereal 
extraction gave impure (+)d1meth1ndene (7 g, 0.02 M) as a yellow
o i l .  To this was added 0 -(-)-ta rta r1 c  acid ( 3 . 6  g, 0.002 M) and 
the two warmed together 1n absolute EtOH. The crystals that formed 
on cooling were filte re d  and after four recrystalHzatlons from 
absolute EtOH gave the D-tartrate sa lt to constant rotation.
69
C rystallization 589 578
[ a ] 25 nm 
546 436 365 concn 
1n MeOH
1 . >132 >140 >162 >310 - 1.06
2. >140 >149 >171 >328 >619 0.998
3 . >141 >150 >174 >331 >623 1.006
4. >144 >155 >178 >338 >631 1.016
Suspending this salt (1 .5  g) 1n water, basifylng (NH ) and 
extracting with ether gave (>)d 1 meth1 ndene base, as a yellow o il .
nm 589 578 546 436 365
[ a ] 25 *136  *140  *164 >311 >583
c. 1.0 1n MeOH
The (-)base (800 mg) was dissolved 1n EtOH, an equlmolar 
quantity of malelc acid, 1n EtOH, added and the solution warmed. 
After cooling, the solution was flooded with anhydrous ether to 
yield (-)dlmethlndene maleate, mp 127-129*C,
nm 589 578 546 436 365
[o]24 -206.6 -214 -243 -456 -847
c. 1.00 1n MeOH
(Found; C, 70.57; H, 6.91; N, 6 . 8 6 ; calculated for 
C24H28N2°4; C> 70*4: H* 6,50; N’ 7  2X)
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Sim ilarly the (*)base gave (*)d1meth1ndene hydrogen maleate, mp 
127-129#C,
nm 589 578 546 436 365
[ a ] 25 * 1 9 7 . 8  *2 0 6 .7  * 2 4 0 . 2  * 4 5 1 . 8  * 8 3 9 . 6
*
c. 1.02 1n MeOH
(Found; C, 70.55; H, 6.72; N, 6.39%)
2.7.3 Resolution of RS carblnoxamlne by ta rta ric  acids
RS carblnoxamlne base, obtained by bas1f1cat1on of the maleate 
sa lt (7 .6  g, 0.026 M) and L -(*)-ta rta r1c  acid (3.92 g, 0.026 M) 
were dissolved 1n hot absolute EtOH (25 ml). The solution was 
allowed to cool s ligh tly , seeded (with McNeill sample, 
rotoxam1ne-L-tartrate) and le f t  for 14 days at room temperature.
The crystals (4 g) were filte re d , washed with anhydrous ether and 
recrysta l11 zed four times from absolute EtOH to give the L -tartra te  
sa lt of constant rotation, mp 142-143*C.
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C rystallization 589 578
[ a ] 25 nm 
546 436 365 cone11 
1 n MeOH
1 . +36 .3 +36 .3 +43.2 +73.7 +119 .8 1 .0 1 8
2 . +36 .8 +40 .0 +49 .8 +84 .4 +146.1 0 .9 2 4
3 . +42 .3 +44 .2 +52.0 +89 .4 + 15 3 .8 1 .0 4
4 . +45 .8 +45 .8 +51.4 +87 .9 +154 .2 1 .0 7
(McNeill value [a ] jjP  ♦ 38.4 (c. 2.00, MeOH)
(McNeill Patent (1962) [ajg? ♦ 37.2 (c. 2 .0, MeOH)
The ta rtra te  salt (3 g) was dissolved in absolute EtOH and an 
excess of methylamine (in  EtOH) added until the solution was basic 
to litmus. Removal of the solvent under reduced pressure yielded a 
white solid (methylamine ( - ) ta r t r a te ) . This was washed with 
acetone and the suspension filte re d . The acetone was removed under 
reduced pressure to give o ily  (-)carblnoxamlne base (C.A., 58, 5643g 
[a ]“  -  6 . 8  (c . 20, MeOH)).
ran 589 578 546 436
[<*]» - 8  -10 -15 -33
c. 0.964, 1n Abs EtOH
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The hydrogen maleate had mp 135-136*v
nm 589 578 546 436 365
[ a ] 25 + 4 0 .8  + 4 4 .7  +49.7 +97 .4  +782 .0
c. 1.01 In MeOH 
(McNeill Patent (1962) [a]jp + 41.2 (c . 2.0, MeOH))
(Found; C, 58.9; Hf 5.6; N, 6.4. Calculated for 
C2 0 H2 3 CIN2 O5 ; C, 59.04; H, 5.70; N, 6.89%).
The mother liquors from the formation of the L-tartrate salt 
were evaporated under reduced pressure, basified (NaOH-ty)) and 
extracted with ether to yield a yellow o il (5 .3 g). This was 
dissolved in warm EtOH and D -(-)-ta rta r ic  acid (2 .6 g) added.
After slight cooling this was seeded with carbinoxamine-D-tartrate 
(McNeill sample). After a few days the crystals which formed were 
collected. Three recrystallizations from absolute EtOH yielded the 
D-tartrate salt of constant rotation, mp 140-141°C.
[a ]25 nm
Crystallization 589 578 546 436 365 concn
in MeOH
1 . -40.3 -39.4 -44.2 -75.8 -127.6 1.04
2 . -44.5 -46.4 -52.4 -87.9 -150.2 1 . 0 1
3. -46.0 -45.0 -52.0 -89.0 -152.0 1 . 0 0
(McNeill value [a]jjw -  38.6 (c. 2.0, MeOH)
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The D -tartra te salt (2 .6  g) was dissolved 1n EtOH, made basic 
(methylamine) and extracted Into acetone, as before, to yield  
(+)carb 1 noxam1 ne base as a straw coloured o i l .
nm 589 578 546 436
[ a ] 25 * 6 . 0  + 7 .0  * 1 0 . 0  * 2 6 . 0
c. 2.2 1n Abs EtOH 
I t  formed a hydrogen maleate, mp 135-137*C,
nm 589 578 546 436 365
[ a ] 25 -47.8 -48.8 -56.9 -102.6 -189.0
c. 0.948 1n HeOH
(Found; C, 58.95; H, 5.78; H, 6.79X)
Resolution of mebrophenhydramlne by D1-p-toluoyltartar1c acids
RS-mebrophenhydram1ne (4.1 gf 0.012 M) and (-)d1-|>-toluoyl 
-L -ta rtra te  acid monohydrate (4.76 g, 0.012 M) were dissolved 1n 
warm absolute EtOH (20 m l). The solution was allowed to cool and 
le f t  at room temperature for four weeks. The crystals which 
separated during th is period were f i l te re d , washed and 
recrystalHzed three times from absolute EtOH to give an 
L-d1-j>-toluoyl ta rtra te  of constant rotation.
C rystallization 589
[ a ] 25 nm 
578 546 436 365 concn 
1n MeOH
1 . -77.9 -82.7 -94.1 -188.2 -378.3 1.05
2 . -82.9 -88.5 -101.9 -204.8 -408.7 1.04
3. -89.4 -87.3 -102.4 -203.7 -405.2 0.928
These (600 mg) were dissolved 1n absolute EtOH, made basic with 
methylamine and the product Isolated (as 2.7 .3) to give 
(-)mebrophenhydramlne,
nm 589 578 546 436
[ a ] 25 - 3 2 . 1  - 3 4 . 3  - 3 8 . 9  - 7 4 . 3
c. 5 . 0 2  1n MeOH
The o ily  (-)base was dissolved 1n absolute EtOH and an equlmolar 
quantity of malelc acid added. Crystals readily formed on cooling 
of (-)mebrophenhydramlne hydrogen maleate (3 0 0  mg), mp 144-146°C
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nm 589 578 546 436 365
[a]25 -20.9 -17.9 -19.9 -30.9 -50.8
c. 1.00 1n MeOH
(Found; C, 56.97; H, 5.56; N, 3.13, calculated for C„H„ Br
22 26
N05; C, 56.91; H, 5.64; N, 3.02%)
The other Isomer, (3.91 g) Impure, enriched in the dextro 
antipode was collected, as previously described, by basification of 
the mother liquors. Addition of (+) d1-j>-toluoyl-D-tartar1c acid 
(4.54 g) in warm EtOH, followed by three recrystallizations from 
absolute EtOH gave a D1-j>-toluoyl ta rtra te  (630 mg) salt of 
constant ro tation ,
C rysta lliza tion  589
[a ] - * 5  nm 
578 546 436 365 concn 
in MeOH
1 . +78.3 +85.1 +99.6 +2 0 0 . 2 +398.4 1.03
2 . +80.2 +8 6 . 1  +1 0 2 . 0 +205.0 +405.0 1 . 0 1
3. +90.8 +98.2 +111.7 +224.3 +429.5 1 . 0 1
4. +91.2 +97.5 +112.2 +2 2 1 . 2 +431.9 0.954
Basification of the 
(430 mg).
sa lt, gave o ily  (+)mebrophenhydramine bas<
nm 589 578 546 436 365
[ * ] » +28 +30 +34 +61 +109
c. 1.4 in MeOH
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and formation of hydrogen maleate followed to give 
(+)mebrophenhydram1ne hydrogen maleate (225 mg), mp 140-142*C,
nm 589 578 546 436 365
[ a ] 25 + 5 .06  + 7 . 0 8  + 8 .10  +18.22  +3 0 .36
c. 0.988 1n MeOH
(Found; Cf 56.88; H, 5.40; N, 2.92%)
2 .7 .5  Resolution of RS phenylsucdnlc acid bv brucine
RS phenylsucdnlc acid (6.15 g, 0.03 M) and (-)bruc1ne.2H20 
(27.3 g, 0.06 M) were dissolved 1n warm 90% EtOH (490 ml). After 4 
days the crystals that formed were filte re d , washed, dried and 
recrystalHzed twice from 90% EtOH to form a (-)b rudne salt of 
(+)pheny1 succ1 n1 c acid of constant rotation.
[ a ] 25 nm
Crystallization 589 578 546 436 365 concn 1n
95% EtOH
1 . -13.5 -14.5 -19.4 -54.6 -132.8 1.032
2 . -13.6 -13.6 -17.5 -53.5 -129.4 1.028
3. -14.1 -14.1 - 2 0 . 2 -54.4 -137.1 0.992
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The above s a lt (12.0 g) was dissolved 1n water, made acidic 
(c . HC1) and extracted with ether. Evaporation of the ether under 
reduced pressure followed by four recrystalHzatlons from water 
yielded (+)-pheny1succ1n1c acid (2.48 g) constant rotation.
C rysta llization
( a ) 25 nm 
589 578 546 436 365 concn In 
acetone
1 . +160.0 +164.0 +194.0 +350.0 +598.0 1 . 0 0
2 . +161.3 +168.9 +195.3 +352.8 +610.4 1.006
3. +168.3 +177.0 +206.0 +368.5 +635.4 1.03
4 . +170.4 +180.0 +210.7 +390.2 +651.6 1 . 0 2
(Wren and Williams, 1916, d-Pheny1succ1n1c acid [a ]D + 168 1n 
acetone)
The mother liquors from the formation of (+)-phenylsucc1n1c add  
were evaporated under reduced pressure to yield white/yellow  
crystals. Three recrystalllzatlons from water yielded (-)brudne  
sa lt of 1 -pheny1 succ1 n1 c add.
[ a ] 25 nm
C rystallization 589 578 546 436 365 concn 1n
acetone
1 . -58.0 -59.0 -71.0 -145.0 -300.0 1 . 0 0
2 . -71.0 -73.0 -81.0 -163.0 -331.0 1 . 0 0
3. -73.5 -76.5 -90.2 -187.3 -377.5 1 . 0 2
4. -74.0 -76.3 -87.1 -176.1 -365.9 1 . 0 2
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Acidification of the sa lt (15.3 g) with c. HC1 followed by 
ethereal extraction yielded a cream crystalline product. Three 
further recrystalHzatlons from water yielded (-)phenylsuccinlc 
acid ( 2 . 0  g) to constant rotation.
Crystallization 589 578
[ a ] *
546
nm
436 365 concn 1 n 
acetone
1. -138.0 -143.8 -166.0 -304.1 -504.8 1.04
2. -156.0 -154.0 -171.0 -306.0 -523.0 1 . 0 0
3. -169.6 -177.4 -205.7 -367.0 -628.3 1.06
4. -168.0 -176.4 -206.6 -367.9 -631.1 1 . 0 2
(Wren and Williams, 1916, l-pheny1succ1n1c acid [a ]D -173.3)
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3. Introduction
Since trad itional methods of resolving racemlc mixtures, 1e 
fractional crys ta llisa tion  of dlastereomerlc salts (as already 
described) are re la tiv e ly  d if f ic u lt ,  time consuming and limited  
In app licab ility , there has been tremendous Impetus In recent 
years to develop e ffic ie n t liquid chromatographic techniques for 
such separations.
In order to achieve separation of enantlomers I t  1s necessary 
to use some kind of chiral discriminator eg, a chiral stationary 
phase or a chiral additive to the mobile phase.
A third possib ility  Is an Indirect separation, where the 
enantlomers are converted to a mixture of dlastereomers via a 
suitable chemical reaction using a chiral reagent. The 
dlastereomers can then be separated by reverse or normal phase 
chromatography. There are, however, two major drawbacks to this 
technique.
1. I t  Is not always possible to maintain or even obtain the 
necessary reagents with very high optical purity.
2. Enantlomers have quite d ifferent rates of reaction when 
reacted with another chiral molecule (Mlslow and Raban, 
1967) resulting 1 n the production of two dlastereomers of 
differing proportion to the starting enantiomeric pair.
These factors do not, however, eliminate the need for 
der1 vat1 sat1 on which may s t i l l  be necessary I f  the compounds of 
Interest have poor chromatographic properties eg, amines and 
carboxyllc acids, whereas amides generally chromatograph w ell.
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3.1 Chiral Mobile Phase Additives (Dobashl and Hara, 1983; Tscherne 
and Capltano, 1977)
Using this technique racemlc mixtures are resolved because of 
differences In the s ta b ilitie s  of the dlastereomerlc complexes so 
formed In the mobile phase, eg, so lub ility  or binding to the 
achiral stationary phase.
Although not ch ira l, transition metal 1ons Including A1( I I ) , 
(G1l-Av et a l ,  1980) N 1 ( II) ,  Z n (II) and Cd(II) (Lepage et a l,  
1979) have been used. I f  the formation of a dlastereomerlc 
te rtia ry  complex between the metal 1 on and the enantlomers 
results In one of the ligands forming a stronger mixed complex 
then resolution w ill be achieved. Their applicability  Is , 
however, lim ited to the separation of racemlc mixtures of amino 
acids eg l-prol1ne (G1l-Av et a l,  1980).
Dlastereomerlc Ion pairs formed between a charged solute and a 
chiral counter 1 on of opposite charge may show d ifferent 
chromatographic properties. The counter Ions that have been 
employed Include d-10 camphorsulphonlc acid (Petterson and 
S chlll, 1981) quinine, qulnldlne and other cinchona alkaloids 
(Petterson and No, 1983). Mobile phases of low polarity eg, 
dlchloromethane are preferential and the presence of water even 
1 n very low concentrations has been shown to have an adverse 
effect on separation.
I 1 qu1 d-1 1 qu1 d chromatography can be utilised using a sparingly 
soluble optically  pure reagent In the mobile phase eg, 
(+ )-d 1 buty ltartra te  for the separation of chiral amines e.g. 
ephedrlne (Petterson and Stuurman, 1984).
o *
3.2 Chiral Stationary Phases (CSP) (Reviews: Souter, 1985; Oappen 
et a l f 1986; lochmuller and Souter, 1975)
Many chiral stationary phases are now commercially available.  
Two types have been used 1n this work, namely cyclodextrln 
columns and the a.-amino glycoprotein ( Enantlopac ) column.
3.2.1. Plrkle Type (Walner and Doyle, review, 1984)
Plrkle columns were developed on the basis of the three point 
chiral recognition model (Dalglelsh, 1952) which proposed that 
chiral recognition required a minimum of three simultaneous 
Interactions between a chiral stationary phase and a solute. 
These could be « -  » bonding, H-bond1ng or Van der Waals 
Interactions - but at least one must be stereochemically 





In this example, enantiomer 1 Interacts with the chiral 
stationary phase (CSP) at three sites I .e .  A—A*f B--B', C—C'. 
Its  mirror Image (enantiomer 2 ), however, only Interacts at two 
sites. I f  the C—C' Interaction 1s a ttractive  then enantiomer 1_ 
w ill be retained longer than 2 , 1 f repulsive then vice versa and 
1f the C--C' Interaction 1s only minimal or non-existent then no 
separation w ill be seen.
One of the CSP's developed by Plrkle uses 
R-N-(3,5-d1n1trobenzoyl)phenylglyc1ne bound to a y-am1nopropyl 
packing either 1 on1 cally or covalently.
I .e .
F1 g 3.2 lonlcally bound (R)-N-(3,5,d1n1trobenzoyl)pheny1glyc1ne
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This CSP has a number of possible sites for 1nteract1on:- 
S1te 1. The dipole formed by the amide linkage between the 
3,5-DNB moiety and the phenylglyclne.
Site 2. The amide hydrogen -  available for hydrogen bonding.
S ite 3. The amide carbonyl -  available for hydrogen bonding.
S ite 4. The 3,5-DNB ring (electron deficient) -  available for 
*  -  ft bonding with other aromatic rings.
Site 5. The carbonyl and phenyl groups on the phenylglyclne
moiety which can In teract with solute either
attractive ly  or repulsively (because of Its  sterlc  
bu lk).
The many combinations of these sites provide a large number of 
ways for the CSP to Interact with the solute, as well as the 
possib ility  of Interaction with a wide range of molecules.
There are now many d ifferen t varieties of P1rkle-type 
stationary phases ; both tr -  electron acceptor and donor groups 
are used. The large number of possible Interactions give a 
P1rkle-type CSP Its  broad ap p lic ab ility . Examples of compounds 
resolved using this type of CSP Include numerous enantiomeric 
amides (derived from amines or acids), alkyl carblnols, 
sulphoxldes, lactones (P lrk le  et a l ,  1980; Plrkle and House, 
1979), propranolol analogues (P lrk le  et a l, 1981) and amino 
alcohols (as oxazolldlnes) (Walner et a l, 1986). Preparative 
resolution of a wide range of racemates has also been reported 
(P lrk le  and Finn, 1982).
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3.2.2. Chiral Cyclodextrln Bonded Phases
This CSP consists of cyclodextrln host molecules covalently 
bound to 5 micron s i l ica  gel via a ten atom spacer (Astec 
Informer, 1987). The coupling contains no nitrogen or S1-0-C 
linkages and 1s therefore hydrolytically stable.












F1g 3.3 Chemical structure of 6 cyclodextrln molecule.
Cyclodextrlns (CyO) are cyclic oligosaccharides composed of 
six ( a ) ,  seven ( B ) ,  or eight ( y)  glucopyranose units, linked by 
a - 1 - 4  bonds (S z e j tH ,  1982). Their structure 1s unique 1n that 1t 
resembles a truncated cone, with both ends open. The larger 
opening of the cone 1s rimmed with 14 secondary hydroxyl groups 
(1n the B CyO) with C-2 1n a clockwise direction and C-3 
anti-clockwise. Thus the hydroxyl groups of adjacent 
glucopyranose units form hydrogen bonds which stabi l ize the shape 
of the molecule ( S z e j t l l ,  1982). The smaller opening 1s rimmed 
with the more polar primary hydroxyl groups (7 1n to ta l ) .
Edge o f  sec ondary
glycosldlc oxygen bridges
Inner cavity -
Edge of primary 
hydroxyls
hydroxyls
F1g 3.4 The molecular shape of CyO showing the central cavity.
The In terior of the cavity contains no hydroxyl groups and 1s 
re la t ive ly  hydrophobic overall. The result 1s a molecule with a 
hydrophobic centre and relatively hydrophilic outer surface. 
Consequently such molecules are able to complex a variety of water 
Insoluble or sparingly soluble molecules.
The B-cyclodextr1ns have been more widely applied (Armstrong, 
1984) than a or y because of their optimum size for inclusion-  
complex formation e.g. biphenyl and somewhat larger compounds may 
be accommodated 1n the B but not 1n the y  polymer.
0*78
1-53 nm
Fig 3.5 Representation of the size and shape of the B CyO as 
1t exists attached to a solid support.
8 6
Each glucose unit contributes five chiral centres, thus B-CyD 
contains 35 chiral centres. Guest solutes can Interact through 
Van der Waals forces and also via Hydrogen bonds, with the 
hydroxyls at the mouth of the cavity I f  the chiral solute has the 
suitable polar sustltuents.
In aqueous solution the s lightly  apolar CyO cavity Is occupied 
by the water molecules which are energetically unfavoured 
(polar-apolar Interaction) and are therefore readily substituted 
by the appropriate guest molecules which are less polar than 
water. Inclusion se lec tiv ity  Is formed only In the presence of 
water or a combination of water and organic modifiers such as 
DMSO, DMF, aceton ltrlle  or alcohols. These organic modifiers tend 
to compete with a ll solutes for the prefered location In the 
hydrophobic cavity. Therefore Increasing the concentration of an 
organic modifier w ill decrease retention. Generally, the binding 
strength of Ionic species to the CyO Is less than for the 
corresponding neutral species. Thus the efficiency of separations 
has been substantially Increased 1 n some cases by the use of 
buffers (Beesley, 1985), within the allowable pH range of 4.0 to 
7.5.
Successful resolutions have been achieved using bonded CyO 
columns for a variety of compounds Including geometric Isomers of 
tamoxifen (Armstrong et a l,  1987), structural Isomers (Armstrong 
et a l, 1985; Armstrong and Demond, 1984), and many drug 
enantloroers (Armstrong et a l ,  1986; Hlnze et a l,  1985).
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F1g 3.6 Schematic diagram of CyO bound to a sil ica gel support and 
reverslbly forming an Inclusion complex with a chiral molecule.
8 8
3 .2 .3 . Protein Type
Interaction between acidic and basic drug compounds and 
proteins is well known. The proteins involved are albumin, which 
is the primary binding protein for acidic drugs and a^-add 
glycoprotein (AGP), which primarily binds basic drugs. These 
proteins are polymers composed of naturally occurring chiral 
amino acids and the binding that occurs can often be 
stereospecific.
This effect was f i r s t  used for chromatographic separations by 
Stewart and Doherty (1973) who succeeded in resolving D and L 
tryptophan on bovine serum albumin ( 6 SA) bound to agarose. 
Allenmark (1983) and Hermansson (1983) have developed bonded 
phase columns that take advantage of the albumin and AGP 
interactions respectively.
The separation mechanism of protein columns is not clearly  
understood. The separation appears to take place through 
d iffe re n tia l interactions of enantiomers via a combination of 
hydrogen bonding. Van der Waals mechanisms, ion-pairing (Sch ill 
et a l ,  19861) and steric effects (Allenmark et a l,  1984).
Protein columns are demanding in that the chiral separation
depends on the chromatographic conditions i .e . pH, ionic strength,
organic modifier concentration (charged or uncharged) and
2
temperature (Schill et a l,  1986 ) .  Used in the trad itional 
reversed phase mode with aqueous buffered mobile phases, the 
recommended values are pH 3.0-7.5 , ionic strength 0-500HM,  
organic modifiers up to 5% of 1- or 2-propanol or O-IOhM 
tetrabutylammonium bromide, temperature up to 35°C and a maximum 
flow -rate of 0.3ml/m1n.
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The primary advantage of protein columns 1s their wide 
apl1 cab1 1 1 ty to enantiomeric separations of drug compounds 
(Walner et a l, 1986; Hermansson, 1985; Hermansson and Eriksson, 
1986). Analysis of biological flu ids 1s made simpler by the fact 
that aqueous mobile phases are used. Due to the very low flow 
rate, protein columns require more time than other types of 
chiral phases, resulting 1 n broader peaks and poor sensitiv ity . 
This may 11m1t the ir use for low dose drugs 1n biological flu id s .
3.3 The Choice of Detector
U ltra -v io le t spectroscopy 1s the typical choice of detector 
for HPLC. UV detection can be used 1n the separation of 
enantlomers using HPLC -  providing the compound has a suitable 
chromophore.
The main disadvantage of UV detection 1s that 1t discloses 
nothing about the nature of the separation between the two chiral 
components. I t  1s not a specific detector for chiral separations 
and often the presence of Impurities can hinder the analysis. 
During the course of the development of the separation 1t 1s not 
possible to detect whether the leading edge or the ta l l  of the 
peak 1s enriched with one enantlomer. A sample which appears as 
one peak may well be only p a rtia lly  resolved.
In the separation of enantlomers 1t 1s not possible to 
determine the order of elution using UV detection. This must be 
derived from sem1 -preparat1 ve techniques and optical rotations 
using a polarlmeter.
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UV detection does, however, have its  advantages. Once the 
enantlomers have been resolved and the peaks assigned, then 
providing there 1 s su ffic ien t resolution, quantitation, giving 
weight for weight concentrations, can be obtained using values of 
either peak height or peak area.
There are two other types of detectors available, which 
provide more peak Information 1n the separation of optical 
Isomers:-
1. Polarlmeters, f it te d  with small volume flow cells are 
available. These detect the change 1n optical rotation as the 
peaks are eluted. They are however, very lim ited, since the 
degree of rotation varies enormously from one compound to the 
next. A compound with a very low specific rotation would have a 
very poor 1 1 m1 t of detection using a polarlmeter and quantitation 
of for e.g. 0.5% w/w of one of enantlomer 1n the other , may well 
be Impossible. Certainly for development work the polarlmeter 
would provide more Information about the separation, than a UV 
detector, but Its  application 1 s lim ited.
2. A more sensitive and versatile detector 1s one that u tilises  
the phenomenon of Circular D1chro1sm (CO). A beam of plane 
polarised light may be considered to be made up of a le f t  and 
right c ircu larly polarised component. Optical rotation w ill be 
observed when a medium transmits the two c ircu larly  polarised 
components with unequal velocity, (see also 2 . 6 .)
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I f  In addition to unequal velocity, there occurs unequal 
absorption of le f t  and right c ircu larly  polarised lig h t, the 
emergent lig h t w ill  be e lU p tlc a lly  polarised and this unequal 
absorption 1s referred to as Circular Dlchrolsm (CO).
A CD detector measures the optical properties of eluting  
components and because the phenomenon 1 s derived from light 
absorption, sen s itiv ity  Is In the same order of magnitude as 
conventional UV/HPLC detection. I t  Is therefore a far more 
versatile and sensitive technique than polarlmetry.
The detector simultaneously measures the UV absorption and CO 
of the eluent passing through the flow c e ll .  At a particular 
wavelength, the two enantlomers of a racemlc mixture produce a CD 
peak of equal and opposite signs.
Providing the chromatographic peak consists of two p artia lly  
resolved enantlomers, the CO trace Is a composite of two 
overlapping peaks of opposite sign. Therefore, although by 
absorption there appears to be no resolution -  the peak Is 
resolved when the CD Is measured (Salvadorl et a l,  1984).
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3.4. Optimization of the Separation
Throughout the HPLC development work the following parameters 
are employed to describe the quality of separation:
Capacity factor K'= ( TR-TQ)
T T-void time




Separation factor a » K1 > 1
K‘ f capacity factor for the f i r s t  eluted enantlomer. 
K'j capacity factor for the last eluted enantlomer.
Resolution Rs = -  T
0.5 (Wr Wf )
Tj and T represent elution times ( 1 n minutes) 
and Wf represent peak widths at baseline
For a racemlc mixture a value of R > 1.5 1s equivalent to 
baseline separation.
S3
3.5 . Results and Discussion
3 .5 .1 . Mobile phase additives
In principle, the technique of using d1-[>-toluoyl-tartar1c 
acid to discriminate between R and S chlorpheniramine should also 
be transferable to chromatographic systems. D1astereomer1c Ion 
pair formation should enable separation to be achieved.
Attempts to achieve this practically proved unsuccessful. A 
mobile phase of AcN (25%) and water containing 5flM or I hM of 
d1-i>-toluoy1-tartar1c acid meant that , using a UV detector, the 
signal was off-scale. Reducing the concentration of d1-i>-toluoyl- 
ta rtra te  to O.InM enabled the signal to be brought on scale but 
the peaks were too broad to be of any value. An alternative to 
this was to use sim ilar mobile phase conditions but use 
electrochemical detection. This method looked promising and 1s 
s t i l l  under Investigation (Jefferies , unpublished).
Petterson and Schill (1981) reported the separation of 
enantiomeric amines using 1 on-pa1 r chromatography, Involving the 
use of a weaker chromophore d- 1 0  camphor sulphonlc add (d - 1 0  
CSA) as the counter 1on. Although use of this add 1n the 
resolution of the antihistamines had not proved successfu1 - 1 t  was 
s t i l l  considered worthy of evaluation by HPLC techniques.
I t  was proposed (Petterson and S chill, 1981) that 
stereoselective association of the racemlc amines (B-blockers) 
and d-10 CSA occurred via dlastereomerlc 1on pair formation.
These 1on pairs were believed to have structural differences, 
substantial enough to d istribute themselves d ifferen tly  between 
the organic mobile phase and the stationary adsorbent.
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Again the three point Interaction (Da1g1e1shf 1952) necessary for 
stereoselectiv ity , was thought to be Important.
The system used Involves a non polar stationary phase 
(Hypersll 5 ODS) and a mobile phase of greater polarity (DCM-AcN) 
containing d-10 CSA. In it ia l t r ia ls  at Bath with a mobile phase 
of DCM-AcN 1% containing 5 or 10 P#1 d-10 CSA showed no 
resolution and rather broad peaks -  due possibly to free base 
binding to uncapped sllanol groups on the column.
Addition of a competing base (L1« et a1t 1985) sharpened the 
peaks and enabled some slight separation to be seen. Optimum 
enantiomeric resolution was obtained with a ratio  of 2:1 d-10 CSA 
to the competing base, diethylamlne (OEA) (Table 3 .1 ).
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Compound Kl K 2 a [DEA]
fas maleates)
chlorpheniramine 0.67 - -
carblnoxamlne 0.67 - - 1.25MM
dlmethlndene 0.67 - -
t
chlorpheniramine 0.52 0.67 1.29
carblnoxamlne 0.62 0.81 1.31 2hM
dlmethlndene^ 0.51 0 . 6 6 1.29
chlorpheniramine 0.44 0.57 1.30
carblnoxamlne 0.39 0.52 1.33 2.5MM
dlmethlndene 0 44 0.57 1.30
Mobile phase: DCM:AcN 1%, containing 5hM d-10 CSA.
K- capacity factor 
a -  separation factor 
K value for malelc acid =1.17
Table 3.1 . shows the effect of Increasing amounts of DEA on 
the K and a values of the test antihistamines.
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Table 3.1 shows that with a low concentration of DEA there 1s 
no resolution. On Increasing the amount of DEA, the retention 
time and thus the capacity factor 1s reduced. The results for the 
separation factor, a, are deceptively good. Since the capacity 
factor (K) values are low only a small difference between the two 
w ill result 1n an acceptable a value. Visually the separation was 
poor.
T ria ls  using trlethylamlne (TEA) as the competing base were 
not successful. TEA appeared too strong and the retention times 
were shortened again.
In i t ia l  studies to find a mobile phase of choice Included 
water as one of the sustltuents. A ll the attempts using water 
fa iled  and no separation was seen. Similar effects for other 
H-bond1ng agents have also been reported (Petterson and S ch ill, 
1981). They proposed that this negative Influence 1s probably due 
to the Interaction with hydrogen bonding groups of the 1 on pair 
components, which then decreases the bonding strength within the 
1 on pair.
The retention mechanism Involved would appear to be more than 
simple partitioning of ant1 h1 stam1 ne-d-1 0 -camphorsu1 phonate 1 on 
pairs between the mobile and stationary phases. In the absence of 
competing base the retention times were long and erratic , but 1 n 
the presence of Increasing amounts of competing base the K and a 
values decreased. This suggests a mechanism similar to that of 
L1m et al (1985) I .e .  DEA-d-10 CSA 1on pairs saturate the 
non>po1 ar stationary phase through hydrophobic Interactions 
(during equilibration). This gives rise to an equilibrium between 
free and bound 1on pairs. Enantlomers of the antihistamines then 
1 on exchange with protonated competing base.
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3.5 .2 . Protein-Type Columns
Hermansson (1983, 1984) developed a chiral HPLC column based 
on the human plasma protein (a^acid glycoprotein, 
aj-AGP). The stationary phase is based on N,N-d1ethy1am1no 
ethyl derlvatized s ilic a  particles (10 yin) to which o^ -AGP 
has been adsorbed and Immobilized. Within the pH range 3-7 .5 , 
the method of immobilization ensures that the a -^AGP does not 
leak. Attempts were made in this laboratory to prepare an 
a f-AGP column as directed (Hermansson, 1983; Herman et a l,
1981) but unfortunately the resulting column showed very poor 
resolution. Finally an Enantlopac (100 x 4 mm) cartridge column 
was purchased from LKB.
Following the details  given by Hermansson, (1984) for 
chlorpheniramine, separation of a series of racemlc 
ant1 h1 stam1 n1 c bases Including the phenlramlnes, carblnoxamlne, 
dlmethlndene was undertaken (Method 1). The results showed 
satisfactory separation of only a few of the compounds under 
test. The retention times however, were very long and about 
2  hours were required for some separations to be completed.
The results (Table 3.2) showed best separation for RS 
phenlramlne, giving a resolution factor Rs of 1.50 i .e .  baseline 
separation. The Inclusion of a halogen atom Into the phenlramlne 
structure has a detrimental effect on the resolution. RS 
chlorpheniramine maleate was resolved slightly  (Rs 0.91) but RS 
brompheniramine showed no separation at a l l .  Under these 
conditions the presence and Increase in size of the halogen 
substituent was evidently reducing the stereo selectivity of the 
<kj-AGP towards the compounds.
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In order to check the optical purity of chlorpheniramine more 
precisely a dehalogenatIon experiment (Shafl'ee and Hite, 1969) 
was performed using Pd/C as the catalyst and MeOH as the solvent, 
dehalogenatlon was complete a fte r  reaction overnight at room 
temperature (60ps1). The RS phenlramlne produced by this reaction 
on RS chlorpheniramine showed superior separation to 
chlorpheniramine and comparable separation to the original RS 
phenlramlne. Similarly dehalogenatlon of resolved ( - ) -  
chlorpheniramine to ( - ) -phenlramlne Identified the f ir s t  peak as 
the (-)-lsom er and showed ( - ) -chlorpheniramine (from which i t  was 
derived) to be of high optical pu rity .
The only other compound to show any separation under these 
conditions was RS carblnoxamlne (Rs 1.27) Table 3.2. I t  Is 
Interesting to note at this point that whereas In the 
phenlramlnes the dextro base has the greatest retention, 1 n 
carblnoxamlne the laevo base Is retained longer. These are both 
the more active forms of the two compounds and share the same (S) 
configuration.
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T l K1 T2 K2 a Rs
RS phenlramlne 51 7 . 5 1 1 8 .5 18.7 2 .5 0 1 .5 0
RS phenlramlne 3 7 . 5 5 .2 5 84 13 .0 2 . 4 8 1 .1 5
(frojn chlorpheniramine) 4 0 . 5 5 .7 5 9 7 . 5 15.25 2 . 6 5 1 .7 3
( - ) -phenlramlne 
(from chlorpheniramine)
4 2 .7 5 6 .1 3
\
RS chlorpheniramine 80 1 5 . 0 105 20 1 .3 3 0.91
66 10 85 13.2 1 .2 9 0 .9 5
(■*■)-chlorpheniramine - - 105 20 - -
- - 81 12.5 - -
( - ) -chlorpheniramine 80 15 - - -
66 10 - - - -
RS brompheniramine 100 15 .7 - - - -
RS carblnoxamlne 84 13 126 20 1 .5 4 1 .27
51 7 .5 69 10 .5 1 .4 0 0 . 9 2
( - ) a-carb1 noxam1 ne^ - - 126 20 - -
(+ )a-carb1 noxam1 ne^ 84 13 - - - -
Mobile phase : 8mM Phosphate buffer containing 0.1M NaCl,
0.4% 4-propanol pH 6.9.
Footnotes
a run as ta rtra te  salts
b sign of rotation refers to the base Its e lf  and not to the sa lt. 
Table 3.2 Resolution details using Method 1.
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d-carb1 noxam1 ne
l-carb 1 noxam1 ne
RS carblnoxamlne tartrate









F1g 3.8. Chromatograms for the phenlramlnes, racemates and their
Isomers, using Method 1.
1 0 2
Since the retention times were so great, no more work was 
carried out under these conditions. Schill et al (1986 ) ,  
using the Enantlopac column, but under d iffering  conditions I .e .  
tetrabutylammonlum phosphate Instead of propanol/NaCl 1n the 
phosphate buffer, reported the resolution of chlorpheniramine (o 
2.26£ with greater success than that achieved previously.
These conditions were applied 1n the present work (Method 2). 
The resolution of the phenlramlnes Increased greatly, RS 
phenlramlne (Rs 2.76), chlorpheniramine (Rs 1.33) and even 
brompheniramine showed the beginnings of a separation (Rs 0 .8 ). 
Again the (+)-1somer (S-conf1gurat1on) was retained the longest. 
Resolution of carblnoxamlne did not a lte r  greatly (Table 3 .3 ).
Attempts to resolve the other antihistamines of Interest 
showed no advantage over Method 1. In the case of 
mebrophenhydramlne, meclozlne and hydroxyzine no resolution was 
seen. The use of a UV detector was possibly the reason -  the 
A. max for these compounds 1s around 220-230nm and may be 
causing Interference with solvent end absorption. Perhaps use of 




T, K 1 T 2 * 2 a Rs
RS phenlramlne 
RS phenlramlne
18.3 4.1 60.0 15.7 3.84 2.76




RS chlorpheniramine 28.8 7.0 48.0 12.33 1.76 1.33
29.4 7.17 47.4 12.17 1.70 1 . 1 0
(+)-chlorphen1 ram1 ne - - 43.2 1 1 . 0 - -
- - 45.0 11.5 - -
( - ) -chlorpheniramine 24.6 5.83 - - - -
27.0 6.50 - - - -
RS brompheniramine 39 9.83 48.6 12.5 1.27 0 . 8
(♦)-bromphen1 ram1 ne - - 47.1 1 2 . 1 - -
RS carblnoxamlne 23.4 6.08 37.8 9.5 1.56 1 . 0 0
24.6 5.83 36.0 9.0 1.55 1.05
( - ) a-carb1 noxam1 ne - - 33.6 8.33 - -
- - 30.6 7.5 - -
(+ )a-carb1 noxam1 ne 24.6 5.83 - - - -
2 2 . 8 5.33
Footnotes as for Table 3.2




carblnoxamlne tartrate RS phenlramlne maleate brompheniramine maleate
F1g 3.9 Chromatograms of the phenlramlnes and carblnoxamlne (racemates and
their Isomers) using Method 2.
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Using Method 2 a sensitiv ity  experiment was carried out, 
whereby a solution of (-)-chlorphenlramlne was spiked with 
Increasing quantities of (+)-ch1orphen1ram1ne. The results showed 
that a 1 % Impurity of the (+ ) - 1 somer 1 n the ( - ) - 1 somer was just 
v is ib le  on the chromatogram but that < IX would not have been 
detected. Unfortunately no Integrator was available at the time 
of completing this work.
The addition of tetrabutylammonium phosphate to the mobile 
phase reduced the retention greatly when compared to Method 1. 
(NaCl/propanol). The reason 1s probably that the charged modifier 
competes for both the chiral and non-chlral binding sites of the 
protein (Schill et a l, 19861) .  Since a^ -AGP 1s very 
acid ic , at pH 7 (pH of the mobile phase) the protein molecule has 
a negative net charge. I t  1s possible that the hydrophobic 
cationic additive competes with the solute for 1 on1 c binding to 
the negatively charged groups of the protein e.g. the s ia lic  acid 
residues and also for binding at the hydrophobic part.
I t  should be noted that most of the separations have been 
carried out using a new Enantlopac column. In it ia l columns proved 
unsuccessful and the l i f e  of the columns was only *  4 weeks. 
Improvements 1n the manufacture of these columns enabled better 




( - )  chlorpheniramine maleate
1% (+) Isomer 1n ( - )  Isomer
5% (+) Isomer 1n ( - )  Isomer
10% (♦) Isomer 1n ( - )  Isomer
10 Results of sens it iv ity  experiment for chlorpheniramine
Isomers.
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3 .5 .3  Cyclodextrln (CyD) Bonded Phases
Cyclodextrln (CyD) HPLC columns are commercially available, 
through Advanced Separations Technology, as Cydobond I ,  I I ,  and 
I I I ,  I .e .  8 , y and a CyD respectively. The CyD moiety 1s bonded 
to a five  micron spherical s ilica  gel via a six to ten atom 
spacer. The ‘o rig in a l8 Cyclobond columns consisted of CyD bound 
to s ilic a  particles whose particle size was not clearly defined. 
The f i r s t  part of the work at Bath was carried out using this 
'o rig ina l* type of Cyclobond column. An Improved B-CyD phase has 
since been Introduced. These columns have nearly twice the 
efficiency and loading of the 'orig inal* columns (Ward and 
Armstrong, 1986). Packed using better technology, these columns 
resulted 1 n separations which were not able to be achieved on the 
'o rig in a l' column. The effect of these changes on the column w ill 
be discussed and comparisons, to the results obtained with the 
'o rig inal* column drawn.
Trials to separate our test antihistamines (RS 
chlorpheniramine, RS carblnoxamlne and RS dlmethlndene ) using an 
'o rig ina l* Cyclobond I column and a mobile phase of methanol /  
water were In itia te d . At 90% water a ll the test samples eluted 
just a fte r the solvent front (SF) and peak shape was 
unsatisfactory 1n the extreme. To suppress Ionisation and enhance 
peak shape, the aqueous water phase was replaced with an aqueous 
ammonium acetate buffer (0.1H), pH6 .
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Effect of decreasing the organic phase content.
Using a mobile phase of 50% methanol: 50% ammonium acetate, 
pH 6 , no separation of the test antihistamine peaks was seen. A ll 
the samples were run as th e ir maleate salts dissolved 1 n the 
mobile phase. The peak due to the malelc acid (Identified  by 
In jection of pure malelc acid dissolved 1 n the mobile phase) was 
retained for a shorter time than was carblnoxamlne Its e lf  but for 
an equal length as dlmethlndene and chlorpheniramine. Decreasing 
the methanol content to 40% Increased the retention time (RT) 
and separated the malelc add peak from that of chlorpheniramine 
and dlmethlndene but did not affect the resolution of the 
respective enantlomers. At 20% methanol, the separation of the 
enantlomers of carblnoxamlne was beginning to be vis ib le , RT 
s 45 mlns, a 1.02. The other samples did not show such promise.
The methanol content was maintained at this proportion and 
attempts to Improve the separation continued by altering other 
factors.
Effect of temperature
Reducing the temperature from room temperature to 15, 10 and 
then 5 *C Increased the retention time but again had l i t t l e  
effec t on the separation factor, a.
Effect of pH
Changing the pH from 6  down to 4 showed no appreciable change 
1 n peak shape, retention time or separation factor.
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Effect of Ionic Strength
Increasing the ionic strength from 0.1-0.5M ammonium acetate 
should force the test compounds Into the cavity resulting 1 n an 
Increase 1n the retention time. This e ffect was Infact seen and 
the retention time Increased to *  100 mlns. Although the peaks 
were s t i l l  very broad, separation of the enantlomers was 
beginning to be seen, carblnoxamlne and chlorpheniramine, 
a * 1 .04 .Further Increase 1n 1on1c strength to IN ammonium 
acetate, necessitated the Inclusion of a s ilic a  guard column 
1 1 n - l 1 ne' between the pump and rheodyne In jector, to saturate the 
mobile phase before reaching the Cyclobond column. After 
equilibration overnight, the RT for both carblnoxamlne and 
chlorpheniramine had both Increased further, RT *  140 mlns 
accompanied also by an Increase 1 n the separation factor, a = 
1.06.
Effect of Flow Rate
Reducing the flow rate from 0.5 to 0.3 m1/m1n under the above 
conditions had l i t t l e  advantage for carblnoxamlne, the a value 
was now 1.09, but the peaks were just as broad.
Preliminary t r ia ls  using a y  CyD column (Cyclobond I I )  were 
not encouraging but the B-acetylated column (Cyclobond I -  
acetylated) showed similar separation to the underlvatlsed 8 .
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Inclusion of an ion pair reagent, sodium perchlorate 0 . 1 M, 
into the mobile phase, to prevent drug binding to the free 
silanol groups on the column, had the desired effect of reducing 
ta iling  and sharpening the peaks but the undesirable effect of 
worsening resolution.
Due to the lack of success with this 'o rig ina l' column, an 
improved column was obtained. Using the same conditions as before 
(20% NeOH : 0.1N ammonium acetate, pH 4, room temperature), the 
Rt of carblnoxamlne and chlorpheniramine had again increased 
to 150 and 170 mins respectively. The separation factors had 
similarly increased to a 1.05 and 1.09 respectively -  but peak 
shape remained the same.
A new buffer system was now investigated to assess the effect 
on peak shape. The new mobile phase was methanol : 1% tr ie th y l -  
ammonium acetate (TEAA), pH 4.1. When the methanol content was 
reduced from 40 to 20%, separation became visible and peak shape 
was enhanced to give the following results -  carblnoxamlne a =
1.05 and chlorpheniramine a » 1.09 (Fig 3.11). To increase 
separation and peak shape further, the methanol organic phase was 
replaced by a more polar organic phase i .e .  aceton itrile .
I l l
RS chlorpheniramine RS carblnoxamlne
80% TEAA (1%) : MeOH
w /
90% TEAA (1%) : AcN
90% TEAA (2%) : AcN
Fig 3.11 Trace chromatograms for the resolution of RS chlorpheniramine 
and RS carbinoxamine using d iffering  mobile phases.
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Armstrong et al (1986) published data for the resolution of 
chlorpheniramine (a 1.07, Rs 1.51) using a 8 -CyD column. These 
results were comparable to those obtained at Bath, as previously 
described using a 20% MeOH : 80% TEAA (1%) mobile phase. Using 
Armstrong (1986) conditions I .e . 85% TEAA (1%), pH 4.1 : 
ac e to n ltrlle , but a t a slower flow rate ( 0.5 m1/m1n ) ,  the 
resolution of chlorpheniramine showed a comparable separation 
factor a 1.09, but the resolution was only Rs * 1.00 Attempts to 
Increase the resolution continued.
Decreasing the organic phase to 10% Increased the separation 
of chlorpheniramine (a * 1 . 1 1 ) and carblnoxamlne (a * 1.08) s t i l l  
further, although baseline separation had s t i l l  not been 
achieved. An Increase 1n the strength of TEAA used, from 1-2% 
sharpened the peaks s t i l l  further but s t i l l  did not give baseline 
separation Rs > 1 .5 . This was, however, the mobile phase used for 




Tl K 1 T 2 * 2 a Rs
85% TEAA (IK) : AcN 
RS chlorpheniramine 22.5 2.75 24.3 3.04 1 . 1 1 1 . 0 0
RS carblnoxamlne 24.3 3.04 25.5 3.25 1.07 0.83
90% TEAA (1%) : AcN 
RS chlorpheniramine 42.8 6 . 1 46.5 6.75 1 . 1 1.14
RS carblnoxamlne 45.3 6.5 48.0 7.0 1.08 0.83
(-)-carblnoxamlne - - 48.8 7.1 - -
(+)-carb 1 noxam1 ne 45.8 6.63 - - - -
Table 3.4 Chromatographic features for carblnoxamlne and 
chlorpheniramine using an Improved Cyclobond I column.
114
The results (F1g 3.12, Table 3.5) show that only successful 
resolutions were achieved with the halogenated phenlramlnes and 
carblnoxamlne. No separation was seen for dlmethlndene (20) 
although 1t was retained by the CyO column (R  ^ « 30 mlns).
Its  structure, although containing two aromatic substituents 
linked to the chiral centre, does not appear to be suffic ient for 
stereoselectivity. I t  1s unlikely that the overall shape of the 
molecule hinders Its  Inclusion Into the CyD cavity since 
NMR data provides clear evidence for the formation of an 
Inclusion complex (4 .4 .1 ).
No resolution was seen for mebrophenhydramlne (11), meclizine 
(13) or hydroxyzine (15). This may again have been due to the 
choice of detector and the problem of solvent cut-o ff. As with 
dlmethlndene *H NMR provides evidence for the formation of an 
Inclusion complex between mebrophenhydramlne and 6  CyD (4 .8 ).
The phenlramlne series (17) showed an Interesting reversal of 
the trend seen with the AGP column 1n that the presence 
and Increase 1 n size of the halogen sustltuent enhanced the 
stereoselectivity. This reinforced Beesley (1987) who stated that 
halogens have a very large a f f in ity  for the CyD cavity.
Interesting also 1s the fact that again 1t 1s the more active 
Isomer of each of the two compounds that 1 s retained the longest 
I .e .  (+) phenlramlnes and ( - )  carblnoxamlne -  both of S 
configuration. This confirmed some preliminary studies using 
'docking experiments' 1 n molecular graphics which showed S- 




T, K, T 2 * 2 a Rs
RS chlorpheniramine 37.5 5.25 40.6 5.75 1 . 1 0 1.33
(+)-chlorphen1 ram1 ne * ’ * 40.5 5.75 - -  .
( - ) -ch1 orpheni rami ne 37.6 5.25 - - - -
RS brompheniramine 26.9 7.83 29.9 8.92 1.14 1.52
(♦ ) -bromphenirami ne - - 30.0 9.0 - -
( - ) -brompheni rami ne 25.7 7.5 - - - -
RS pheniramine 19.2 2 . 2 19.52 2.25 1.03 -
RS carblnoxamlne 41.49 5.92 43.69 6.25 1.06 1 . 0 0
(-)-carbinoxamine - - 43.8 6.29 - -
(♦)-carb 1 noxam1 ne 41.7 5.95 - - - -
Mobile Phase: 90% (TEAA)(2%) : AcN.
Footnotes
* 3% Impurity peak found
Fig 3.5 Chromatographic results for test compounds after 





F1g 3.12 Selection of chromatograms showing the resolution of
the enantlomers.
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Sensitivity experiments carried out using ( - )  chlorpheniramine 
spiked with (+) chlorpheniramine, showed the level of detection 
to be at 0.5% of one Isomer 1n the other (F1g 3 .13).
Such tests using carblnoxamlne, ( - )  Isomer spiked with the (+) 
Isomer were not as successful and under these conditions only a 
1% Impurity of (+) 1n the ( - )  could be detected (F1g 3.14).
The use of the cyclodextrln column has highlighted some points 
made earlie r (Chapter 2) I .e .  that crysta llisation  to a constant 
rotation 1 s not 'an absolute Indication of optical p u rity '. 
Although the chlorpheniramine maleates had constant rotations, 
equal but opposite 1 n sign,
241 .e .(+ ) chlorpheniramine maleate [o ] 0  +23.2 (c 1.2
1n H2 0)
24( - )  chlorpheniramine maleate [a ]Q -23.9 (c 1.08
in H2 0)
chromatographic techniques using the CyD column have shown that 
resolved (+) chlorpheniramine maleate does actually contain a 3% 
impurity of the weaker ( - )  Isomer (perhaps this explains the 0.7 
difference 1n the two a values). This 1s not as much of a problem 
as I f  the ( - )  Isomer (weaker) had been contaminated with (+) 
isomer -  but 1t may affect the human study results. HPLC results 
have shown the ( - )  Isomer to be 100% pure (F1g 3.15).
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3 8 . 8  mlns
( - )
4 2 6
Mobile phase : 90% TEAA (2%) : AcN
K1 Integ K2 Integ
1 5.5 88.1 6.08 11.9
2 5.5 96.04 6.08 3.96
3 5.5 98.91 6.08 1.09
4 5.5 99.7 6.08
lml stock solution (2mg/ml) 
(-)chlorphenlramlne maleate 
was spiked with varying 
volumes of (♦) Isomer (2mg/ml)
1 1 0 0 y l ( ♦ )  — — 1 m l ( - )  » 10%
2 5 0 p l ( * )  — ► lm l ( - )  .  5%
3 1 0 p l ( * )  — ^ l m l ( - )  « 1%
4 5 p l ( ♦) — ► l m l ( - )  = 0 . 5 %
F1g 3.13 Chromatogram Il lus tra ting  sensitiv ity  experiment for 
( - )  chlorpheniramine maleate spiked with the (♦) Isomer.
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4 2 5  mlns
lOOyl  ( 2 m g / m l ) o f  ( ♦ )  
c a r b l n o x a m l n e  s p i k e d  w i t h  ( - )  
I so m er  up t o  vo lum e  o f  1ml
50y l ( + )  — —lml ( - )
1 Oyl  ( ♦ )  — ►lml  ( - )
( - )  I s o m e r  o n l y
F1g 3 . 1 4  C h r o m a t o g r a m  I l l u s t r a t i n g  s e n s i t i v i t y  e x p e r i m e n t  f o r  
( - )  c a r b l n o x a m l n e  m a l e a t e  s p i k e d  w i t h  ( ♦ )  I s o m e r .
1 2 0
c h l o r p h e n i r a m i n e  m a l e a t e
F 1g 3 . 1 5  HPtC t r a c e  sh o w in g  ( - ) c h l o r p h e n l r a m l n e  t o  be 100% p u r e  
w h i l s t  t h e  ( ♦ )  I so m e r  has a 3% I m p u r i t y
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3.6 Materials and Methods
3.6.1 Instrumentation
All measurements were carried out on an LOC /  Milton Roy 
constametrlc 3000 pump linked to an LDC /  Milton Roy 
spectrophotometer 3000 variable wavelength detector and a BBC 
SE12 chart recorder.
3.6 .2 Materials
(RS)- antihistamines were supplied by the pharmaceutical 
Industry as follows : dlmethlndene maleate (Zyma), carblnoxamlne 
maleate (Wyeth Research UK)V doxylamlne succinate (Merrell Dow 
Pharmaceuticals), phenlramlne maleate (A.H. Robins and Hoechst 
UK), chlorpheniramine maleate (Smith K11ne and French Research), 
brompheniramine maleate (A.H. Robins), mebrophenhydramlne HCL 
(Smith KUne and French Research ) .
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3.6 .3 Experimental Details 
Enantlopac Column Work
Method 1 (Hermansson, 1984)
Column : Enantlopac cartridge column
Mobile Phase: 8 mM Na2 HP04  /  NaHP04  buffer
containing 0.1M NaCI, 0.4% 4-propanol, pH6.9. 
Flow rate: 0.3m1/m1n.
Oetectlon: 254 nm.
Injection volume: 10 y l.
Sample preparation: s2 yg salt dissolved 1n the mobile phase.
Temperature: 15#C.
Method 2 (SchUI et a l ,  19862)
Column : Enantlopac cartridge column




Injection volume: 20 y l.
Sample preparation: «4mg sa lt dissolved in 25 ml mobile phase. 
Temperature: 20*C.
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Cyclobond I  column
Column : Cyclobond I  25cm column.
Mobile Phase: 90% TEAA (2%) : AcN.
Flow rate: 0.5m1/m1n.
Detection: 254 nm.
Injection volume: 20 »il.
Sample preparation: 0.02mg /  ml 1n mobile phase.
Method for dehalogenatlon of chlorpheniramine
Reduction (50mg of 10% Pd-Cf 22*C, 60ps1, 50ml MeOH) of 5g 
chlorpheniramine (RS or levo) obtained from Its  hydrogen maleate was 
continued un til absorption of had ceased (8-12 hours). The 
Pd-C was removed by f ltra tlo n  through c e llte . The f i l t r a te  was 
evaporated under reduced pressure to yield a purple o il of 
phenlramlne. Formation of the hydrogen maleate (as Chapter 2) yielded 
a white crystalline solid (2.95g 46%). Evidence of the success of 
th is method was by HPLC study as previously described and by 
1 3 C-NMR which showed an Increase of one CH aromatic resonance 
a fte r dehalogenatlon.
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UV absorption characteristics of compounds
I t  was necessary to check I f  the compounds possessed suitable UY 
absorption characteristics to enable a UV detector to be employed In 
the subsequent HPLC studies.
Solutions of the compounds (0.001%) 1n water were prepared. The UV 
absorbance or each solution was recorded on a Perkin Elmer 550S UV 
spectrophotometer from 200 - 300 nm wavelengths, using water as the 
blanks.
X. max A
Brompheniramine maleate 261 0.241 241
Carblnoxamlne maleate 260 0.290 290
Chlorpheniramine maleate 261 0.279 279
Dlmethlndene maleate 257 0.641 641
Hydroxyzine D1HC1 230 0.733 733
Mebrophenhydramlne HC1 225 0.704 704
The results show that most of the compounds (with the exception of 
mebrophenhydramlne and hydroxyzine) have a X max near 260nm and so 
a UV detector could be used In the HPLC analysis of the compounds. 
The wavelength of choice for the assay w i l l ,  however, depend on the 
mobile phase as well as the compound being analysed.
UV detection may not be suitable for mebrophenhydramlne or 
hydroxyzine since th e ir X max may be too low -  detection at this  
wavelength may Increase the Interference from the solvent end 
absorption.
Chapter 4




The use of cyclodextrins (CyD) 1n forming Inclusion complexes 
with medicinal agents 1s currently a topic of In terest. The 
chief pharmaceutical Interest relates to the possible 
stab ilization  (Anderson and Bundgaard, 19841, 19842) and 
solubilization of Included guest molecules and the improved drug 
release, absorbtlon and b loavailab ility  (Uekama et a l,  1982) of 
poorly soluble drugs. Other applications (SzeJtH , 1982) are 1n 
the reduction of side effects (Nambu et a l,  1978), masking of 
unpleasant taste (Fujloka et a l,  1983) and smells, the conversion 
of liquid drugs to a crystalline form and analytical separations.
Although there are several reports on the use of *H NMR 
spectroscopy 1 n the study of such complexes (Nakajlma et a l,  
1984), a recent paper (Greatbanks & Plckford, 1987) has drawn 
attention to the stereochemical value 1 n the case of Inclusion 
complexes formed with chiral guest molecules. Following th e ir  
success with RS propranolol hydrochloride -  t r ia ls  at Bath 
between CyD (a , B & y) and racemlc ant1h1stam1n1cs were 
undertaken to Illu s tra te  the potential value of this data with 
regard to optical purity analysis and as a guide to whether the 
development of chromatographic separations of stereoisomers based 
on CyD (bonded as 1n Chapter 3 or 1n the eluate) was lik e ly  to be 
successful.
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These results of *H NHR analyses, as w ill be shown, also 
provide Information about the orientation of the guest molecule 
and Its  conformation within the host cavity. Evidence for the 
formation of an Inclusion complex, between the CyD and guest 
molecule 1 s provided by changes 1 n the chemical shifts (and 
m ultip lic ities ) of signals due to both partners, while locations 
of such changes pinpoint the regions of the molecules Implicated 
1 n the Interaction.
*H NHR features of cvclodextrlns In D^ O
The *H NHR spectrum of y CyD was studied by Rao & Foster 
(1963) at 60 MHz who observed only the signal of a single kind of 
anomerlc proton In the NHR spectrum. The NHR spectrum of 
a CyD was further studied by Wood et al (1977) at 100 and 220 
MHz. This work confirmed that the Cl chair of glucose was not 
disturbed In the cyclic polymer.
CHPHCH2OH
C-l Chair 1-C Chair
Fig 4.1 Shows the conformations of glucose 
(p artia l structures)
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The work at Bath, using a - , B- and y-CyD, was carried out at 
270 or 400 MHz and thus provided better resolution of the signals 
than that of spectra previously reported. The *H NHR spectra 
of each CyD resembles that of their closest monomeric analogue, 
a-methylglucoslde.
OMe





^  L —-A/ 'Ju__
PPMt—r T t—rT T 1— i— i— r T T 1 1----1----1----f T T3.739 3.5 3.3
F1g 4 . 3  400 MHz *H NMR s p e c t r u m  o f  a - m e t h y l g l u c o s l d e  ru n  I n  0^0
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Only five  of the seven proton signals were resolved. The 
lowest fie ld  proton, seen as a doublet (d) at 4.75 ppm, 1s due to 
the anoraerlc proton, H -l, because 1t Is flanked by two 
deshielding oxygen atoms. The small coupling (*4 Hz) 1s 
consistent with Its  equatorial conformation, showing an 
equatorial (eq)/ax1a1 (ax) coupling to the axial H-2 proton.
Peak number 4, at 3.51 ppm , 1s assigned as H-2 since this  
also showed a small eq/ax coupling, of 3.$ Hz, to the H-1 
proton. In addition this doublet of doublets (dd) also shows a 
large ax/ax coupling, to H-3, of 9.5 Hz.
Peak number 5 (3.59 ppm) 1s assigned to H-4. This apparent 
tr ip le t  ( t )  signal (the lowest fie ld  line was obscured by the 
O-Me signal) 1s made up of two large ax/ax couplings (to H-3 and 
H-5) of 9 Hz.
Peak number 2 1s assigned as the two non-equivalent H^ - 6
signals. This eight line signal 1s typical of an AB system.
Each half of the pattern Includes a coupling (12.5 Hz) typical of 
2
a J gemlnal coupling. In addition the two H- 6  protons are 
coupled 1n d iffering  degrees (2 .6  Hz and 5.3 Hz) to H-5.
Peak number 3 1s a compound signal due to the resonances of 
H-3 and H-5; H-3 gives a t r ip le t  at 3.61 ppm, due to two large 
ax/ax couplings of approximately the same magnitude (9 Hz), the 
highest fie ld  line overlapping with the H-5 resonance. The H-5 
signal 1 s more complex and a ll the peaks of the m ultlplet cannot 
be clearly analysed.
This analysis agrees with that of De Bruyn et al (1975), 
carried out at 300 HHz.
The analysis of the cyclodextrlns by ’h NHR (400 and 270 
MHz) followed. At 400 HHz four (out of seven) proton signals of 
B-CyO were resolved.
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- r - p r - ,  — ,--.   1   I   I 1 I I ' '  1   1     1     1 r -
S OS J.9 J. 6  J «.
F1g 4.4 400 MHz spectrum of B-CyD run 1n 020
The analysis was aided by the assignments of o-methylglucos1de 
and by the chemical shifts of the protons of a-CyD (Wood et a l ,  
1977). The lowest f ie ld  doublet (5.05 ppm) with the small 
coupling *4 Hz was assigned as the anomerlc proton H - l . The H-2 
proton was again v isib le as a doublet of doublets at 3.63 ppm 
showing a large ax/ax coupling to H-3 (9.8 Hz) and a smaller 
ax/eq coupling (3.5 Hz) to H -l. In the B-CyD spectrum H-4 and 
H-3 are both clearly v is ib le  as tr ip le ts  at 3.56 and 3.94 ppm 
respectively. Protons H-5 and H2~6 overlap to give a 
multlplet at = 3.86 ppm.
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Assignment of the two tr ip le t  signals was not Immediately 
evident. The signal at 3.56 ppm assigned as H-4, was s ligh tly  
broader than that at 3.94 ppm. One possible explanation of this  
1s that the H-4 proton 1s showing long-range coupling to H2 - 6 .
A sim ilar pattern emerged for the 400 MHz spectrum of a - and 
Y-CyO. See Table 4.1 for details.
I t  1s Interesting to note a downfleld s h ift of a ll  the protons of 
CyO compared to those of a-methylglucoslde (Table 4.2)
Table 4.2 Downfleld shifts (1n ppm) of CyD protons 1n relation  
to those of o-methylglucoslde
1-H 2-H
glucose proton 
3-H 4-H 5-H 6 -H2
B-CyD 0.30 0 . 1 1 0.33 0 . 2 2 (0.26) 0.03/0.1S
a-CyD 0.28 0 . 1 0 0.35 0.25 (0.26) 0.03/0.15
Y-CyD 0.33 0 . 1 2 0.30 0.25 (0.26) 0.03/0.15
The downfleld s h ift seen 1n the CyD moiety 1s most pronounced at 
H-l and the two Inner protons H-3 and H-5 (see F1g 4.5 for schematic 
diagram of CyD). As a result of this sh ift H-3 moves downfleld of 
H2 - 6  and 1s fu lly  resolved and H-5 overlaps with the H2 - 6  
signal to produce a signal that 1 s not fu lly  resolved, as a complex 
m ultlp let.
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Table 4.1: 400 HHz NHR characteristics In DgO of three cvclodextrlns 
and their monomer equivalent. a-methvlolucoslde1
Carbohydrate 1-H 2-H 3-H 4-H 5-H 6-CH2
a-methylglucoslde^ 4.75 3.S1 3.61 3.34 nr 3.59 3.82 dd(2.6,12)
(OHe s 3.36) d(4) dd(4,9.5) t(9) t(9) ddd° 3.70 dd(5.3,12)
beta (8-) 5.05 3.62 3.94 3.56 - e e
cyclodextrln d(4) dd(3.5,9. 8) t(9.5) bt(9)*>
alpha (a  -) 5.03 3.61 3.96 3.59
cyclodextrln* d(3.5) dd(3.4,10) t (9.5) t (9) e e
gamma ( 7  -) 5.06 3.63 3.91 3.59 e e
cyclodextrln d(3.7) dd(3.4,9. 5) t(9.5) t(9.5)
Footnotes
a = chemical shifts In ppm from THS using acetone (2.1 ppm) as external reference; multlplet 
separations (Hz) In parentheses; abbreviations s singlet, d doublet, t  trip let, m multlplet, 
b broad.
b = cf 300 HHz study of Or Bruyn et al (1975)
c ■ overlaps 3-H signal, only 2.6 Hz coupling resolved
d x broader than 3-H signal probably due to long range coupling to 6-CH2
e x overlap to form a multlplet centred near 3.85 ppm




F1g 4.5 Cross section of the torus of a CyD, 
Indicating the approximate position of the sugar protons
In the 270 MHz spectra, a l l  the features of the 400 MHz 
spectra were apparent. However, the multlplet near 3.86 ppm, 
( I . e .  the H-5 and H2~6 signal) was less well resolved and the 
H-2/H-4 signals overlapped.
4.3 *H NMR studies of pyrldyl compounds
Since several of the chiral antihistamines studied 1n this  
thesis are 2-pyr1dyl derivatives, analysis of the 'h NMR 
spectra of pyridine and 2-ethylpyr1d1ne and their protonated 




The 270 MHz spectrum of the non>protonated pyridine molecule 
1 n DgO and that of Its  protonated maleate sa lt show the same 
rank order of the signals but an Increase 1 n the resolution of 
the fine structure.
H
Fig 4.6 Chemical sh ift values (ppm) of non protonated 
and protonated pyridine run at 270 MHz In 020
The lowest fie ld  signal (maleate) seen as a doublet at 
8.48 ppm is due to the protons, ortho to the ring nitrogen. The 
deshleldlng Influence of this ring nitrogen 1 s least at the 
proton meta to the nitrogen, this signal being seen as a tr ip le t  
at 7.78 ppm. The tr ip le t  at 8.29 ppm. Incorporating ortho and 
meta coupling was due to the proton para to the ring nitrogen.
4.3.2 2-Ethylpyr1d1ne
Although the commercial sample Included Impurity signals, the 
principal signals could be resolved and assigned on the basis of 
th e ir chemical shifts and m u ltip lic ities . The lowest fie ld  peak 
(8.27 ppm) was a doublet (5Hz) and was assigned as the proton 
ortho to the nitrogen ( H-6 *).
7.49 ( t ) 8.29 ( t )
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The H-4• proton signal was resolved at 7.64 ppm, showing ortho 
coupling ( 8  Hz) to H-3' and H-5* and meta coupling to H-6 ' (1 .7  
Hz). H-3* and H-5* signals overlapped near 7.18 ppm, but I t  was 
possible to identify the H-3' proton as a doublet (7.18 ppm, 8  
Hz), and H-5' as a t r ip le t  (7.13 ppm, 8  Hz).
7.13 ( t )
Fig 4.7 Chemical s h ift values (in  ppm) of 2-ethylpyridine
1n 02 0, at 270 MHz
Thus in 2-subst1tuted pyridines the rank order of the pyridyl 
protons is H-6 * (lowest f ie ld ) ,  H -4 ', H-3* and H-5* (highest 
f ie ld ) .
The spectra of 2-ethylpyridine run in the presence of 8 -CyO 
showed much sharper peaks and clearly resolved the H-3' and H-5' 
proton signals (a t 270 MHz).
Fig 4.8 Chemical sh ift values (in  ppm) of 2-ethylpyridine, 
in 02 0, in the presence of 8 -CyO (270 MHz)
c h 2c h
c h 2c h
7.22 ( t )
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NMR features of antihistamines 1n the presence and 
absence of cyclodextrlns
4.4 RS 01meth1ndene Maleate (20)
4.4.1 *H NMR features of dlroethlndene maleate
( 20)
At 400 MHz, the spectrum for dlmethlndene maleate was fu lly  
resolved. In the low fie ld  region, a l l  eight aromatic protons 
were resolved (Table 4 .3 ). Four of these signals had chemical 
s h ifts , m u ltip lic ities  and rank order typical of the protons of 
2-ethy1pyr1d1ne (F1g 4 .7 ).
The doublet (7 Hz) near 7.4 ppm, placed between the H-31 and 
H-5' pyrldyl signals and the doublet (7 Hz) at 6.9 ppm are 
assigned to H-4 and H-7 (not necessarily respectively) of the 
Indene ring system. The closely paired doublet of tr ip le ts  (d t) ,  
centred at 7.1 ppm, are assigned as H-5 and H- 6  of this ring 
system. Firm evidence of these assignments 1s provided by the 
results of the 20 ] H / }H COSY 45 plot (Fig 4.9) which 
revealed ortho, meta. and para couplings -  the last not being 
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F1 g 4.9 20 'h/ h COSY 45 plot of dlmethlndene maleate
1n 0^0, run at 400 MHz
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COSY 45
The COSY 45 'h- ' h NMR experiment produces a plot 1n
which the Identical 1-D spectra are displayed along the two 
axes. Corresponding resonances give rise to contour lines along 
the diagonal while coupled resonances produce lines offset from 
the diagonal (o ff  diagonal or crosspeaks).
For example
Thus 1f signal a 1s coupled to signals b and cv two offset
lines w il l  be seen paralle l with signal a and one each for b and
c (Benn and 6unther, 1983).
The results of the low f ie ld  COSY plot for dlmethlndene




Table 4.4 Low fie ld  COSY couplings for dlmethlndene maleate





6 * (Py) 3 '* ,  5'
4* (Py) 6 ' ,  3 *. 5'
3' (Py) 6 ' * .  4 \  5'
7(4) 5/6. 4(7)*
5' (Py) 6 ' .  4 '.  3'
5/6 7 (4 ), 4(7)
4(7) 7 (4 )* . 5/6
a Indicates a very weak, ( para) coupling
These results confirm that the doublets near 7.4 ppm is either 
H-4 or H-7, while the doublet Immediately to low fie ld  (near 7.6 
ppm) 1s a pyridyl proton ( 3 ') .  The COSY experiment also clearly  
reveals the three coupling interactions of each pyridyl proton -  
these were not evident from the 1-D spectrum in the cases of 
H -3', H-5' and H-6 *.
Assignments in the high fie ld  region (0-6.2 ppm) are as 
follows: The maleate protons give rise to a sharp singlet at
6.14 ppm. The quartet at 4.54 ppm ( 6 . 8  Hz) must be due to Me-CH 
of C-8 , linking the indene to the pyridyl ring, whilst the 
doublet at 1.69 ppm ( 6 . 8  Hz) was assigned to the Me-CH of the 
same carbon. The broad singlet at 2.87 ppm, integrating for six 
protons, was assigned to the N-Me group.
Table 4,3: 400 HHz NHR characteristics of RS dimethindene salts in 0^0 in the
absence and presence of ) mole equivalent (approx.) of B-cyclodextrln*
Aromatic proton signalsf
Compound 6 ’ (py)c 4'(py) 3*(py) 7(4) 5'(py) 5,6 4(7) Other
signals
RS dimethindene (20) 8.37
maleate** in D2O d(5)d
7.88 7.59 7.44 7.34 7.12 6.9 8-H 4.54
dt d(8.5) d( 7) dd 7.06 d(7) q(7.5)
(8 ,8 ,1.5) (5,7) d t(7 ,l)
plus 8-cyclodextrin 8.46 7.93 7.53
narrow t t t ( 8 ,8 , 7,48










RS dimethindene (20) 8.4




















RS dimethindene (20) 8.46











































Footnotes -  Table 4.3
a =chemical shifts in ppm from THS, ; multiplet separations (Hz) in parentheses 
abbreviations s singlet, d doublet, t  t r ip le t, m multiplet, b broad, 
b =6.14 ppm s 
c =of pyridyl ring
d =each line shows fine structure 1Hz 
e =m near 7.38 ppm
f =aromatic assignments confirmed by a COSY plot 
g =6.37 ppm s 
h =centre lines overlap 
i =4.32 ppm s
j  =probable assignment 5-H
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The remaining signals at 3.42 ppm (s , 2H), 3.37 ppm (m, 1H) 3.27 
ppm (mv 1H) and 2.96 ppm (m, 2H) are assigned to C-1 methylene 
and the ethylamlno side chain. More specific assignments are not 
possible.
4 .4 .2  Spectral changes 1n the presence of B-CvO
Significant changes 1n the resonance signals of both the host 
( 6 -CyD) and guest (dlmethlndene) were seen when a 1:1 mixture 
(approximately) of the two components, 1 n D2 0 , was examined
and compared with spectra of the two components 1 n Isolation (see 
Table 4 .3 ).
Host Signals
Upfleld shifts of the host molecule signals were seen for H-3, 
H-5 and H2 6  I .e .  those due to the protons attached to the 
In terio r of the CyD cavity, while resonances of the external 
protons (H -l, H-5 and H-4) were l i t t l e  altered.
In the spectra of these complexes, the CyO signals were best 
resolved with (+ )-d 1 meth1 ndene ta rtra te  as the guest molecule 
(F1g 4.11). Under these conditions the upfleld shifts (1n ppm) of 
the CyD protons noted, were; H-1 n i l ,  H-3 0.25, H-6 a6 b 0.07,
H-5 *  0.25, H-2 n il and H-4 0.05.
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F1g 4.11 Expanded *H NMR spectrum of 0-CyD signals 
when complexed with dlmethlndene
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Guest Signals
The pyridyl H-6' .  H-4' and H-3' and the highest f ie ld  aromatic 
proton H-4(7) resonances a l l  appeared 1n duplicate form, with 
those of H-3' and H-4(7) showing the greatest separation of the 
antipodal signals (F1g 4.12).
T —
S.0 T
F1 g 4.12 Expanded 'h NMR spectrum of the low f ie ld  region 
of dlmethlndene a fte r  complexation with 0-CyD
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Thus duplication of the H-41 (d t) leads to a tr ip le t of 
tr ip le ts  ( t t )  separated by *2 Hz at 400 MHz, while the H-31 
doublet Is converted to a pair of well resolved doublets ( 2 d) of 
separation « 16 Hz. The H-5* and H-7(4) signals converged 
together to form an unresolved m ultlp le t. The H-5/6 tr ip le ts  
were l i t t l e  changed although some loss of fine structure was 
noted, while the H-4(7) resonance appeared as a pair of doublets 
of separation «7 Hz.
The only high fie ld  signal that was s ignificantly  affected was 
the CH-CH proton of C- 8  which appeared as two quartets 
(4.58 ppm) of «3 Hz separation.
4 .4 .3  The nature of the complex
The stoichiometry of the complex can be obtained by recording 
the spectra of solutions, 1 n 0 0^ , where the ratio  of the two 
components I .e .  host (B-CyD) and guest (dlmethlndene maleate). Is 
varied, but where the overall molar concentration Is constant. 
Table 4.5 shows the shifts for 6 -CyO: dlmethlndene maleate 
solutions of seven chosen molar ra tios , at 400 NHz. Then, by 
performing a Job Plot (Nakajlma et a l ,  1984) fo r, for example,
H-3 of the CyD (Table 4.6, Fig 4 .13), the curve maximizes at 0 .5 , 
Indicating a 1 : 1  complex.
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Table 4.6 Data for Job Plot of H-3 (B-CyD) of 
dlmethlndene maleate:B-CyD complex 
(calculated from 270MHz spectra)
[B-CyD] [dim] a Hz




3/4 1/4 56 42 0.25
2/3 1/3 60 40 0.33
1 / 2 1 / 2 92 46 0.50
1/3 2/3 108 36 0.67
1/4 3/4 1 1 2 28 0.75
Similar plots were obtained for H-5 and the aromatic protons, 












F1g 4.13 Job Plot for a variety of dlmethlndene and CyD 
protons when complexed with B-CyD
Table 4.5 Experimental data for constant variation (Job) plots of 
dimethindene maleate:B-CyD complex (270 MHz)
Chemical Shifts (ppm)
&-CyO aromatic dimethindene maleate
Job Plot [B-CyD]:[dim] H-l 2 3 4 5 6-H2 6' 4’ 3* 7(4) 5* 5/6 4(7)
1 1 : 0 8.37 7.88 7.61 7.45 7.36 7.12 6.91
2 3/4 1/4 4.96 3.62 3.66 3.49 2.50 3.74 8.40 7.91 7.58 7.45 7.37 7.09 6.93
3 2/3 : 1/3 4.99 3.62 3.67 3.51 3.53 3.77 8.43 7.92 7.57 7.43 7.38 7.09 6.95
4 1/2 : 1/2 5.00 3.62 3.71 3.53 3.58 3.79 8.46 7.93 7.54 7.40 7.40 7.10 6.97
5 1/3 : 2/3 5.02 3.62 3.79 3.53 3.68 3.81 8.48 7.94 7.50 7.40 7.40 7.10 7.00
6 1/4 : 3/4 5.02 3.63 3.80 3.53 3.69 3.82 8.49 7.94 7.50 7.41 7.41 7.12 7.00
7 0 1 5.05 3.62 3.94 3.56 3.85 3.85 - - - - - - -
Hz - - - 0.28 - 0.35 0.11 0.12 0.06 0.11 0.05 0.05 - 0.09
Hz is the difference between the free value and the complexed value
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The spectra of the fumarate and tartra te  salts of RS 
dlmethlndene were similar to that of the maleate except that the 
H-5' (Py) and H-7(4) resonances were Interchanged (see Table 
4 .3 ).  This gives us evidence of the unique shielding Influence 
of the maleate anion 1n the 1on pair. After addition of 6-CyD to 
the tartrate  sa lt ,  a l l  the aromatic signals remained resolved and 
a l l  except H-7(4) and H-5/6 were duplicated. The separations for 
the tartrate  were H-6' (Py) *2 Hz, H-4' *3.5 Hz, H-3' 12 Hz, H-5' 
12 Hz, H-5(6) *3 Hz and H-4(7) *8 Hz.
F 1g 4 . 1 4  Expanded ] H NMR s p ec t r u m  o f  low f i e l d  r e g i o n  o f  
d l m e t h l n d e n e  ( t a r t r a t e )  a f t e r  c o m p l e x a t l o n  w i t h  8 -C yO
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On the basis of extents of separation of the chiral 
resonances, rather than chemical sh ift  differences following 
complexatlon - 1t 1s probable that the protonated dlmethlndene 
molecule enters the CyO torus with a carbon 5 -4 -8 -3 '-4 , - 5 , -6 '  
leading. (F1g 4.15)
F1g 4.15 Cross section of CyD complex with the protonated dlmethlndene 
Indicating the proposed position of the guest 1n the cavity
4.4.4 Effect of ring size
The spectra of RS dlmethlndene salts were l i t t l e  affected by 
changing the CyD to that of either a or y. The separation of the 
chiral resonances were not as clear and although some changes 
were v is ib le , the resolution was not as good as that with B-CyD.
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4 .4 .5  Optical purity measurements
From the aspect of optical purity, the appearance of the H-3' 
(Py) resonance has the greatest potential since this occurs as a 
pair of resolved doublets of separation 16 Hz In the 400 MHz 
spectrum of the racemlc maleate. The H-3' (Py) signals 1n the 
270 MHz spectra of antipodal maleates (recrysta l11 zed to constant 
optical rotations) formed near-symmetrical doublets with no 
evidence of antipodal Impurity I .e .  no distortion of the slope of 
the lower fie ld  edge of the dextro signal, or higher fie ld  edge 
of the levo signal (Table 4 .7 ).
Table 4.7 Doublet line chemical sh ift values (1n ppm) for the H-3' 
proton of racemlc, dextro and levo dlmethlndene maleate 
1n the presence of B-CyD (270 MHz, D2 0).
Chemical sh ift (ppm)
RS 7.48 7.50 7.52 7.54
dextro 7.48 7.51 - -
levo - - 7.52 7.55
Spiking experiments were performed by recording inclusion 
spectra of the dextro Isomer (10.5 mg 1n 0.5 ml D2 0) mixed 
with Increasing amounts of the levo Isomer (2 y l ,  5 y l ,  10 y l ,
20 y l and 50 y l of a 12.5 mg 1n 0.3 ml D20 solution) and 
monitoring the appearance of the H-3' doublet. The lim it of 
detection was found to be between 0.76 (2 y l  levo Isomer added) 
and 1.96% (5 y l levo Isomer added) (F1g 4 .16). On this basis 
resolved material contained no more than 1 % of the minor Isomeric
form.
4.16 Expanded 270 MHz §H NMR spectrum of H-3' proton resonance 
signal showing change of dextro signal on addition of levo Isomer.
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(♦) dlmethlndene maleate
plus IX ( - )  Isomer
plus 2% ( - )  Isomer
plus 5% ( - )  Isomer
plus 10X ( - )  Isomer
plus 25X ( - )  Isomer
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4.5 RS Carb1noxam1ne Maleate (9)




In the low fie ld  region of the spectrum of the RS (9) maleate 
(400 MHz, 02 0) three of the eight aromatic proton signals 
were resolved (Table 4 .8 ). Evidently these were the pyridyl 
protons from their chemical shifts and m u ltip lic ities  I .e .  H-6 * 
dd near 8.44 ppm, H-4' dt centred at 7.8 ppm and H-31 as a 
doublet near 7.47 ppm. The H-5' (Py) and the four protons of the 
p-chlorophenyl ring gave a near singlet at 7.31 ppm.
In the high fie ld  region (0-6.2  ppm), the assignments are as 
follows. The two maleate protons produce a singlet at 6.17 ppm. 
The one proton singlet at 5.57 ppm must be due to the methlne 
proton attached to the benzyl1 c carbon that links the two aryl 
groups. The narrow t r ip le t  at 3.75 ppm and the m ultlplet at 
3.38 ppm, both Integrating as two protons, are assigned as the 
OC^ (0) and C^N (a) protons respectively. The NMe^
signal formed two closely placed broad singlets near 2.83 ppm, 
showing evidence of non-equivalent NMe? groups.
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4.5 .2 Spectral changes on addition of B-CvD
Addition of B-CyD to a solution of RS carb1noxara1ne maleate,
1n 02 0, resulted in duplication of the pyridyl H-41 (sepn
2.5 Hz)v benzyllc CH (sepn 3.2 Hz) and one of the 
non-equivalent N-methyl resonances. The pyridyl H-6 ' signal was 
l i t t l e  changed while H-3‘ and the rest of the aromatic signals 
(doublet and apparent singlet before Inclusion) overlapped to 
form a complex m ultlplet (Table 4.8)
In the spectrum of the RS ta rtra te  (Table 4 .8 ), a l l  the 
aromatic resonances were resolved, but again after Inclusion Into 
the B-CyD, only the pyridyl H-6 ' and H-4' signals (the la tte r  
duplicated) remained Isolated. Duplication of the high fie ld  
N-methyl resonance was clear as was also that of the benzyllc 
signal.
4.5 .3 Effect of ring size
Full resolution of the aromatic resonances was also achieved 
when the RS maleate was Included 1n r-CyD and a ll except the H-6 * 
(Py) signal were duplicated (Table 4 .8 ). Remarkably the N-methyl 
resonance appeared as a broad 6 -proton singlet. The benzyllc 
signal was also duplicated and chemical sh ift differences of
6 . 6  Hz, at 270 MHz, and 9.8 Hz, at 400 MHz, were greater than 
that observed with B-CyD at 400 MHz (3 .2 Hz). This signal was 
therefore chosen for optical purity assessments.
On the basis of separation of signals a fter Inclusion I .e .  
benzyllc CH, 10 Hz: H -4', 2 Hz: H-3‘ , 4 Hz: H2/6, 3.5 Hz: H3/5,
2 Hz: 1t 1s proposed that the protonated carblnoxamlne molecule 
enters the cavity as shown, F1g 4.17.
Table 4.8: 400 MHz lNMR characteristics of RS carbinoxamine salts in O2O in the presence and absence
of 1 mole equivalent (approx.) of cyclodextrina
Compound 6 *(py)c
Aromatic proton signals 
4 ' (py) 3 ' (py) 5 ' (py) 2 ,3 , 5 ,6 (A2B2 )
of A -C IC ^
Other signals









e e benzylic CH 5.57 s 







(8 ,8 ,1.5, 
sepn 2.5)
f f  f.fl benzyllc CH 5.626, 
5.618, 2s sep° 3.2Hz 
NMe2 2.90 bs
2.86  b signal 
resolved into 2 lines 
at peak







7.45 7.39 h 
2xd dd 
(7.2) (5.5,7) 
sepn 4hz sepn 1.5Hz
benzyllc CH 5.565, 
5.541, 2s sepn 10Hz 
NNe2 s 2.87
RS carbinoxamine (9) 








7.55 7.38 centre 
ddd of A280 
(6,5.5, signalJ 
1.5)
benzyllc CH 5.75 s 









k k ,l benzylic CH 5.69 bs 
2 .88 s
2.85, 2.84 2s
Footnotes -  Table 4.8
a =chemical shifts in ppm from THS ; multiplet separations (Hz) in parentheses;
abbreviations s singlet, d doublet, t  tr ip le t, m multiplet, b broad, 
b = 6.14 ppm s 
c e of pyridyl ring 
d = each line shows fine structure 1Hz
e = overlaps 4-C1 signal to give apparent s at 7.31 ppm, of integral 5.
f  = overlap to form multiplet 7.3-7.5 ppm
g = A2B2 signal resolved: A2 2d (8.3) sepn 4Hz 7.43 ppm
B2 2d (8.3) sepn 3Hz 7.36 ppm
h = A2B2 signal resolved: A2 2d (9.0) sepn 3.5Hz 7.24 ppm
B2 2d (9.0) sepn 2Hz 7.00 ppm
i = 4.32 ppm s
j  = outer lines of low intensity 
k *  overlap to form 7.35-7.55 ppm m
1 *  A2B2 signal resolved: A2 2d (8.3) sepn 4.5Hz 7.48 ppm
B2 2d (8.3) sepn 3Hz 7.41 ppm
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CH,OH
F1g 4.17 Cross section of CyD cavity Indicating the proposed position 
of the protonated RS carbinoxamine
.4 Assessment of optical purity
In the 400 MHz Inclusion spectra (y-CyD) of samples resolved for 
this work (2 .7 .3 ) antipodal benzyllc CH resonances both formed sharp 
singlets, (*)carb1noxam1ne 5.61 ppm and (-)carblnoxamlne 5.63 ppm, 
whtch merged smoothly with base line noise and showed l i t t l e  evidence 
of antipodal Impurity. Spiking experiments, carried out (as described 
for dlmethlndene ) showed that 1% of the minor Isomer could be 
detected by examination of the CH resonance. The methlne resonances 
of the antipodal carbinoxamine samples obtained from McNeill 







Fig 4.18 270MHz ]H NMR benzyllc proton signals of Incompletely 
resolved enantlomers of carblnoxamlne ta rtra te  1n 0?0
complexed with y CyD.
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4.6 RS Doxylamlne Succinate
( 10)
In the low fie ld  region of the spectrum (400 MHz, 0^0) a l l  the 
pyrldyl resonances were resolved and could be Identified as usual 
(Table 4 .9 ). The five  phenyl protons formed a multlplet centred at
7.4 ppm.
At the high fie ld  region, the multlplets centred near 3.68 ppm (1 
proton, 8  line signal), 3.52 ppm (1 proton, 8  line signal) and 
3.35 ppm (2 protons) were assigned as the a and 8  methylene signals.
The NMe2  signal was composed of two broad singlets at 2.87 and 
2.81 ppm of separation 25 Hz - another Indication of the 
non-equivalence of the NMe2  groups (c f NMe2  of carblnoxamlne 
maleate). The four proton singlet at 2.46 ppm was due to the 
succinate protons and the three proton singlet at 1.98 ppm to the 
methyl attached to the benzyllc carbon.
Table 4.9 : 400 MHz NHR characteristis of Rs doxy1 amine succinate in D2O in the 
presence and absence of 1 mole equivalent (approx) of cyclodextrin*
Compound
6' (Py)c
Aromatic Proton Signals 
4*(Py) 3*(Py) 5'(Py) 2.3,4,5,6 
of phenyl
Other Signals
RS doxylamine(10) 8.45 7.92 7.6 7.43 7.39 Nhe2 2.87 bs
succinatebin O2O d(5)<* dt d(8)d ddd m 2.81 bs
(8,8,1,5) (7.5,6,1.5) C-He 1.98 s
plus 8.6 7.88 centre 7.43f 7.5 7.2-7.35 ttfte? 2.83 bs
B-cyclodextrin d(5)d 2dt(8,8,i.5 centre centre m C-He 2.19 s
sepn 13.5) 2d® (8, 2ddd(as
sep^ above, sepn,7)
Footnotes -  Table 4.9
a ^chemical shifts in ppm from THS ; multiplet separations (Hz) in parentheses;
abbreviations s singlet, d doublet, t trip let, m multiplet, b broad, 
b ■ 2.46 ppm singlet 
c ■ of pyridyl
d ■ each line shows fine structure 1 Hz 
e *  five phenyl protons
f  = note relative chemical shifts of 3'(Py) and 5'(Py) signals reversed in presence of 0-CyD 
g = form apparent triplet
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In the presence of B-CyD (Table 4.9) the pyrldyl H -4', H-3* and 
H—5• were a ll  duplicated. H-41 changed from a dt to 2 dt of 
separation 13.5 Hz, H-31 to 2 d (giving an apparent t r ip le t )  of 
separation 8  Hz and H-5* gave a multiplet of separation 7 Hz (the 
signal width of this H-5* resonance actually increased by 6  Hz).
These results are notable in that the separation of the antipodal 
H-4' resonance was much greater than that observed for H-4* of 
dimethindene (2 Hz) and carbinoxamine (2.5 Hz). Separation of the 
H-3' and H-5* resonances were less than that of H-4* but s t i l l  
substantial. Also the re la tive  chemical shifts of the H-3' and H-5* 
pyrldyl protons were reversed on complexation with CyO.
The phenyl aromatic proton resonances increased in width and 
complexity on inclusion.
In the high fie ld  region, the two NMe resonances of the free 
molecule coalesced to form a broad singlet (2.83 ppm) after  
complexation, while the succinate (s , 2.48 ppm) and benzylic C-He 
(s, 2.19 ppm) remained as singlets, the la tte r being shifted downfield 
by 0 . 2 1  ppm.
These results suggest a d ifferent mode of entry of the protonated 
doxylamine molecule into the cavity -  possibly due to the methyl group 
attached to the benzylic carbon. In the case of carbinoxamine a large 
separation was seen for the benzylic CH -  but in the case of 
doxylamine, very l i t t l e  change was visible for the benzylic methyl.
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This compound 1s a non-pyr1dyl analogue of carbinoxamine. In 
contrast to carbinoxamine. Its  spectral features showed no dramatic 
changes a fter Inclusion Into the B-Cyd -  notably the benzylic C-H 
resonance remained unspllt.
The aromatic resonance was complex but the four line  
signal of the |>-tolyl unit was resolved. After complexation, both 
halves of the signal were duplicated with separation of about 1.25 Hz 
(lower fie ld  half) and 7.5 Hz (high fie ld  h a lf).
No NMe non-equivalence was seen -  evidence that Its  appearance 1n 
previous examples 1 s dependent on the presence of the 2 -pyr1 dy1 
substituent. The sugar resonances gave evidence of complex formation 
(as described 4 .4 .2 ).
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( l l )
This compound 1s a non-pyr1dyl analogue of doxylam1ne( and 
once again the sp litt ing of the NHe2  resonance due to the 
non-equivalence of the two methyl groups was not seen.
At 400 MHz, 1n 02 0, the nine proton aromatic signal was 
composed of two halves of the p-bromo-phenyl A2 & 2  
resonance which surrounded a multiplet due to the phenyl 
protons. In the high f ie ld  region the a and 6  CH2  protons 
gave rise to tr ip le ts  at 3.47 and 3.25 ppm respectively. The 
resonance of the two equivalent methyl groups of the NMe2  
substituent gave a six proton singlet at 2.81 ppm and the C-Me 
group was visible as a three proton singlet at 1.77 ppm.
After Inclusion Into the CyO (B) cavity, the aromatic signal 
became more complex. The upper fie ld  half of the A2 B2  
signal (7.28 ppm) remained resolved and was duplicated Into two 
doublets of separation 3 Hz.
F1g 4.19 Illustrates  the optical purity potential of this high 











F1g 4.19 400 HHz ’h NHR spectrum of high f ie ld  portion of
A2B2 signal of mebrophenhydramlne maleate 1n 020
1n the presence and absence of B-CyO
The signal due to the RS maleate mixture showed two 
overlapping doublets, while that of a resolved sample I .e .  dextro 
Isomer maleate (details  of the resolution 2.7.4) showed a sharp 
doublet with no evidence of the other (levo) antipodal signal.
The high fie ld  signals, of the HC1 sa lt , showed l i t t l e  change; 
the NMe2 signal was unchanged and the C-He resonance 
broadened. In the 400 MHz Inclusion spectra of the RS and 
(f)maleate, however, the NMe2 resonance sp lit  Into two 
singlets of a few Hz separation (2.7 Hz) -  Indicating again some 
conformational change but no chiral differences.
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4.9 The next three examples concern the tr io
H -C -C H 2CH2N(CH3)
Where X » H, phenlramlne (17), X = Cl, chlorpheniramine (17c), 
and X * 8 r, brompheniramine (17b).
RS Phenlramlne maleate (17)
In the low fie ld  region (400 MHz, 02 0 ), the pyrldyl 
protons H-6 ' ,  H-41 and H-31 could be assigned as previously 
described. The H-51 signal overlaps with the phenyl proton 
resonances. In the 0-6.1 ppm region, the two maleate protons 
were visible as a singlet at 6.07 ppm and the benzylic CH signal 
as a t r ip le t  at 4.07 ppm (Table 4.10). The non-equivalence of 
the two NMe^  groups were not apparent and this signal was 
therefore seen as a singlet. The 9 line multiplet at 2.92 ppm 
and the multiplet (1n two halves) at 2.44 ppm were assigned as 
the CC^ ( 6 ) and CH^ N (a) protons respectively.
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Addition of B-CyD to a solution of RS phenlramlne maleate 1n
\
DgO, resulted 1n duplication of the pyrldyl signals H-6 *
(sepn 2.5 Hz), H-4' (sepn 1.5 Hz) and H-3' ($epn 5 Hz).
The H-51 and the phenyl resonances overlapped to give an 
unresolved multiplet.
In the high f ie ld  region the benzylic CH signal duplicated to 
become a four line signal of separation 3 Hz. The a and 0 
methylene signals both shifted downfleld, the 6  proton resonances 
splitting the two halves of the signal Into two eight line  
multlplets, centred at 2.77 and 2.50 ppm and the a proton 
resonance sp litt ing  Into two six line signals a 3.2 and 3.1 ppm.
The sugar signals also showed evidence of complexation, as 
previously described (4 .4 .2 ).
RS chlorpheniramine maleate (17c)
In a spectrum run at 400 MHz 1n 02 0, the pyrldyl H-6 ' ,
H-4* and H-3* signals were resolved and Identified as usual 
(Table 4.10). The A2 B2  resonance of the £-Cl-phenyl unit 
was resolved but Its  low fie ld  half overlapped with the H-5' 
pyrldyl signal.
In the high f ie ld  region the t r ip le t  at 4.17 ppm ( 8  Hz) was 
assigned as the benzylic CHt while the t r ip le t  at 3.01 ppm ( 8  Hz) 
and the two multlplets at 2.55 and 2.47 ppm were assigned as the 
a and B CH2  protons. The NMe2  group was again seen as a 
singlet at 2.81 ppm -  Indicating the equivalence of a l l  the. 
protons.
Table 4.10 NNR characteristics of RS phenlramlne maleate and Its analogues, in D2O, in the 
absence and presence of 1 mole equivalent of B-cyclodextrina
Compound H-6 '(Py)
Aromatic Proton Signals (Chemical shifts in ppm)





























f 9 4.17 t (8)


















2d 2.71 & 7.03
4.02 t (8)
plus B-cyclodextrin 8.57
2 d sepn 2.5
7.90
dt sepn 3
j j 2 x dd





Footnotes -  Table 4.10
a c^hemical shifts in ppm from TMS ; multiplet separations (Hz) in parentheses;
abbreviations s singlet, d doublet, t triplet, m multiplet, b broad, 
b 6.14 ppm s
c each line shows fine structure 1 Hz
d overlaps phenyl signal to give m 7.2 ppm (integral 6)
e overlaps phenyl signal to give an unresolved m at 7.35 ppm
f overlaps phenyl signal 7.29 ppm
g A2B2 signal resolved 2 d at 7.23 and 7.29 ppm
h visible as broad t signal
i overlaps to give a m with two major singlet at 7.34 and 7.35 ppm
j  overlap with high field proton of duplicated A2B2 system
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After addition of B-CyO to a solution of RS chlorpheniramine 
maleate 1n D20, duplications of the H-6 ' and H-4' resonances 
were v is ib le . The other aromatic signals fused together to form a 
m ultiplet, but with two major singlets. In the case of the 
spectrum of dextro chlorpheniramine maleate and B-CyD - only one of 
these singlets was visib le. F1g 4.20 Indicates the potential of 








( + ) :BCyD
p o h
T r 'T . ~ ~  
7.40 7.35
Fig 4.20 Expanded 270MHz H NMR spectrum of chlorpheniramine
maleate signals
This aromatic spectral feature of a resolved sample of 
( +)chlorphen1ramlne maleate with B-CyO Indicated a high degree of 
optical purity (although not quantified).
The a CH? and B CH? protons changed as for phenlramlne 
and the methylene CH t r ip le t  became a broad dt with a very small 
separation.
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RS Brompheniramine maleate (17b)
At 400 MHz, 1n D2 0, the pyrldyl signals could again be 
assigned by their chemical shift and m ultip lic ity . The H-3' and 
H-51 signals were positioned in between the A2 B2  signal of 
the £-Br phenyl resonance (Table 4.10). Patterns for the signals 
of the other proton groups were similar to those of phenlramlne and 
chlorpheniramine i .e .  benzylic CH, t  at 4.02 ppm, the NMe2  
resonance was again a s at 2.74 ppm and the a and B CH2  groups 
gave a t r ip le t  (2.93 ppm) and a two halved multiplet (2.35 and 
2.48 ppm) respectively.
After inclusion in the CyD cavity the H-6 ' (sepn 2.5 Hz) and 
H-4' (sepn 3 Hz) pyrldyl resonances were duplicated as for the 
other pheniramines. The H-3' and H-5' signals overlapped with the 
high fie ld  portion of the duplicated A2 B2  resonance. Both 
protons of the A2 B2  signal were duplicated to give a 2  dd
(Table 4.10). The benzylic CH proton signal was also duplicated 
and the methylene CH2  signals showed the same pattern as the 
other pheniramines. This splitting of the a and B CH2  groups 
was also seen when (+ )brompheniramine maleate was mixed with B-CyD 
and is therefore not due to chiral differences of the inclusion 
complex -  but is probably due to a conformational change within the 
molecule upon inclusion into the CyD cavity.
Using the phenyl A2 B2  signals as the best resonance 
duplication, some spiking experiments were carried out (as 
described for dimethindene ) to measure the optical purity of the
resolved samples (obtained from Schering). Using a solution of
(+)brompheniramine and B-CyD and spiking with the (-)isomer -  no 
change of the signal was evident on addition of 1 or 2% of the 
minor Isomer. No further experiments were recorded since the 
sensitivity of the signal of choice proved to be poor.
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4.10 Chiral additives for optical purity assessment 1n NHR
The technique of using a chiral acid 1n the resolution of 
racemlc bases has been attempted by chromatographic techniques 
(Chapter 3) and should be transferable to an NHR experiment. The 
formation of dlastereomerlc 1 on pairs should result 1 n d iffering  
chemical shifts of antipodal resonances.
Trials with RS chlorpheniramine base and a variety of chiral 
acids were carried out. The three acids used were d-10 
camphorsulphonlc acid (d-10 CSA), phenylsucdnlc add (PSA), and 
d1-£-toluoyltartar1c add (d1-£TTA) _ adds that had been used 1n 
attempts to resolve chlorpheniramine by chromatographic methods.
Attempts using d-10 CSA and PSA were not successful and no 
duplication of any signal was seen. The use of d1-j>TTA (270 MHz, 
CDC13) ,  however did prove successful. The best separation was 
seen for the benzylic CH tr ip le t  (7 Hz) near 4.1 ppm. In the 
absence of d1-j)TTA or using pure Isomeric d1 - 2 -to luoyltartaric  salt 
(obtained from resolution experiments ) only a three line signal 
was seen. Using RS chlorpheniramine base and adding either (■»■) or 
( - )  d1-|>TTA to the solution 1n C0C13  gave a six line signal of 
separation 2.7 to 5.4 Hz. Identification of each of the t r ip le t  
lines could be easily achieved (Table 4.11, F1g 4.21).
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A similar result was obtained using RS brompheniramine with 
d1-|)TTA. This would be a useful signal for the assessment of 
optical purity.
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(+) chlorpheniramine RS chlorpheniramine ( - )  chlorphenlramlr 
( - )  d1-£TTA d1 -|)TTA (♦) dl-^TTA
4.154.20 4.054.15 4.05 PPm4.15
Fig 4.21 270MHz *H NHR resonance of the benzylic protons of RS 
chlorpheniramine maleate 1n the presence of d1-^TTA
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The next few examples Involve the following type of compounds.
R = CH_C.H,2-Me meclozlne (13)
Z 6 4
R = CH^ CHJDCH^ CHJJH hydroxyzine (15)
2 2 2 2
Both of these compounds showed very l i t t l e  change In th e ir  
spectral characteristics a fte r  complexation with B-CyD. The 
benzylic CH and the a lip hatic  side chain resonances were concealed 
by the CyD proton signals.
RS meclozlne d1 HC1 (13) showed a complex aromatic signal which 
became more complex on Inclusion Into the CyD cavity. In the case 
of hydroxyzine (d1 HC1) (15 ), the aromatic signals were again 
complex but on addition of B-CyD, duplication of the lower f ie ld  
half of the 2  Cl-phenyl signal was v is ib le .
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4.12 The following achiral compound, trlpelenamlne hydrochloride (30).
CH
NCH2CH2N(CH,);
( 3 0 )
was our only example of a compound showing no spectral changes 
a fte r  the addition of 8-CyD. S im ilarly  the sugar signals showed no 
evidence of complexation.
Chapter 5
Synthesis and Characterisation of Tr1prol1d1ne and some 
of I ts  analogues
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Introduction
In addition to the study of antipodal pairs of chira l
antihistamines. I t  was decided to Include pairs of geometric Isomers
%
Into this study. The classical example 1s that of t r lp ro l ld ln e  (23) 
and Its  Z-lsomer (31 ).
I t  1s of Interest to obtain further data on th is  class and also to  
study the e ffec t of various structural modifications on the 
antlhlstamlnlc a c t iv ity  of t r lp ro l ld ln e  such as replacement of Ar-4-Me 
by Ar-4-Et and 2-pyrldyl by 3 - and 4-pyrldyl.
2-Pyr1dyl analogues
Samples of t r lp ro l ld ln e  (23) and its  Z-isomer (31) were obtained 
from Burroughs-Wellcome (B-W) and were examined by UV spectroscopy and 
high f ie ld  1H-NMPf.
Evidence for the configuration of geometric Isomers of this type 
was in i t i a l l y  made from observation of the ir  UV spectra 1n ethanol, 
using the method of Adamson et al (1957). In the case of 
tr lp ro lld lne*  the E-1somer (23) exhibited two absorption maxima at 229 
and 276 nm to produce a UV spectrum very similar to that of 
2-vinylpyrldlne (3 2 ), whereas the Z-1somer (31) exhibited a single 
maximum at 258 nm, typical of styrene (33). Adamson et al (1957) 
obtained comparable UV parameters for these compounds and Interpreted  
the ir  results according to the re la t iv e  spatial arrangements of the 
aromatic functions about the o le f ln lc  bond. In the E-1somer the Ar 
ring 1s twisted out of plane of the double bond, (thus reducing the 
chromophorlc e ffec t of the styrenold portion of the molecule) to avoid 
non-bonded interaction between the methylene amino (CH^N) protons 
and o-aryl hydrogens that arise 1n a planar conformation.
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At the same time the pyrldyl function remains co-planar with the 
double bond to constitute a system of extended conjugation similar to 
that of the 2-v1nylpyr1d1ne model. S im ilarly  with the Z-1somer# only 
the Ar ring and the C-C double bond are co-planar 1n the preferred 
conformation and thus the UV spectrum of this Isomer strongly 
resembles that of styrene.
Having determined the configuration of the two Isomers by the UV 
method an explanation of the NMR pattern for each Isomer followed. In 
order to do th is , knowledge of the deshleldlng effects of the 
2-pyr1dyl and phenyl aromatic functions was required. The order of 
these effects was obtained by observation of the respective chemical 
sh ifts  of the v inylic  protons of the same two models, 2-v1nylpyr1d1ne 




5.28/ \ / \
H H H H H H
a. 2-v1nylpyr1d1ne (32) b. styrene (33) c. ethylene
F1g 5.1 Chemical shifts (1n ppm) of the v iny lic  protons of
2-v1nylpyr1d1ne,styrene and ethylene. (Ison and Casy, 1971)
I t  1s clear from these data that the 2-pyr1dyl group has a 
deshleldlng effect on both v inylic  protons but that the phenyl group 
has a deshleldlng e ffect for the v iny lic  proton 1n the els position 
and a small shielding e ffe c t  on the trans proton. Both of these 
screening effects w i l l  be reduced the more the ring 1s turned out of 
the plane of the double bond.
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I t  may be anticipated from considerations of shielding, that the 
methylene amino protons c l i  to 2-pyr1dyl w i l l  have a lower chemical 
s h if t  that those cis to phenyl or substituted phenyl. This 1s found 
to be the case, 1n the; absence of solvating solvents (see la t e r ) .
In the case of t r lp ro l ld ln e  (23 ), Ison and Casy (1971), obtained 
the following 60 MHz NMR data (Table 5.1)
Table 5.1 60 HHz Chemical s h if ts , 1n ppm, for tr lp ro l ld ln e  base 
and Its  oxalate sa lt
Vinylic H ( t ) ch2n (d)
Base 1n CDC13 E 6.92 3.21
Z 6.27 3.24
Salt 1n DJ) 2 E 6.65 4.02
(oxalate) Z 6.45 3.95
The vinylic proton of the E-1somer 1n both the base and the 
salt was at a lower f ie ld ,  the difference being A6 0.65 for the 
base and A* 0.2 for the oxalate s a lt .  No significant difference  
was seen for the CH2N signal.
A similar pattern was seen for the hydrochloride sa lt of 
tr lp ro l ld ln e , run at 270 MHz, 1n the two solvents, CDC1 and 
D20 (Table 5 .2).
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Table 5.2 Chemical sh ifts , 1n ppm, of t r lp ro l ld ln e  hydrochloride 
run 1n CDC13 and D20 (270 MHz)
Vinylic H ( t ) CH2N (d).
Hydrochloride 1n CDC13 1
E 7.012 3.80
Z 6.39 3.98




1 referenced to TMS
2 overlapped aromatic signals
3 referenced to HDO at 4.8 ppm
Again the chemical sh ift  of the v in y lic  proton of the E-1somer 1s 
greater (lower f ie ld )  than that of the Z-1somer, as expected due to 
the greater deshleldlng effect of the 2-pyr1dyl function on Its  
adjacent group 1n the trans compound (F1g 5 .1a). In this case the 
difference seen for the salt 1n D20 (AS 0.22) was smaller than 
that found for the salt 1n CDC13 (AS 0.62) -  the same pattern as 
seen for the base (CDC1 ) and salt (D O) 1n the 60 MHz data
w w
(Table 5 .1 ) .
In both examples shown, the largest difference 1n vinylic chemical 
shifts  1s seen using CDC13 as the solvent. This 1s probably due 
to solvation effects of the D20 on the nitrogen lone pair of the 
pyrldyl ring . Thus when the pyrldyl nitrogen of the E-1somer 1s 
solvated the non bonded Interactions between the nitrogen lone pair  
and the v in y lic  proton are raised (F1g 5.2) -  these may be avoided by
1 8 0
a reduction in the p lanarity  of the 2-v1nyl1c pyrldyl chromophore and 
as,a result deshleldlng of the v iny lic  proton 1s reduced as compared 
with that seen 1n the non-solvat1ng solvent, CDC13. Hence the 
v in y lic  proton signal moves upfleld from 7.01 ppm (1n CDC1 ) to
6.45 ppm (1 n D20). Solvation of the pyrldyl group 1n the Z-1somer 
has very l i t t l e  e ffect on the v inylic  proton.
F1g 5.2 Effects of solvation on t r lp ro l ld ln e  and Its  Z Isomer
The Z-CH^N protons of the hydrochloride were lower f ie ld  than 
those of the E-1somer, 1n C0C13, as antic ipated, but took the high 
f ie ld  position when 020 was the solvent. Here too, solvating the 
pyrldyl nitrogen w il l  enhance non-bonded Interactions between the 
pyrldyl lone pair and CH2N protons and thus reduce the deshleldlng 
Influence of the pyrldyl ring.
^H-NMR was also used as a method for purity  assessment for the 
samples of tr lp ro lld lne  and Its  Z-1somer (obtained from B-W). By 
^H-NMR, the sample of the Z-1somer of t r lp ro l ld ln e  was not 100* 
pure I . e .  1t showed duplicated signals of the E-1somer, v is ib le  at the 
low f ie ld  edge of the v in y l ic  t r ip le t  and methylene amino doublet 




F1g 5.3 H^-NMR spectrum of E-tMprol 1d1ne and Its  Z-lsomer
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In view of the relative Insensitiv ities  of ^H-NMR, a second 
method of measuring the stereochemical purity of the samples was 
developed. This Involved the use of HPLC, since this had been 
successfully applied to chiral compounds. The separation of geometric 
Isomers should be less d i f f ic u l t  than that of optical antipodes 
because of their d ifferent chemical and physical properties. The HPLC 
column chosen In i t ia l ly  was a Hypersll 5 ODS (25 cm), -  but results 
with this gave very broad ta i l in g  peaks, even after the Incorporation 
of ammonium acetate buffer (pH6 ) ,  an Ion pair reagent and KC1 Into the 
mobile phase of 25% THF. The ta i l in g  found using this column was due 
to analytes binding the uncapped sllanol groups on the silica  support.
A more polar column, with a shorter, (C3) chain I .e .  Hypersll 5
CPS (10 cm) was chosen. In this cyanopropyl (CPS) column there are
only propyl (C3) chains attached to the S1 support. Therefore 
more sllanol groups are capped and so less ta iling Is seen because of 
the reduced likelihood of the analyte finding any free polar groups. 
Using a mobile phase of 20% THF and 80% water containing KC1 (50 mN), 
Hexanesulphonlc acid (10 mN) and phosphoric acid (0.01%), good 
separation of the Isomeric peaks was seen. The choice of wavelength 
for detection varied with each pair of Isomers tested. The actual 
value used was the Isobestlc point of the two Isomers. In choosing 
the Isobestlc point as the detection wavelength, one Is assured that 
the absorption of each Isomer 1 s the same and thus the true proportion 
of each Isomer, in a given solution, w il l  be Identified. In the case









F1g 5.4 UV spectra of the E and Z Isomers of tr1prol1d1ne 
showing the two Isobestlc points
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By HPLC methods, the original sample of the Z-1somer of 
tr1pro!1d1ne was shown to have a 5% Impurity of the E-1somer ( F1g 5 .5).
F1g 5.5 HPLC trace of the Z-1somer of tr1prol1d1ne 
showing the 5% Impurity of the E-1somer
When the material, recrystalHzed once from absolute ethanol was 
chromatographed only one peak at 17.5 minutes was recorded. Analysis 
of the E-tr1prol1d1ne sample, provided by B-W, showed one peak with a 
retention time of 13.28 mlns.
Another method of establishing the configuration of the Isomers was 
the use of NOE (Nuclear Overhauser Effect) spectroscopy. I f  a proton 
1s Irradiated at a certain frequency 1t may result 1n an Increase or 
decrease 1n the Intensity of another proton. The change 1n Intensity  
only occurs when the Irradiated nucleus and that undergoing the 
Intensity change are close 1n space. This effect 1s known as the 
Nuclear Overhauser Effect (NOE) and 1s Important since 1t gives 
Information about molecular geometry. The NOE 1s a 'through space 
effect and may occur Irrespective of whether the two nuclei are 
sp1n-sp1n coupled.
^  17.17 mins
The spectra quoted 1n this thesis are NOE Difference spectra 
(NOED). Using this method a portion of the spectrum, far removed from 
the signals of Interest, 1 s Irradiated and this effect 1 s subtracted 
from the results obtained on Irradiation of the signals of Interest.
By studying the difference spectra one 1s assured that any NOE seen 1s 
due to the protons being 1 n close proximity to one another and not 
Just an artefact of the technique.
In the case of tr1prol1d1ne, the following results (F1g 5.6) were 
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Ao of AA2 2 2
£ - to ly 1
B, of A B
2 2 2
£ -to ly l
Result
NOE at 6.97 ppm (A? 
of A2B2 signal) and 
at 6.45 ( vinyl 1c CH) 
NOE at 7.05 ppm signal 
between the two halves
of the A B signal 
2 2 3
( H-3' Py)
NOE at 3.9 ppm (CH^) 
and at B2 (7.24 ppm) 
NOE at A2 of 
A2B2 and at 
7.61 ppm ( H-4' Py)
F1g 5.6 400MHz NOE spectrum for tr1prol1d1ne (23)
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Isomeric samples obtained from R.R. Ison (Thesis, 1970), of the 
£-chloro analogues of t r 1prol1d1ne showed the same spectroscopic 
pattern, as previously described.
UV analysis of these two Isomers (salts 1n ethanol) showed the 
E-1somer (24) to have two maxima at 230 (E 14,114) and 274 nm (E 
6 , 686 ) and the Z-1somer (34), one maximum at 259 nm (E 12,907). This 
was 1n agreement with the tr1prol1d1ne results, the E-1somer showing a 
comparable result to that of 2-v 1nyl pyridine.
HPLC analysis of these two Isomers was carried out at a detection
wavelength of 245 nm (the Isobestlc point). This showed results
similar to those obtained with tr1prol1d1ne. The Z-1somer was
retained longer than Its  E-analogue. The Z-1somer was shown to have a 
1.5% Impurity of the E-1somer and the E-1somer a 4% Z-1mpur1ty, but 
these were both removed by a single recrystal 11zatlon from ethanol.
'h-NMR analysis (270 MHz) of the two Isomers, (as oxalates 1n 




Table 5.3 H^-NMR chemical shifts of the £-chloro analogue of
tr1prol1d1ne and Its  Isomer as oxalates 1n D20 (270 MHz)
Vinylic H ( t ) CH2N (d)
E-(24) 6.63 3.91
Z-(34) 6.38 3.86
These NHR results also correlate well with those obtained for 
trlprolid lne (Table 5 .2). Similarly, results from the NOED spectrum 
confirmed the configuration of one of the two samples -  the E-1somer 
(F1g 5.7), since Irradiation of the high fie ld  aromatic doublet 
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Ar - A B
2 2
H-5' ( pyr1dy1)
NOE at the vinylic CH 
(6.36 ppm)
NOE at Ar A B
2 2
(7.22 ppm) and CH2N 
(3.82 ppm)
Large NOE at 7.37 ppm 
and NOE at vinylic CH 
(6.36 ppm)
NOE at H-6 ' (8.63 ppm) 
and H-41 (7.92 ppm)
F1g 5.7 NOEO spectrum for Z j>-chloro analogue (34) of tr1prol1d1ne
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Further confirmation of the a b i l i t y  of these techniques to provide 
suitable methods for configurational assignments of 2-pyr1dyl amino 
propene Isomers was provided by examination of the UV and ^-NMR 
spectra of some other analogues of tr1prol1d1ne
These compounds were In i t i a l l y  prepared using the method of Ison 
(1970) and Adamson and BllHnghurst (1950). 2-Pyr1dyl-l1th1um was the 
reagent used for the Introduction of the 2-pyr1dyl group Into the 
alcohol structure (35) (Scheme 2 ). The synthesis of 2-pyr1dyl lithium  
was by one of two methods.
The f i r s t ,  Involved the preparation of an ethereal solution of 
n-butyl lithium (BuL1) followed by I ts  treatment with 2-bromopyr1d1ne 
under nitrogen at -60°C -  -50°C.
-10° to +10°C




The second method of synthesis of 2-pyr1dyl lithium, was by the 
direct addition of commercial BuL1 (2.5 H 1n hexane) to 
2-bromopyr1d1ne 1n dry ether (Pathway 2. Scheme 1). Both methods were 
successful -  but the la t te r  was eventually taken as the method of 
choice.
The 2-pyr1dyl lithium was reacted with the appropriate Mannlch 
ketone (obtained from an aryl substituted acetophenone, pyrrolidine 
HC1 and paraformaldehyde) to produce the respective alcohol.
OH
2~PyLl» Ar-C-CH, CHj NO
/■- h2o
(E-) ( Z - )
Scheme 2
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Dehydration of the alcohol was effected by heating I t  1n a solution 
of H2 S04  (85%) a t 120°C for varying lengths of time. The 
basic reaction product was isolated, a f te r  clean up through an 
acid/base cycle, and In most cases, negligible amounts of starting  
t-alcohol were found. Acidification of the o i ly  basic reaction 
mixture with a saturated solution of oxalic acid In acetone followed 
by fractional recrysta lH zatlon  yielded pure oxalate salts  of each 
Isomer, 1 n each case.
Configurational assignments of the two oxalate Isomers were made, 
as previously described from observation of th e ir  UV and *H-NNR 
spectra.
The un-substltuted phenyl analogue (36) of t r lp ro l ld ln e  was 
synthesized as previously described. Varying the dehydration time 1n 
85% H2 S04  at 120*C did not give one pure Isomer -  but In a l l  
cases gave mixtures of varying proportions. Using HPLC, (a t  245 nm) to 
quantify the Isomeric ra tio ,  1 s was found that 1 0  mlns dehydration 
gave 60%, 1 hour gave 6 8 % and 3 hours gave 80% of the Z-1somer (37) 
and negligible amounts of starting alcohol were found. A fter numerous 
recrystalHzatlons of the oxalate salts -  the highest proportion of 
Z-1somer In the product was 70%. After 4 hours dehydration and five  
recrystalHzatlons from ethanol a pure sample of E-Isomer (36) (99% by 
HPLC) was obtained. UV analysis showed two maxima at 276 and 226 nm. 
The ^H-NMR d eta ils  are shown 1n Table 5.4
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Table 5.4 ^-NMR chemical sh ifts  for analogues of tr1prol1d1ne









E- (38) oxalate 6.69 4.00








* Aryl group which replaces j) - to ly l  of tr1prol1d1ne 
Base samples were run 1n CHCI3 , oxalate salts 1n D20
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S y n t h e s i s  o f  t h e  £ - b r o m o  d e r i v a t i v e  ( 3 8 )  o f  t r 1 p r o l 1 d 1 n e  f o l l o w e d
t h e  same p a th w a y  as d e s c r i b e d ,  a l t h o u g h  f o r m a t i o n  o f  t h e  a l c o h o l  was
c a r r i e d  o u t  1n an e t h e r / T H F  m i x t u r e ,  because  t h e  ^ B r - M a n n 1 c h  k e t o n e
was n o t  s o l u b l e  1n e t h e r .  V a r y i n g  d e h y d r a t i o n  c o n d i t i o n s  w e r e
e v a l u a t e d .  A f t e r  f o u r  h o u rs  a t  1 2 0 ° C  (85% H SO . )  and t h r e e
2 4
r e c r y s t a l H z a t l o n s  o f  o x a l a t e  s a l t s  f r o m  a b s o l u t e  e t h a n o l  p u r e  
E - 1 s o m e r  ( 3 8 )  was c o l l e c t e d .  T h i s  was I d e n t i f i e d  by I t s  UV s p e c t r u m ,  
s how ing  maxima a t  2 30  and 275  nm and I t ' s  ]H-NMR p a r a m e t e r s ( T a b l e
5 . 4  ) .
I s o l a t i o n  o f  p u r e  Z - 1 s o m e r  ( 3 9 )  was more d i f f i c u l t .  D e h y d r a t i o n  
t i m e s  o f  30 and 60 m i n u t e s  r a i s e d  t h e  p e r c e n t a g e  o f  Z - 1 s o m e r  b u t  a f t e r  
t h r e e  r e c r y s t a l H z a t l o n s  o f  t h e  o x a l a t e  s a l t ,  f r o m  e t h a n o l ,  t h i s  d i d  
n o t  a l t e r  g r e a t l y .  The ^H-NMR d e t a i l s  g i v e n  1n T a b l e  5 . 4  a r e  f o r  
t h e  Z - 1 s o m e r  (70%) p l u s  E I m p u r i t y .
HPLC a n a l y s i s  was c a r r i e d  o u t  a t  245 nm -  t h e  I s o b e s t l c  p o i n t  f o r  
t h e  t h r e e  p r e v i o u s  e x a m p l e s .  T h i s  c o n f i r m e d  t h e  m i x t u r e  p r o p o r t i o n s  
t h a t  w e r e  c a l c u l a t e d  u s i n g  ]H-NMR. A g a in  1 t  was t h e  Z - 1 s o m e r  t h a t  
was r e t a i n e d  t h e  l o n g e s t  on t h e  c o l u m n .
2 4 . 4 4 100%
43%
70%57%
30 m l n s , 1 2 0 ° C 4 h o u r s ,  12 0° C
F 1 g 5 . 8  HPLC t r a c e  f o r  t h e  j^-bromo d e r i v a t i v e  ( 3 8 )  o f  t r 1 p r o l 1 d 1 n e  
a f t e r  v a r y i n g  d e h y d r a t i o n  t i m e s .
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The j>-ethyl derivative (40) was synthesized as previously described 
via the Hannlch ketone and Its  conversion to the te r t ia ry  alcohol. 
Dehydration of the alcohol with 85% H2 ^ 4  a* f ° n ° wed» 
and again varying proportions of the two Isomers were obtained, 
depending on the length of time the alcohol was subjected to 
dehydration. In th is |>-ethyl analogue 1 hour at 120°C was su ff ic ien t  
to produce pure E-1somer (40). Id en tif ica tio n  of this Isomer was as 
before. UV results Indicated two maxima at 229 and 275 nm, the 
H^-NMR resonances are shown 1n Table 5 .4 , and HPLC analysis a t 245 
nm showed one peak a t approximately 2 0  mlns retention.
Dehydration of the alcohol for a 10 minute period gave a f i r s t  crop 
consisting of a mixture of Isomers 60 (20 mlns RT): 40 (30 mlns 
Rt ) (E:Z) by HPLC. RecrystalHzatlon from ethanol Increased the 
proportion of E-1somer and a fter three recrystalHzatlons more pure 
E-1somer was collected. The second and third crops from the 10 minute 
dehydration showed an Increase 1n Z-1somer (41) 92% (30 mlns by 
HPLC). Sim ilarly collection of the solid from the mother liquors of 
the recrystalHzations yielded a sample also rich 1n the Z-1somer (41) 
(93% by HPLC). The ^-NMR parameters are shown 1n Table 5.4. The 
UV spectrum showed one maximum at 260 nm.
All the results from these 2-pyr1dyl analogues confirm the results 
for the configurational analysis of tr1prol1d1ne. The v iny lic  and 
CH2N protons resonances of the oxalate salts 1 n D2 0  for the 
E-1somer are always lower f ie ld  than th e ir  Z- counterpart.The UV 
parameters also followed the same pattern as observed for 
tr1prol1d1ne, the E-1somer showing two maxima comparable to the 
spectrum of 2-v1nyl pyridine and the Z-1somer one maximum as for  
styrene.
196
HPLC analysis has shown consistent results throughout -  the 




A 3-pyr1dyl analogue of tr1prol1d1ne 1s commercially 
availab le , namely Z1meld1ne (27 ), a compound which has the 
Z-conf1gurat1on (Abrahamson et a l ,  1976).
Br





Z1meld1ne 1s marketed for use as an antidepressant agent 
although 1t does have a weak ant1h1stam1n1c action (Hall and 
Ogren, 1984)
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Table 5.5 Pharmacological data for zlmeldlne and 
some analogues (Hall and Ogren, 1984)
Histamine antagonist effects  
(IC 5 0  pm)
GP Ileum [ 3 H]-mepyram1ne binding 
cerebral cortex
Zlmeldlne (27) 20.4 2.9
E-1somer (42) 1 . 8 0.4
NHMe of Z-(27) 42.3 8.3
NHMe of E (27) 2 1 . 2 3.4
The data of Table 5.5 shows that the corresponding E-1somer
(42) 1s the more active as an H^antagonlst, as was the case 
for the 2-pyr1dy1 compounds. The E-1somer 1s 11 times more 
potent than zlmeldlne at gu1nea-p1g Ileum sites and 7 times the
3
more effective at displacing [ H]-mepyram1ne from rat  
cerebral cortex. The overall potency, however, of the more 
active E-1somer was only 6 % that of brompheniramine. Similar 
results were obtained for the corresponding methylamlno analogues.
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5.3 .2  Configurational analysis
Abrahamson et al (1976) have reported the X-ray analysis of 
zlmeldlne, Identifying I t  as the Z-1somer. Our analyses have 
Involved the use of UV, 'h-NMR, NOED spectra and HPLC (as 
employed for the 2 -pyrldyl compounds) to confirm configuration 1n 
th is series.
In order to identify  the configuration of the hydrochloride 
salts of zlmeldlne and I ts  E-1somer (kindly supplied by Astra 
Pharmaceuticals, Sweden), i t  was necessary to study the UV and 
’h-NMR spectra of model compounds. The models chosen were 
3-v1nylpyr1d1ne (43) and styrene (33) (as used previously). The 
UV spectrum of 3-v1nylpyr1d1ne (Organic Electronic Spectral 
Data.) showed two maxima (as did 2-v1ny1pyr1d1ne) at 238 nm (c 
12,600) and 278 nm (c 2,500). Styrene showed only one maximum at 
254 nm.
The UV spectrum of zlmeldlne and Its  E-Isomer showed a s im ilar  
pattern (F1g 5 .9 ). Zlmeldlne (27) showed a single maximum at 260 
nm (c 12,062), similar to that of styrene, and the E-Isomer (38) 
showed a maximum at 232 nm (c 14,119), similar to that of 
3-v1nylpyr1d1ne. The second, longer wavelength maximum of 
3-vlnylpyrld lne was not v is ib le . These results Indicate that a 
styrene-1 1 ke chromophore operates In zlmeldlne, and one akin to  
3-v1nylpyr1d1ne In the related E-Isomer, and support the 
configurational assignments by the same arguments as those 








F 1g 5 . 9  UV s p e c t r u m  o f  z l m e l d l n e  HC1 ( 2 7 )  and I t s  
E - 1 s o m e r  ( 4 2 )  ( 1 n  H20 )
2 0 0
^H-NMR analysis of the two Isomers was aided by the 
reported 60 MHz H^-NMR analysis of the model compound 
3-v1nylpry1d1ne (43) (Klemm and McCoy., 1969). This report 
Id en tif ied  the same deshleldlng pattern for this 3-pyr1dyl 
compound as was seen for Its 2-pyr1dyl analogue I . e .  c1s-H more 
deshlelded than the trans-H (A6  = 0.46 ppm at 60 MHz).
H 5.75
6.67 H H 5.29
(43)
Hence the same arguments, as previously reported, w i l l  s t i l l  
apply.
Unfortunately 1n the case of zlmeldlne and Its  E-1somer, the 
differences between the Isomeric v iny lic  and methylamlno proton 
resonances were only small and therefore of less value for the 
configurational argument. Table 5.6 shows, however, that the 
signals were resolved and thus ^H-NMR was useful for Isomeric 
purity assessment.
? 0 1
Table 5.6 ^H-NNR chemical sh ifts  of zlmeldlne HC1 and some 
oxalate analogues. In D2 O. (270 MHz)
Chemical Shifts  
v iny lic  CH
(ppm from TNS) 
CH^ N
zlmeldlne E (42) 6.47 3.89
Z (27) 6.51 3.90
phenyl analogue E (45) 6.43 3.97
Z (44)* 6.38 3.90
f)-methyl analogue E (46) 6.38 3.98
Z * (6.35) 3.89
Footnotes:
* Results obtained from an Isomeric mixture of E and Z.
The use of N0E0 spectroscopy again proved useful in confirming 
the configuration of the 3-pyr1dyl isomers and Fig 5.10 shows the 
results obtained for zlmeldlne.2HC1 in D^ O. By Irrad iating  
the v in y l ic  proton -  a clear NOE was seen at the jD-bromophenyl 
protons and vice versa -  Indicating the presence of Z-lsomer.
2 0 2
Position of 









H 6.48 ( t )
8.51 (d)







v in y lic  CH
Ao0f AA  2 2 2
B of A„B„ 2 2 2
No significant NOE 
except NMe2 signal 
NOE at A2 
(7.19 ppm)
Excellent NOE for  
v iny lic  CH (6.48 ppm) 
and B2 (7.53 ppm) 
Clear NOE for A„
(7.18 ppm)
NOEO spectrum for zlmeldlne dlhydrochlorlde (27)
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HPLC, using the same chromatographic conditions as for 2-pyrldyl 
compounds, again proved useful 1 n the measurement of Isomeric purity. 
Using the Isobestlc point, 242 nm, as the detection wavelength, both 
zlmeldlne hydrochloride and Its E-1 somer gave chromatograms that 





Fig 5.11 HPLC traces of zlmeldlne hydrochloride and Its E-1somer
Once again, the Z-1somer was retained the longest on the column, as 
1n the 2-pyr1dyl compounds. This could be a useful Indication of the 
configuration of a novel compound.
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The synthesis of some analogues of zlmeldlne was undertaken.
Reports (Astra Patent, 1978) of the synthesis of some analogues of 
zlmeldlne describe a pathway similar to that previously employed for 
trlproHdlne, and thus this was the chosen route. This pathway 
Included the formation of a Mannlch base followed by reaction of this 
Mannlch ketone with 3-pyrldyl lithium. Preparation of
3-pyr1dyl-l1th1um (Gilman and Spatz, 1951) involved the dropwlse 
addition of 3-bromo-pyr1d1ne, 1n anhydrous ether, to a rapidly stirred  
solution of butyl lithium (BuL1) 1n ether at -5-0°C. Each addition of
3-bromo-pyr1d1ne formed a yellow flocculant precipitate which 
gradually changed to red/brown. Dropwlse addition of the Mannlch 
ketone base 1n anhydrous ether, to 3-pyr1dyl-l1th1um, at -50°C, 
followed by acid/base extraction of the reaction mixture yielded the 
t-alcohol base as a yellow o i l .
The t-alcohol was dehydrated 1n the same way as the 2-pyrldyl 
analogues, using 85% H_S0. at 120°C for varying lengths of 
time. Acidification of the basic reaction mixture with a saturated 
solution of oxalic acid, 1 n acetone, yielded an Isomeric mixture of 
the oxalate salts.
Analysis of the Isomeric purity of these oxalate salts was carried 
out by ^-NMR and HPLC using a detection wavelength of 242 nm (the 
Isobestlc point for zlmeldlne and Its  E-1somer).
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The unsubstituted phenyl analogue of zlmeldlne (44) (Fig 5.1?) was 
synthesized as previously described . Dehydration of the t-alcohol 
overnight at room temperature, with 85% H SO yielded only the
2 4
starting alcohol. A 30 minute dehydration at 120°C, however, showed 
an 80% majority of one isomer. After two recrystalllzatlons of the 
oxalate salt, from absolute ethanol, a sample 90% rich In one Isomer 
was obtained. S imilarly, using a dehydration time of 1 hour, at 
120°C, followed by three recrystalllzatlons from EtOH, a sample 91% 
rich, by *H-NMR and HPLC, In the same Isomer was obtained.
Both the E and the Z, vinylic and methylene amino proton resonances 
were very close (Table 5 .6 ) .  I t  was clear that the lower f ie ld  
vinylic signal was the more intense. Identification of the 
configuration of the Isomer 1n the highest concentration (91%) was 
d if f ic u lt  using ^-NMR because of the small A6  value of the 
vinylic resonances. Zlmeldine (the Z Isomer) shows a lower fie ld  
vinylic signal than Its  E-Isomer (Table 5 .6 ).
UV analysis, 1n ethanol showed two peaks at 226 nm (c 12,617) and
244 nm (e 10,721). This spectrum resembled that of the E-analogue of
zlmeldlne (and 3-v1nyl-pyr1d1ne) and would therefore suggest that the 
product was the E-Isomer (45). This contradicts the In i t ia l  
conclusions made from the ^-NMR data which points to a 
Z-conf1gurat1on (44). Obviously more data was necessary.
The use of N0ED spectroscopy again proved very helpful In this 
configurational analysis. The N0ED data showed the sample to be the 
E-Isomer (45) (Fig 5.12) since Irradiation at the vinylic CH caused an






























NOE at vinylic CH 
(6.43 ppm)
Clear NOE at H-4'
(8.3 ppm) and H-2'
(8.56 ppm) -  pyrldyl 
NOE at phenyl signal 
(7.2 ppm)
NOE at phenyl signal 
(7.52 ppm) and at 
vinylic CH (6.43 ppm) 
NOE at CH2N (3.95 
ppm and some pyrldyl 
signals
NOE at vinylic CH (6.43 
ppm and at pyrldyl H-5*
F1g 5.12 N0E0 spectrum for E-phenyl (N-pyrrol1d1no) analogue of
zlmeldlne (44)
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Confirmation of the presence of the E-1somer (45) was gained from 
HPLC analysis of the oxalate sample. The largest peak of the 
chromatogram (91% by area) was that which was retained for the 
shortest time (7.81 mlns) ( F1g 5.13).  In all  previous examples the 





RT AREA TYPE h P H T  AREA’
7 . 8 1  7 8 3 6 6 8 8  PB 0  7*26 91 3 8 .
11 31 7 3 :8 0 9 0  PR 0 6 7 3  8 . 6 1 :
F1g 5.13 HPLC trace for the Isomers of the phenyl analogue 
of zlmeldlne (44 and 45)
In the synthesis of the £>-tolyl analogue of zlmeldlne, dehydration 
of the alcohol for 15 minutes at 120°C had no effect and only starting 
alcohol remained. A 30 minute dehydration time, at 120°C, was, 
however, suff ic ient  to produce a 90:10 ratio of Isomers. Three 
recrystal 11zatlons from absolute ethanol yielded a maximum of 96% of 
the major Isomer.
UV analysis of this compound showed only one peak at 227 nm 
(c 14,413) suggesting the E-1somer was dominant. 'h-NMR showed 
only one vinylic t r ip le t  centred at 6.37 ppm (1n ear l ie r ,  less pure 
samples another overlapping t r ip le t  at higher f ie ld  was noticeable) 
but showed two methylene amino doublets, the largest being at lower 
f ie ld. Comparing this to the H^-NMR results for the unsubstituted 
analogue this would confirm the UV results I .e .  the presence of the 
E-1somer (46).  HPLC analysis, again showed the major peak to be that 
which eluted f i r s t  -  Indicating presence of the E-1somer (46).
2 0 8
4-Pyr1dyl compounds
Further modifications to the tr1prol1d1ne structure are now 
discussed. These Involve the Incorporation of a 4-subst1tuted pyrldyl 
ring, as a replacement of the 2 -pyr 1 dyl group. Into the propene 
structure.
Synthesis of these compounds was as described 1n Scheme 2 (Pagerci) 
but using 4-subst1tuted pyrldyl lithium. Preparation of the 4-pyr1dyl 
lithium required the In i t ia l  liberation of 4-bromopyr1d1ne from Its  
hydrochloride salt by bas1 f 1 cat1 on with K2 C0 3  followed by 
ethereal extraction. The 4-bromopyr1d1ne was obtained by removing the 
ether 1n vacuo just before use. 4-Bromopyr1d1ne, 1n anhydrous ether, 
was added dropwlse to a solution of n BuL1, 1n ether, at -50- -60°C to 
produce a yellow'suspension. This was le ft  stirring for 1 hour, after  
which time the usual Mannlch ketone base 1 n dry ether was added 
dropwlse. The reaction was le f t  to rise to room temperature and then 
le f t  stirring overnight. The 4-pyr1dyl tertiary alcohol product was 
dehydrated, as previously described, varying the conditions to a lte r  
the proportions of each Isomer. Purification of the reaction mixture 
was by recrystalHzatlon of the oxalate salts.
As an aid to the configurational assignment of these oxalate salts, 
the model compound 4-v1nylpyr1d1ne (47) was used. UV analysis of this 
model Indicated one large maximum at 242 nm and a shoulder at 263 nm. 
The difference between the X max for 4-v1nyl-pyr1d1ne and that of 
styrene (the model compound for the other Isomer) was only small and 
therefore UV analysis may be of limited use for configurational 
analysis of these 4-pyr1dyl analogues.
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' h-NMR analysis of 4-v1nylpyr1d1ne, 1n CDCLg, showed a 







Again the vinylic proton c1s_ to the pyrldyl ring was lower fie ld  
that the trans proton (A6  0.48 ppm at 270 MHz), because of the greater 
deshleldlng effect of the pyrldyl function on this adjacent proton.
The te rtia ry  alcohol of the unsubstituted phenyl analogue (48) was 
dehydrated with 85% H2 S04 ’ for minutes and 1 hour, at 
120°C. Under these conditions the reaction mixture was found to 
contain 80% of one Isomer. Three recrystalllzatlons from absolute 
ethanol yielded samples that by ^-NMR were pure. The *H-NMR 
results for the vinylic and methyleneamlno signals are detailed In 
Table 5.7. By comparison of the *H-NMR data obtained from the 
model compound, study of the vinylic proton chemical shifts , of the 
synthesized compound, would Indicate the presence of the Z-lsomer (48) 
(F1g 5.14) since the higher fie ld  t r ip le t  was greatest intensity (in  
the earlie r  less pure samples).
2 1 0
Table 5.7 Chemical sh ifts . In ppm, of the oxalate salts of (48) and 
(49), run 1n D20 at 400 MHz (Dehydration times for the 
t-alcohol are shown In parentheses)
Compound
Chemical Shifts (ppm from TMS) 
vinyl1c proton ( t )  CH2N (d)
Z- (48) 6.41 3.90
(30 mlns, 1 hour)
E- (49) 6.77 4.00
(4 hour)
UV analysis of these recrystal 11 zed samples show only one maximum at 
242 nm (c 8,050)i Since the Xmax for both model compounds,
4-v1nyl-pyr1d1ne and styrene, are very similar, 1t Is not possible to 
assign the configuration for this compound using UV data.
Evidence of configuration was obtained most directly by the aid of 
NOED spectroscopy. Using this technique, the sample was Identified as 
being the Z-1somer (48), since Irradiation of the vinylic signal 
caused an NOE at the position of the phenyl signals and Irradiation of 
the CH2N protons position resulted In an NOE at the H-3' and H-5' 






















H-2' and H-6 ' 
pyrldyl
H-31 and H-5' 
pyrldyl
NOE for vinylic proton (6.38 
ppm)
NOE high f ie ld  phenyl signal 
(7.3 ppm) and CH2N signal 
(3.86 ppm)
NOE for high fie ld  phenyl 
signals (7.3 ppm)
Clear NOE at vinylic CH (6.38 
ppm) and low fie ld  signals 
Large NOE for other Py protons 
(8.74 ppm). Small NOE for 
CH2N (3.86 ppm) and high 
f ie ld  phenyl aromatlcs.
Large NOE for other pyrldyl 
protons (7.69 ppm)
F1g 5.14 NOEO spectrum for (48)
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Dehydration of the alcohol for the more prolonged period of 4 hours 
at 120°C gave a sample 90% rich 1n a d ifferen t Isomer, the E Isomer 
(49). The H^-NMR spectrum of this product showed lower f ie ld  
chemical shift values for the vinylic and methylene amino protons, 
compared with those of the Isomer Isolated under less vigorous 
dehydration conditions.
Attempts to dehydrate the E-tolyl 4-pyr1dyl analogue were 
unsuccessful. Dehydration of the t-alcohol for a 4 hour period 





*H-NMR spectra were recorded on a JOEL GX 270 MHz Fourier 
Transform (FT) NMR spectometer unless otherwise stated. The following 
abbreviations are used to describe the appearance of the signals 1 n 
the 'h-NMR spectra: singlet, s; doublet, d: t r ip le t ,  t ;  quartet,
q; m ultlplet, m.
13C-NMR spectra were recorded on a JOEL GX 270 FT NMR spectrometer 
operating at 67.8 MHz unless otherwise stated. The m ultip lic ity  of 
the resonances was obtained from DEPT (Distortionless Enhancement by 
Polarization Transfer) and INEPT (Insensitive Nuclei Enhanced by 
Polarization Transfer) spectra In which the phase of the signal 
Indicated the number of protons attached to the carbon atom giving 
rise to that signal. (See 3.6 .3 -  dehalogenatlon of chlorpheniramine)
The Infra-Red spectra (liquids as films, solids as KBr discs or 
Nujol mulls) were recorded on a Unlearn SP1025 spectrometer.
HPLC data quoted are quoted as retention times (1n minutes) measured 
on a 10cm Hypersll (5pm) CPS column, using a mobile phase of 20% THF, 
80% water containing 50mM KC1, lOmM Hexane Sulphonlc acid and 
0.1% H3 P0 .^ The detection wavelength being the 1sobest1c point 
for the Isomers being resolved.
Mass spectra were measured on a VG micromass 7070 E mass 
spectrometer operating at 70 EV El.
?14
Elemental analyses were carried out by Butterworth Laboratories 
Ltd, Middlesex.
Melting points were recorded on a Gallenkamp apparatus, and are 
uncorrected.
5.6 Synthesis of the 'Tr lprolld lne* analogues
5.6.1 Synthesis of start ing Hannlch ketone
5 . 6 .1.1 Preparation of 3-( l-pyrrol1d1no)- l -p-tolv lpropan-l-one (50)
An aqueous solution of pyrrolidine hydrochloride was prepared by 
careful ac id i f icat ion  of pyrrolidine free base (35.6 g; 0.5 M) with 
concentrated HC1, cooling 1n an 1ce-bath. Paraformaldehyde (22.0 g; 
0.7 M), j)-methyl-acetophenone (60 g; 0.448 M) and ethanol (100 ml) 
were then added to the reaction flask and the mixture heated under 
reflux for 13 hours. Cooling to 0°C and d i lu t ion  with ether failed  
to separate a solid product. A Dean-Stark head was attached to the 
reaction vessel and a f te r  addition of Toluene (200 ml) the water
present was removed by azeotroplc d i s t i l l a t io n  (over 8 hours). On
cooling a brown crysta l l ine  product formed. F i l t ra t io n  followed by 
t r i tu ra t io n  with ethylacetate and recrysta l l lza t lon  from 
ethanol/ether gave the pure 3 - ( 1-pyrrol1d1no)-1-p-tolylpropan-1 -one 
hydrochloride (75 g; 65%), m.p. 165°C (Ison, 1970 gave mp 167°C). 
|]-NMR 7.87 (d) 2H, 7.28 (d) 2H. 3.72 ( t )  2H, 3.55 ( t )  2H, 3.3
(broad) 4H, 2.4 (s) 3H, 2.2 (s) 4H.
5 . 6 .1.2 Preparation of 3-(l-pyrrol1d1no)l-phenylpropan-l-one (51)
Acetophenone (30 g; 0.25 M), paraformaldehyde (9.9 g; 0.33 M) and 
ac id i f ied  pyrrolidine (17.8  g; 0.25 M) were heated under reflux for 6 
hours. On cooling the crude crystall ine Mannlch ketone hydrochloride 
separated (45.2 g; 69%), m.p. 94-95°C, 'h-NMR 7.98 (d) 2H, 7.68 
( t )  1H, 7.56 ( t )  2H, 3.71 (m) 2H, 3.59 (s) 4H, 3.17 (m) 2H, 2.18 (m) 
4H.
5 .6 .1.3 Preparation of 3-(l-pyrro11dino)-l-p-ethylphenylpropan-l-one (52)
p.-Ethyl acetophenone (37.2 g; 0.25 M), paraformaldehyde
(1 1 .7g; 0.39 M) and ac id i f ied  pyrrolidine (20 g; 0.28 M) were heated 
under reflux for 12 hours. Removal of the water by azeotropic 
d i s t i l l a t io n  over 8 hours, cooling, t r i tu ra t io n  with ethyl acetate 
and recrys ta l l iza t ion  from ethanol yielded the pure Mannlch ketone 
hydrochloride (53.2 g; 79%) m.p. 151°C, ]H-NMR 7.95 (d) 2H, 7.45 
(d) 2H, 3.63 (s) 4H, 3.47 (broad) 4H, 2.74 (q) 2H, 2.14 (S) 4H,
1.26 ( t )  3H.
5 .6 .1.4 Preparation of 3~(l-pyrrolidino)-l-p-bromophenvlpropan-l-one (53)
jo-Bromoacetophenone (37.5 g; 0.19M), paraformaldehyde (8.82 g;
0.3 M), ac id i f ied pyrrolid ine (15 g; 0.2 M) and ethanol (50 ml) were 
heated under reflux for  10 hours. The water was then removed by 
azeotropic d i s t i l l a t io n  under a Dean-Stark head for 6 hours. 
Triturat ion of the solid with ethyl acetate and recrysta l l iza t ion  
from ethanol yielded the Mannich ketone hydrochloride (56 g; 93%) 
m.p. 190°C ’H-NMR, 7.83 (d) 2H, 7.60 (d) 2H, 3.17 ( t )  2H,'2.90  
( t )  2H, 2.55 ( t )  4H, 1.80 (q) 4H.
of I n t e r m e d i a t e  2-pyr1dy1 t e r t i a r y  a l c o h o l s
L of 1 - ( 2-pyr1dyl)-l-(p-ethylphenyl) -3 - (  1 -pyrrol 1d1 no) 
il (5 4 )
lithium 1n hexane (4.1g, 0.065H) was added dropwlse to 
Irldlne (6.91g, 0.047H) under nitrogen at -60°C. The mixture 
led at -60°C for 1 hour and an ethereal solution of the 
j o g ,  0.04M) was added, with st irr ing,  over a 30 minute 
The mixture was stirred at -50°C for 1 hour and then allowed 
to room temperature (overnight). The reaction mixture was 
Iw1th Iced water, acidified with N-HC1 (6M) and then 
id with ether (3 x lOOmls). The aqueous layer was baslfled 
m ( 5M) and the product extracted with ether. The ether layer 
L e d  with water (2 x 25ml), dried (MgSOJ and evaporated 
red uced  pressure to yield a cream solid of 1- ( 2-pyr1dyl)-1- 
ilphenyl ) -3 - (  1 -pyrrol 1d1 no)-propan-1-ol (54) (4g, 28%), m.p. 
rC^H-NMR 8.53 (d, 1H, Py H-6') , 8.00 ( t ,  1H, Py H -4 ' ) ,  
d ,  1H, Py H-31) ,  7.61 ( t ,  1H, Py H-5') ,  7.50 (d, 2H, of
1.20 (d, 2H, B2 of A2B?), 2.50 (m, 10H), 
k  4H, pyrrol1d1no), 1.20 ( t ,  3H, Ar-CH2-CH3) .
jpyrldyl)-l - ( phenyl)-3-(1-pyrrol1d1 no)propan-1-ol (55) 
its tert iary  alcohol was prepared 1n the same way as the 
tdltlons outlined 1n Table 5.8. The product separated as a brown 
Abut formation of the oxalate salt yielded a white solid of 
|(?-pyr1dyl)-3-(phenyl)-3-( 1 -pyrrol 1d1 no)propan-1 -ol (55) (4.6g. 38%), 
1.164 -165°C, V nMR, 8.53 (d, 1H, Py H-6 ' ) ,  8.16 ( t ,  1H, Py 
I ' ) ,  8.84 (d, 1H, Py H-3*), 7.60 ( t ,  1H, Py H -5 ' ) ,  7.4 (m, 5H, 
fnyl) 3.60 (m, 2H), 3.15 (m, 2H), 2.94 (m, 4H), 2.00 (s, 4H. 









55 H 2 -pyr1 dyl 0.05M






He 2 -pyrldyl 0.046M






54 Et 2 -pyrldyl 0.04M






56 Br 2 -pyr1 dyl 0.06M 
(15 .9g)
0.07M




57 H 3-pyr1dyl 0.05M






58 Me 3-pyr1dyl 0.046M
( 1 0 g)
0.055M











60 Me 4-pyr1dyl 0.046M






Table 5.8 Experimental details for preparation of propan-l-ols 
Footnotes 
BuL1 = 2 . 5 M solution 1 n hexane
2 1 8
5 . 6 .2.3 1- ( 2-pyridvl) -1 - ( p-bromophenyl) - 3 - ( 1-pyrro lId1 no)propan-1 -ol ( 56)
Prepared as for (54), using the conditions outlined in Table 5.8. 
The final extraction with ether yielded a brown o il  which was 
azeotroped with acetone, redissolved In anhydrous ether and scratched 
to give a brown solid. Recrystallisation with absolute ethanol 
yielded a cream solid (3g, 20%), m.p. 140*C, ’h-NHR, 8.44 (d, 1H,
Py H-6 ' ) ,  7.63 (d, 1H. Py H -3 ') ,  7.55 ( t ,  1H. Py H -4 ') ,  7.45 (d. 2H, 
A2  of A2 B2) ,  7.32 (d, 2H, B2  of A ^ ) . 7.00 ( t ,
1H, Py H -5 ') ,  2.3 - 2.6 (m, 8 H, CH2 -CH2 -H(CH2)2) , 1.65 (s,
4H, pyrrolid ino).
5.6.3 Preparation of 3-pyr1dvl te r t ia ry  alcohol intermediates
The following compounds were prepared in the usual manner (5 . 6 .2.1) 
but using 3-pyridyl lithium and the appropriate Mannlch ketone . 
Details of proportions and yield are given in Table 5.8.
5 . 6 .3.1 1-(3 -p yridv l) - l- (p he n y l)-3 -( l-p yrro lid  1 no)propan-1-ol (57)
m.p. 141°C, ^-NMR 8.74 (s, 1H, Py H-2'), 8.50 (very broad s,
1H, disappears on deuteration), 8.41 (d, 1H, Py H-6 ' ) ,  7.78 (d, 1H,
Py H-4 '), 7.46 (d, 2H, phenyl), 7.30 ( t ,  2H, Py H-5' and phenyl),
7.21 ( t ,  2H, phenyl), 2.62 ( t ,  2H, CH - C i y , 2.43 ( t ,  2H,
CH2 -CH2), 1.75 (s, 4H, pyrrolidino).
Found C, 77.2%; H, 8.25%; N, 9,59%. Calculated C1QH N 0,
C, 76.56%, H, 7.85%; N, 9.92%.
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5 . 6 .3.2 1 - ( 3 -pyr1 dvl)-l-(p-methyl phenyl)-3-(l-pyrrol 1d1 no)propan-1 -ol (58)
m.p. m - C .  ’h-NHR 8.73 (s , 1H. Py H -2 ') ,  8.5* (s, 1H,
disappears on deuteratlon), 8.43 (d, 1H, Py H-6 ' ) ,  7.76 (d t 1H,
Py H-4*) ,  7.35 (d, 2H, A of A B ) ,  7.21 ( t ,  1H, Py H -5 '),
2 2 2
7.17 (d, 2H, B2  of A2 B2) ,  2.65 (m, 6 H CH2 -CH2  and 
pyrrolidino), 2.42 ( t f 2H, CH2 -CH2) t 2.30 (s, 3H, methyl),
1.76 (s, 4H, pyrrolidino).
Found C, 77.4%; H, 8.36%; N, 9.53%. Calculated CloHOJNo0I? Z4 c
C. 76.99%; H, 8.16%; N, 9.45%.
5.6.4 Preparation of 4-pyrldyl Intermediates
Once again the compounds were synthesized using the general method 
of 5 . 6 .2.1 (details In Table 5.8). The 4-bromopyr1d1ne used was 
liberated from Its hydrochloride prior to the start of the reaction.
5 . 6 .4.1 1 - ( 4-pyr1dy1 ) -1 - (phenyl) - 3 - ( 1-pyrrol1d1 no)propan-1-ol (59) 
m.p. 155.6°C, ^-NMR 8.63 (broad s, 1H, disappears on 
deuteratlon), 8.52 (d, 2H Py H-2' and H-6 ’ ) ,  7.46 (d, 2H, phenyl), 
7.41 (d, 2H, Py H-3* and H-5‘ ) ,  7.31 ( t ,  2H, phenyl), 7.22 ( t ,  1H, 
phenyl), 2.62 (m, 2H, CJ^-Cty, 2.54 (s, 4H, pyrrolidino).
2.40 (m. 2H, CH2 -CH2 N), 1.80 (s, 4H, pyrrolidino).
Found C, 77.0%; H, 7.85%; N, 9.73%. Calculated, C ^ H ^ O ,
C, 76.56%; H, 7.85%; N,9.92%.
2 2 0
5.6.4.2 1 - ( 4-pyrldv 1)-1 - ( p-methylphenyl) -3 -(  1 -pyrrol 1d1no)propan-l -ol (60) 
m.p. 177-179’ C, ’h-NMR 8.62 (d, 2H Py H-2' and H-6 ' ) ,  8.07 (d,2H,
Py H-3' and H -5 ') ,  7.31 (d. 2H. A of * 8  ) ,  7.20 (d, 2H,
B2  of A2 B2) ,  3.63 (m, 2H), 3.0 (n, 4H), 2.20 (s, 3H, 
methyl) 2.00 (s , 6 H, pyrrolidino).
5.6.5 Acid catalysed dehydration of 2-pvrldvl. 3-pyrldyl and 4-pyridvl 
propan-1 -ols
Dehydration of the alcohols was achieved using 85% 
and a temperature range of 100 -  120WC. Varying lengths of 
dehydration times at the above condition yielded the d ifferent  
Isomers. The o ily  reaction mixture was poured onto 1ce/NH3  and 
extracted with ether (3 x lOOmls). The ether layer was dried 
(MgSOJ and evaporated under reduced pressure to yield an 
orange/brown o i l .  Purification of the dehydrated product so formed 
was by recrystalHsatlon of the oxalate salt.
The dehydration conditions for the various compounds are given 
1n Table 5.9.
5 .6 .5.1 E-1- ( 2-pyrldyl) - 1 - ( p-ethylphenyl) -3-pyrrolIdlno prop-1-ene (40) 
m.p. 149-150'C, A max 229 and 275nm, 'h-NMR 8.52 (d, 1H, Py 
H-6 1) ,  8.14 ( t ,  1H, Py H -4 ') ,  7.67 ( t ,  1H, Py H-5 '). 7.58 (d, 1H, Py 
H -3 ') ,  7.36 (d, 2H. A2  of A ^ ) ,  7.14 (d, 2H, B2  of A ^ ) .
6.63 ( t ,  1H. v inylic  CH). 3.99 (d, 2H. CHZN). ) ,  3.63 (m, 2H, 
pyrrolidino), 2.97 (m, 2H, pyrrolidino), 2.65 (q, 2H, Ar-CH^-CH^)
2.00 (s, 4H, pyrrolidino), 1.17 ( t ,  3H, Ar-CH2 -CH3).




X Y Isomer Conditions1 Purity Rx 2
40 2 -pyr1 dyl j)-ethyl- 
phenyl
E 120°C, 1 hour 1 0 0 % 1
41 2 -e thy l-  
phenyl
2 -pyrldyl Z 120°C, 10 mlns 92% 3
36 2 -pyr1 dyl phenyl E 120°C, 4 hours 90% 2






38 2 -pyr1 dyl 2 -bromo-
phenyl
E 120°C 4 hours 1 0 0 % 3
39 2 -bromo-
phenyl












46 3-pyr1dyl 2 -methyl- 
phenyl
E 120°C, 30 mlns 96% 3
49 4-pyr1dyl phenyl E 120°C 4 hours 90% 1
48 phenyl 4-pyr1dyl Z 120°C, 30 mlns 





Table 5.9 Experimental conditions for dehydration of propan-l-ols 
Footnotes:
1 All dehydrations were carried out using 85% H2 S04
2 Rx, means the number of recrystallIsatlons of the oxalate salt from 
EtOH
222
5.6 .5 .2  Z-l-(2 -pyr1dvl)- l-(p -e thv lphenvl)-3 -pyrro l1d1no prop-l-ene (41)
A max 260 nm, ’ h-NMR 8.62 (d , 1H, Py H -6 ') ,  8.01 ( t ,  1H, Py 
H - * ' ) ,  7.66 ( t ,  1H, Py H -5 ' ) ,  7.60 (d , 1H. Py H-3* ) ,  7.31 (d, 2H,
A2 of A2B2) ,  7.10 (d , 2H, B2 of A2B2) ,  6.33
( t ,  1H, v inylic  CH), 3.83 (d , 2H, CH,N), ) ,  3.61 (m, 2H,
pyrro lid ino), 2.93 (m, 2H, pyrro lid ino ), 2.50 (q, 2H, Ar-DL-CH )
£  3
1.97 (s , 4H, p yrro lid ino ), 1.06 ( t ,  3H, Ar-CH^CHg).
HPLC, Ry 29 mlns.
5 .6 .5 .3  E -l-(2 -pyr1dyl)- l-(phenvl)-3-pyrro l1d1no prop-l-ene (36)
m.p. 166°C, X max 226.5 and 276.5 nm, ^H-NMR 8.55 (d, 1H, Py H -6 ') ,
8.20 ( t ,  1H, Py H -4 ' ) ,  7.68 (m, 2H, Py H-3' and H-5’ ) ,  7.58 (m, 3H, 
phenyl), 7.28 (m, 2H, phenyl), 6.69 ( t .  1H, vinylic CH), 4.00 (d, 2H, 
CH2N), ) ,  3.63 (s , 2H, pyrro lid ino ), 3.00 (s , 2H, pyrrolid ino), 2.01 
(s , 4H, pyrro lid ino),
HPLC, R 8 mlns.
5 .6 .5 .4  Z-l-(2-pyr1dyl)-l-(phenyl)-3-pyrro11d1no prop-l-ene (37)
m.p. 166°C, X max 242 nm, H^-NMR 8.64 (d, 1H, Py H-6‘ ) ,  8.08 ( t ,  1H,
Py H-41) ,  7.73 ( t ,  1H, Py H -5 ') ,  7.53 (d. 2H, Py H-31 and phenyl), 7.40 
(d, 2H, phenyl), 7.28 (d, 2H, phenyl), 6.38 ( t ,  1H. v iny lic  CH), 3.84 (d, 
2H, CH^N), ) ,  3.62 (s , 2H, pyrro lid ino ), 3.00 (s, 2H, pyrro lid ino),
2.00 (s , 4H, pyrro lid ino ),
HPLC, Rt 11 mlns.
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5 .6 .5 .5  E-l-(2-pyr1dyl)-l-(p-bromophenyl)-3-pyrrol1d1no prop-1 -ene (38) 
m.p. 176 -  178*C, A max 230 and 275 nm, ’ h-NHR 8.50 (d, 1H, Py 
H -6 ' ) ,  8.08 ( t ,  1H, Py H -4 ') ,  7.65 ( t ,  3H, Py H-5'and A of 
A2B2) ,  7.56 (d, 1H, Py H -3 ') ,  7 .1 *  (d , 2H, B? of
A B2) ,  6.65 ( t ,  1H, v inylic  CH). 3.97 (d, 2H, C tyt). ) ,  3.62 
(s , 2H, pyrro lid ino ), 2.98 (s , 2H, pyrro lid ino), 2.00 (s ,  4H, 
p yrro lid in o ),
HPLC, R 24 mlns.
Found C, 55.6%; H, 4.86%; N, 6.37%. Calculated C1QH1 N Br 
C, 55.44%; H, 4.88%; N, 6.47%.
5 .6 .5 .6  Z - l - ( 2-pyr1dyl) - 1 - ( p-bromophenyl) -3-pyrrol 1d1 no prop-1-ene ( 3 9 )  
m.p. 181 -  182°C, Xmax 260 nm, VnMR 8.62 (d, 1H, Py H -6 ') ,  8.08 
( t ,  1H, Py H -4 ') ,  7.64 ( t ,  1H, Py H -5 ' ) , ,  7.44 (m, 3H, Py H-31 and 
of A2B2) ,  7.08 (d, 2H, B2 of A ^ ) , 6.35 ( t ,  1H,
v iny lic  CH). 3.84 (d , 2H, CH2N), ) ,  3.61 (s , 2H, pyrro lid ino), 2.97 
(s , 2H, p y rro lid ino ), 1.98 (s , 4H, pyrrolid ino),
HPLC, Rt 32 mlns.
5 .6 .5 .7  E -l-(3-pyr1dyl)-l-(pheny1)-3-pyrrol1d1no prop-l-ene (45)
m.p. 165 -166°C, X max 226 and 244 nm, V nMR 8.63 (d, 1H, Py H -6 ') ,
8.58 (s , 1H, Py H -2 ' ) ,  8.25 (d, 1H, Py H -4 ') ,  7.80 ( t ,  1H, Py H -5 ') ,
7.53 (d, 3H, phenyl), 7.27 ( t ,  2H, phenyl), 6.43 ( t ,  1H, v inylic CH),
3.96 (d, 2H, C ty j) ,  ) ,  3.65 (m, 2H, pyrro lid ino), 3.00 (s ,  2H,
pyrro lid ino), 2.01 (s ,  4H, pyrro lid ino),
HPLC, R_ 7.81 mlns (Z-1somer Impurity R 10.04 mlns).
T i T
Found C, 68.0%; H, 6.26%; N, 7.90%. Calculated C ^ H ^
C, 67.78%; H, 6.21%; N, 7.91%.
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5 .6 .5 .8  E-1- ( 3-pvr1dyl)-1- ( p-methvlphenyl) -3-pyrrol1d1no prop-1-ene (46)
m.p. 194-196*C, X max 227 nm, ’ h-NMR 8.63 (d, 1H, Py H -6 ') ,  8.60
(s , 1H, Py H-21) ,  8.22 (d, 1H, Py H -4 ' ) ,  7.78 ( t ,  1H. Py H -5 ') ,  7.38 
(d , 2H, A2 of A2B2) ,  7.17 (d, 2H, B? of A ^ ) ,
6.38 ( t ,  1H, v iny lic  CH). 3.97 (d , 2H, C iy i) ,  ) ,  3.64 (s , 2H, 
pyrro lid ino), 3.00 (s , 2H, pyrro lid ino ), 2.39 (s , 3H, Ar-Me), 2.01 (s ,  
4H, pyrro lid ino).
Found C, 68.9%; H, 6.62%; N, 7.60%. Calculated C H N 
C,68.46%; H, 6.57%; N, 7.60%.
5 .6 .5 .9  Z-l-(4-pyr1dvl)-1-(phenvl)-3-pyrrol1d1no prop-l-ene (48)
m.p. 189 -191 °C, X max 242 nm, V nMR 8.76 (d, 2H, Py H-2' and
H -6 ') ,  7.71 (d, 2H, Py H-3' and H -5 ') ,  7.41 ( t ,  3H, phenyl), 7.30 (d,
2H, phenyl), 6.41 ( t ,  1H, vinylic CH), 3.90 (d, 2H, Cf^N). ) ,  3.64
(s , 2H, pyrro lid ino ), 2.99 (s, 2H, pyrro lid ino), 2.00 (s , 4H,
pyrro lid ino).
Found C, 68.1%; H, 6.31%; N, 7.95%. Calculated C H N18 20 2
C, 67.78%; H, 6.21%; N, 7.91%
5.6 .5 .10  E-l-(4-pYr1dvl)-l-(phenyl)-3-pvrrol1d1no prop-l-ene (49)
’ h-NMR 8.67 (d, 2H, Py H-2‘ and H -6 ') ,  7.93 (d, 2H, Py H-3' and
H -5 ') ,  7.56 ( t ,  3H, phenyl), 7.28 (d , 2H, phenyl), 6.77 ( t ,  1H,
v inylic  CH), 3.99 (d, 2H, CH^N), ) ,  3.66 (s , 2H, pyrro lid ino), 2.99
(s , 2H, p y rro lid in o ), 2.00 (s, 4H, p yrro lid ino ).
Chapter 6
Pharmacological Testing and Discussion of Results
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6.1 Introduction
Typical Hj agonist actions of histamine relate to the 
contraction of bronchlolar and gastro -ln testlna l smooth muscle 
and therefore, antagonist compounds discussed here 
characteris tica lly  oppose these actions. The methods of 
assessing the ant1-h1stam1ne a c t iv i ty  of the compounds cited In 
th is  thesis are detailed In this chapter.
I )  In -v itro  methods Including Isolated guinea-pig Ileum studies 
and binding experiments.
I I )  In-vivo studies using a histamine releasing stimulant 
administered by 1.v. (48/80 le th a l i ty  te s t) .
6 .2 In -v i t ro  Methods
6 .2 .1  Isolated Guinea Pig Ileum Studies
Inhibition of the contractions of Isolated guinea-pig Ileum, 
Induced by histamine 1s the most commonly used In -v i t ro  test  
method for quantita tive  assessment of antagonist a c t iv i ty .
The potency of an antagonist Is usually expressed by 
determination of the pA? value 1e. the negative logarithm of 
the dose of antagonist that reduces the effects of a double dose 
of agonist to that of a single dose (Schlld, 1947).
A lternatively , log a f f in i t y  constants (log Kfe) are reported 
(Adamson et a l ,  1969) -  these two parameters are numerically 
equivalent (1e. pA? = log Kb) .
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Testing Methods
The following results were carried out 1n the Department of 
Pharmacology, University of B ris to l,  under the direction of Dr. 
R.B. Barlow. The a f f in i t y  constants were measured on the guinea 
pig Isolated ileum, at 30°C and/or 37°C using an automated 
apparatus (Edinburgh S ta f f ,  1974). The Ileum was bathed 1n Krebs 
solution (Edinburgh S ta f f ,  1974) and the organ baths were aerated 
with 95% oxygen; 5% carbon dioxide. A regular two minute dosing 
regime was maintained using a Commondore Pet computer and 
e le c tr ic a l  relays to control the drug administration.
T1me(s)
0 -  Add low dose of agonist
30 -  Krebs wash
120 -  Add high dose of agonist
150 -  Krebs wash
240 -  Add low dose
The high dose of agonist was always twice that of the low 
dose. Control doses were normally 1 & 2 x 10”7M histamine 
(NB. -  both responses should H e  on the linear portion of the log 
dose -  response curve). The histamine Induced Ileum contractions 
were measured 1soton1ca1ly against a 0.5g load using a transducer 
and moving chart pen recorder. Exposure of the Ileum to control 
doses was maintained u n ti l  regular sized responses were produced 
for  a minimum of four pairs of high and low doses.
The antagonist was diluted 1n the Krebs solution and histamine 
solutions were made up with this antagonist wash.
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The effects of the antagonists were slow 1n onset and equilibrium  
was complete only a f te r  15-45 m1n (depending upon the 
concentration of the antagonist) when the responses became 
constant. Approximate dose ratios were chosen for each 
concentration of antagonist, so that the responses produced by the 
histamine/antagonist mixture were approximately the same as those 
of the histamine control solutions.
The dose ratio  (1 e . the dose 1n the absence of antagonist 
against the dose 1n the presence of antagonist) produced by one 
particu la r  concentration of antagonist was calculated by comparing 
the concentration of histamine used 1n the presence and absence of 
antagonist and taking Into account the actual size of the 
responses (Edinburgh S ta f f ,  1974).
The a f f in i ty  constant K. was calculated from the dose ra tio
D
and the concentration of antagonist -  according to the Gaddum -  
Schlld equation ( Schlld, 1947; Schlld, 1949).
DR = 1 + BIC Gaddum Schlld Equation
D
(derivation from Barlow, 1980)
DR = Dose ra t io
K = A f f in i ty  constant
D
B = Antagonist concentration
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The graph of OR against concentration (B) should be a straight
line with a slope K.. Since every antagonist was tested atb
several concentrations, so that the dose ra tio  ranged from 
10-700 -  1t 1s more convenient to plot log (DR-1) against log B. 
This should be a straight line with a slope of 1 and when log 
(DR-1) = 0, log B = -log Kfc.
Log Kb = log (DR-1)
( B )
Fresh solutions of the histamine and antagonist were made up 
each day -  so eliminating any risk of deterioration 1n the 
efficacy of these agents.
6 .2 .2  Results and Discussion
I t  was found that the responses 1n the presence of antagonist 
did not exactly match the standard agonist responses. A 
correction factor was calculated on a microcomputer using a 
programme based on the theory of the 4-po1nt bioassay (Edinburgh 
S ta f f ,  1974).
For each antagonist concentration, the results were averaged to 
produce a mean dose ratio  and mean log Ku. Also calculatedb
was a weighted mean dose ratio  and log -  this involved theb
use of a microcomputer to apply a weighting to the difference  
between the tr ie d  dose-rat1o and the dose-rat1o obtained a fter  
correction.
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Tables 6.1 to 6.5 show estimates of log + s.e. at
d if fe re n t  concentrations of histamine agonist and at the two 
temperatures 1e: 30 and 37°C. (Figures 1n parentheses show the 
number of results at that concentration).
Table 6 .1 : Estimates of log 1C for chlorpheniramine maleateb
(17c) at d i f fe re n t  concentrations 
(•»•) Chlorpheniramine maleate
30°C 37*C
InM 9.870 t  0.018 (6) 9.451 + 0.049 (6)
5nM 9.896 + 0.039 (5) 9.331 t  0.027 (5)
lOnH 10.123 + 0.092 (2) 9.381 t  0.067 (3)
20nM 10.122 t  0.034 (5) 9.289 + 0.071 (3)
50nM - 9.133 + 0.026 (3)
MEAN 9.975 + 0.029 (18) 9.339 ± 0.024 (20)
( - )  Chlorpheniramine maleate
0 . 5yM 6.949 t  0.005 (2) 6.674 ± 0.118 (2)
M 6.831 i  0.028 (4) 6.701 ± 0.063 (4)
5yM 6.642 t  0.048 (4) 6.383 + 0.092 (4)
lOyH 6.596 i  0.113 (2) 6.488 + 0.056 (2)
MEAN 6.749 ± 0.039 (12) 6.55 + 0.043 (12)
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Table 6.2: Estimates of log K. for brompheniramine
D
maleate (17b) at d if fe ren t concentrations
(+) Brompheniramine maleate
30°C 37°C
5nM 10.137 ±  0.071 (8)
lOnM 10.225 ±  0.063 (13) 9.499 + 0.062 (5)
30nM 10.482 * 0.068 (9) 9.214 * 0.074 (6)
50nM -  9.177 + 0.079 (3)
lOOnM 10.396 + 0.097 (5) 9.258 + 0.066 (7)
500nH -  9.092 ± 0.139 (4)
MEAN 10.295 ± 0.023 (35) 9.259 + 0.257 (25)
( - )  Brompheniramine maleate
3yM 7.198 i  0.101 (3) 6.801 + 0.054 (3)
10yM 7.081 + 0.099 (3) 6.568 + 0.088 (4)
20yM 7.053 i  0.168 (3) 6.730 ± 0.072 (3)
MEAN 7.111 ± 0.022 (9) 6.687 + 0.034 (10)
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Table 6.3: Estimates of log K fo r  carblnoxamlne ta tra te  (9)
D
at d ifferen t concentrations 
Carblnoxamlne (dextro L ta r t r a te  salt)
30°C 37'#C
30nM 9.174 i  0.042 (3) 8.796 i 0.075 (4)
92.3nM 9.065 t  0.053 (7) 8.762 + 0.052 (7)
277nM 8.976 i  0.018 (5) 8.727 t 0.087 (5)
461nM 8.878 1 0.042 (5) 8.565 i 0.063 (5)
lOOOnM 8.970 ± 0.016 (4) 8.486 t 0.080 (5)
MEAN 9.005 ± 0.019 (24) 8.670 ± 0.024 (26)
(♦) Carblnoxamlne (levo 0 ta r t r a te  sa lt)
0.2yM 7.324 + 0.023 (5) 7.227 1 0.025 (5)
3yM 7.161 ♦ 0.052 (5) 7.103 ± 0.059 (5)
lOyM 7.091 + 0.059 (5) 7.096 t  0.080 (5)
MEAN 7.192 + 0.026 (15) 7.142 ± 0.016 (15)
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Table 6.4: Estimates of log for mebrophenhydramlne (11) 
maleate at d if fe ren t concentrations
( - )  Mebrophenhydramlne maleate
30#C 37°C
2nH 9.983 + 0.064 (6) 9.794 t  0.085 (7)
lOnM 9.841 + 0.101 (5) 9.695 i  0.086 (7)
50nM 10.018 t  0.128 (5) 9.656 + 0.112 (7)
MEAN 9.949 + 0.019 (16) 9.715 + 0.013 (21)
(+) MebroDhenhvdramlne maleate
O.lyM 8.332 i  0.090 (5) 8.308 l  0.056 (5)
0 .5yM 8.234 + 0.099 (5) 8.124 ± 0.066 (5)
2.5yM 8.274 + 0.111 (5) 8.187 + 0.068 (5)
MEAN 8.280 +. 0.011 (15) 8.206 t  0.020 (15)
RS MebroDhenhvdramlne maleate
2nM 9.866 + 0.06 (4) 9.745 t  0.06 (4)
lOnM 9.886 ± 0.07 (4) 9.568 + 0.05 (4)
50nM 10.021 ± 0.10 (3) 9.559 t  0.03 (4)
0.25yM - 9.516 ±  0.15 (2)
MEAN 9.916 t  0.021 (11) 9.609 + 0.024 (14)
P h a rm a co lo g ica l da ta  o f  (+). (-)
and RS mebrophenhydramine 
on gu inea p ig  i leu m  assay.
b - -
4 - ~  




4 - “ 
2 - -  
o--
B - -  
B - -  




11.0  - 10.8
30 C (-) mebrophenhydramine
0 . 982833*X +9.008661
37 C ( - ) mebrophenhydramine
O.099142HX +8.906466
30 C (+) mebrophenhydramine
0.952074KX +7.977687








Table 6.5: Estimates of log for tr1prol1d1ne (23)
D
hydrochloride at d ifferent concentrations 
E-tr1prol1d1ne
37°C
InM 9.973 + 0.055 (6)
2nM 10.067 + 0.027 (4)
5nM 9.982 ±  0.071 (6)
lOnM 10.088 ± 0.021 (2)
50nM 10.089 t  0.081 (8)
MEAN 10.034 + 0.011 (26)
Z-tr1prol1d1ne
lyM 7.436 i  0.022 (7)
5yM 7.195 ±  0.021 (7)
25yM 7.137 + 0.039 (7)






P h a rm a co lo g ica l da ta  f o r  E and Z 
t r i p r o l i d i n e  on gu inea p ig  i leu m  assay (at 37C)
3 .0 -r
2 . 8 - -
1 . 0“ -
0 . 4- -
0.0
11.0  - 10.5  - 10.0  - 9 .5  - 9.0  - 8 .5  - 8.0  - 7 .5  - 7.0  - 6 .5  - 6 .0  - 5 .5  - 5.0  - 4 .5  - 4.0
Z t r i p r o l i d i n e  
0.750358KX +5.914313 







6.2 .3 Do the Results F it 1n with the Gaddum -  Schlld Equation?
I f  the results obey the Gaddum-Schlld equation
1e. Dose-rat1o ( DR)= 1 BK. B = antagonist concentration.b
K = a f f in ity  constant of b
antagonist for receptor
then the antagonism 1s a simple competitive process and 1t 1s 
valid to make comparisons of the efficacy. The Schlld plot of log 
[DR-1] against log B should give a straight line with a gradient 
of 1 and when log [DR-1] = 0 then log B = log K..b
Applying a t test to the slopes obtained establishes whether 
there 1s any significant deviation from unity and 1s an Indication 
of whether the simple competitive mechanism does apply.
Values of t are given by:-
t  = _______slope -  1_______
standard error of slope
This may be compared to probability values for t for n-2 
degrees of freedom. The threshold for significance was taken as 
the value of t for P(0.05) 1e. less than 1 1n 20 chance of 
obtaining the observed slope.
The results are shown 1n table 6.6.
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Table 6.6: Stastistical analysis of the Schild plots of the results
Compound
Temp.





(♦) Chlorpheniramine 30 1.189 ± 0.091 4 2.08 4.30 NO
37 0.800 t  0.064 5 3.13 3.18 NO
(- )  Chlorpheniramine 30 0.721 ±  0.031 4 9.00 4.30 YES
37 0.800 ±  0.095 4 2.11 4.30 NO
(♦) Brompheniramine 30 1.232 ±  0.111 4 2.09 4.30 NO
37 0.739 ±  0.104 4 2.51 4.30 NO
(- )  Brompheniramine 30 0.833 ± 0.071 3 2.35 12.7 NO
37 0.862 ± 0.243 3 0.57 12.7 NO
(- )  Carbinoxamine 30 0.711 ± 0.065 3 4.45 12.7 NO
37 0.712 ± 0.205 3 1.40 12.7 NO
(♦) Carbinoxamine 30 0.872 ± 0.001 3 12.8 12.7 YES
37 0.925 ± 0.027 3 2.78 12.7 NO
(- )  Mebrophenhydramine 30 0.983 + 0.14 3 0.12 12.7 NO
37 0.899 ± 0.02 3 5.05 12.7 NO
(♦) Mebrophenydramine 30 0.952 ± 0.06 3 0.80 12.7 NO
37 0.903 + 0.10 3 0.97 12.7 NO
RS Mebrophenhydramine 30 1.098 ± 0.05 3 1.96 12.7 NO
37 0.8%  ± 0.04 4 2.60 4.30 NO
E-Triprolidine
37 1.050 + 0.04 5 1.25 3.18 NO
Z-Triprolidine
37 0.750 ± 0.09 3 2.79 12.7 NO
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From the t  tests on the slopes In the Schlld plots -  I t  Is not 
possible to conclude that the compounds antagonistic action Is 
purely competitive; s im ilarly , i t  1s not possible to prove that 
they are not. Better Information on this would have been 
obtained from Improved experimental design eg. a wider range of 
antagonist concentrations would have given a more precise 
extrapolated value of log K and would have led to a better 
Indication of the slope of the Schlld plot.
6.2.4 Changes 1n Log K with Temperature
Table 6.7 shows the change 1n log K (using mean logb
K.) with temperature for each enantiomer. The figures areb
given for 30°C relative to 37°C
1e. antllog [Mean log K at 30°C - mean log K at 37°C].
The results show that the more active enantiomer 1s more 
sensitive to temperature rise than the less active Isomer and 
that greater antagonism Is produced at 30°C than at 37°C 1e. 
stereospeclfIclty Is Inversely related to temperature. This 
increased binding of the antagonists at lower temperatures 
provides Information about the enthalpy of reaction between drug 
and receptor. These effects may be guantlfled 1n terms of the 
enthalpy (Internal energy) change for the reaction (A H) (Table 
6 . 8 ) : -
AH = - R AlnK
A 1/T AH = Enthalpy change
R = 8.314 joules deg mol 
Al/T = 7.45 x 10"5
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Table 6.7: Change 1n Log K. with temperature and enthalpy
D
change (AH).
Difference Ratio AH KJ rnol*^
Compound Mean Log K 30 : 37
+) Chlorpheniramine 0.636 4.33 -164
- )  Chlorpheniramine 0.194 1.56 -50
+) Brompheniramine 1.036 10.86 -266
- )  Brompheniramine 0.424 2.66 -108
- )  Carblnoxamlne 0.335 2.16 -86
♦) Carblnoxamlne 0.050 1.12 -12.9
- )  Mebrophenhydramine 0.234 1.71 -60
+) Mebrophenhydramine 0.074 1.19 -19
In a l l  cases the sign 1s negative Indicating that the drug 
receptor Interaction 1s an exothermic process and binding 1s 
greater at lower temperatures. Studies of this type are confined 
1n the range of temperatures used because of the limits 1n the 
performance of the biological preparations.
2 4 0
6.2.5 Differences In activ ity  of enantiomeric pairs
Comparison of activ ity  between enantlomers may be made from
the ratio  of a ff in ity  constants 1e. the antllog of the difference
between the log K.s of the enantiomeric pair (Table 6 .8 ). b
There are two possible methods of calculating the value of log K
for each enantiomer at each temperature. The f i r s t  Involves
taking the mean log K for a l l  values obtained over a ll
concentrations and the second by extrapolation of the Schlld plot
to where log DR -  1 =0. This la t te r  method 1s limited by the
spread of the results and since this Is rather wide 1n some
casest this method has not been employed as such these results
have not been quoted.
These results have shown that the log K values for (♦)b
chlorpheniramine (S-configuratlon) and (+) brompheniramine (S) 
are greater than those for the corresponding levo Isomers. 
Similarly ( - )  -  carblnoxamlne (S) and ( - )  mebrophenhydramine 
(R-confIguratlon from ea rlie r  circular dlchrolsm studies) have 
larger log K. values than the ir  corresponding dextro Isomers.b
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Table 6.0: The ratio of the enantiomeric and geometric pairs using 




Log K + (S.E.)
(-) Mean 
Log K + (S.E.) Di fference
Ratio of 
activity
Chlorpheniramine 37 9.339 + 0.024 (20) 6.555 + 0.043 (12) 2.784 608
30 9.975 + 0.029 (18) 6.749 + 0.039 (12) 3.226 1683
Brompheniramine 37 9.259 + 0.027 (25) 6.687 + 0.034 (10) 2.572 373
30 10.295 + 0.023 7.111 + 0.022 (9) 3.184 1528
' (-) (+)
Carbinoxamine 37 8.670 + 0.024 (26) 7.142 + 0.016 (15) 1.528 34
30 9.005 + 0.019 (24) 7.192 + 0.026 (15) 1.813 65
Mebrophenhydraroi ne 37 9.715 + 0.013 (21) 8.206 + 0.020 (15) 1.509 32
30 9.949 + 0.019 (16) 8.280 + 0.011 (15) 1.669 47
E Z
Triprolidine 37 10.034 + 0.011 (26) 7.256 + 0.029 (21) 2.778 600
2 4 2
6.2.6 In v itro  studies with dlmethlndene (20)
These experiments were carried out 1n the Pharmacology 
Department of Smith Kline & French Research Ltd and the results 
quoted are against histamine stimulated contraction of guinea pig 
Ileum after 8 minute equilibrium at 30°C (Table 6 .9 ).
Isomer pA2 (95% lim its )
Slope of 
Schlld plot N
(♦) dlmethlndene 7.86 (7.71 -  8.07) 0.74 + 0.19 3
( - )  tartrate
( - )  dlmethlndene 9.54 (9.31 -  9.83) 0.73 + 0.33 4
(* )  tartrate
Table 6.9 pA2 values for the two Isomers of dlmethlndene
The results show that ( - )  dlmethlndene ((+) tartrate) 1s more 
active than Its  dextro isomer, results in agreement with Borchard 
et al (1985) who published pA? values (on guinea pig Ileum) 
of 9.1 for the levo Isomer and 7.8 for the dextro. The 
stereospeclf1c Index for these two Isomers 1s approximately 50 




Direct study of the binding of antagonist ligand to 
Hj-receptors is now a procedure of Increasing application. 
(Review, H111, 1987). The procedure Involves measuring 
displacement of radiolabelled ( 3H) mepyramlne from the 
membrane fraction of guinea pig brain deemed to contain a high 
population of H^hlstamlne receptors. Irrelevant 
contributions due to non-specific uptake of the radlo-Hgand are 
established by carrying out the binding experiment In the 
presence of a large excess of 'cold' ligand.
Mepyramlne (6) 1s the compound which has been principally  used 
as a probe for H^receptor responses 1n both central and 




The selectivity of mepyramlne and other compounds for the 
Hj-receptor 1s much dependent upon the concentration used.
Thus, although, mepyramlne can be considered to act selectivity  
on Hj-receptors 1n the concentration range l-100nM, at higher 
concentrations i t  w ill begin to antagonize muscarinic and 
Hj-receptors also.
H111 et al (1978) found that the a f f in i ty  constant for (+)
9 -lchlorpheniramine (1.2 x 10 M ) was over 200 times 
greater than that of the levo Isomer (5 x 106 H_1) and 
that these values closely resembled those measured at guinea pig 
Ileum sites. Chang et al (1979) also compared the binding 
a f f in i t ie s  of (+) and ( - )  chlorpheniramine and large differences 
between antipodes were found for a variety of mammalian brains 
(Table 6.10).
2 4 5
values 1 for binding to mammalian brains
Human
Guinea
-pig Rat Rabbit Monkey
(+) chlorpheniramine 4.2±0.7 1.4±0.8 8.0±2.7 21 9.1
( - )  chlorpheniramine 350±170 130±50 700±110 2100 730
Table 6.10: K. values for binding of chlorpheniramine isomers 
to mammalian brains
Footnotes:
1. K, (nM) = _ _ I C 5 o__________
(1 + [ 3 H] mepyramine)K0
InM for guinea pig and 2nM for rest.
Non-specific binding 1n the presence of 2nM tr ip ro lid ine  
Kd -  dissociation constant from Scatchard plot.
IC5 0  -  antipodal concentration that displaces 50% of the 
specifically bound radioligand.
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6.3.2 Binding Study Results
3
The following binding study results, using [ H] mepyramlne 
were measured by Dr M. Young, Department of Pharmacology at the 
University of Cambridge.
Dlmethlndene (ta rtra te )
Three measurements were made on each dlmethlndene Isomer (as 
ta rtra te  salts) using guinea pig cerebellar membranes and one 
measurement of each on a dlgltonln solubilized preparation. The 
combined results were as follows (Table 6.11).
M M -1) ( 1  s .e .)
(-)dlmethlndene (+)d1meth1ndene 
tartrate ta rtra te
Ratio
Membrane Bound 5.05 ±0.15 X109 2.21 ±0.09 X107 229 ±12
Soluble 2.20 ±0.39 XI09 9.45 ±1.10 XI06 233 ±49
Table 6.11 A ffin ity  constants for the two Isomers of dlmethlndene
Triprolidine and Its analogues
The a f f in i ty  constants guoted below (Table 6.12) for the 
tr ipro lid ine and Its  Z Isomer were measured on a particulate 
fraction of guinea pig cerebellum. The f i r s t  results were obtained 
for samples of tr ipro lid ine and Its Isomer known to contain 
Impurities of the minor Isomer. The la tte r  results (3 1n to tal) are 
for Isomerlcally pure (by HPLC) samples of each isomer.
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E-Isomer Z-Isomer
Ka(H-’ ) ( H m  coefficient) Ka( M-*1) ( HI 11 coeffic ient)
1.2 ±0.1xl09 (1.09 +0.05) 6.2 ±0.3x10* (0.94 ±0.05)
1.9 ±0.1xl09 (1.00 ±0.03) 2.0 ±0.2x10* (0.95 ±0.07)
2.3 +0.2x109 (0.95 ±0.06) 1.7 ±0.2x10* (1.08 ±0.09)
2.3 ±0.1x109 (1.02 ±0.06)* 2.0 ±0.1x10* (1.19 ±0.05)*
* guinea pig cerebral cortex
Table 6.12 A ffin ity  constants for the two Isomers of tr ip ro lid in e
Each pair of results were measured on the same homogenate, 1n the same 
experiment. These results show a potency ratio of 100, results 1n 
agreement with those obtained using guinea pig Ileum tests.
The following measurements on the compounds synthesized for this thesis 
(Chapter 5) were made on homogenates of guinea pig cerebral cortex. The 




A ffin ity  Constant 
(No of experiments)
40 E-p.-ethyl phenyl 1.84 ± 0.16 x 109
38 E-f)-bromophenyl 6.61 ± 0.54 x 108
24 E-£-chlorophenyl 8.99 ± 0.61 x 108
34 Z-j)-chlorophenyl 3.95 ± 0.18 x 10*
48 Z 4-pyr1dylphenyl 4.52 ± 1.27 x 10*
Table 6.13 A ff in ity  constants for synthesized analogues 
of tr ip ro lid in e
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I t  1s unfortunate that Insufficient quantities of purified samples of 
each Isomer were available for testing. I t  can be seen from Table 6.13, 
however, that the E Isomer of the 2 -  pyrldyl analogues of tr iprolid ine
p g
show high a f f in i ty  constants (10 -  10 ) while the Z Isomers 
tested (34 and 48) show values of the same magnitude to each other but 
lower than the E Isomers. These results are 1n agreement with those 
previously quoted for tr ipro lid ine and Its  Z-lsomer.
Using the same conditions, the a f f in i ty  constants for the Isomers of 
mebrophenhydramine were measured. The results (Table 6.14) were 1n 
agreement with those calculated from guinea pig Ileum assay (Table 6.4).
Isomer A ffin ity  constant
(+) Mebrophenhydramine 9.80 ± 0.06 x 107 (2)
maleate
( - )  Mebrophenhydramine 3.58 ± 0.30 x 109 (3)
maleate
3.46 ± 0.21 x 109 (2)
Table 6.14 A ff in ity  constants for the Isomers of mebrophenhydramine
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Binding studies were also measured at the Schwartz laboratory 1n 
Paris. The compounds, dlmethlndene and mebrophenhydramine, were tested 
as binding ligands on membranes derived from guinea pig cerebellum and
1 oc
auricle against [ I ]  lodobolpyramlne. The results from these 




(-)dlmethlndene 0.028 ±0.009 0.05 ±0.01
(+)d1meth1ndene 14.4 ±1.8 7.9 ±2.7
(+)mebrophenhydram1ne 0.58 ±0.03 1.42 ±0.35
(-)mebrophenhydramlne 0.27 ±0.02 0.33±0.04
Table 6.15 Kj values for binding to guinea pig cerebellum and 
auricle
Footnotes for Table 6.14:
1. (nM) = _________ ICgo__________
(1 + [3H] mepyram1ne)KD
2. 0.16nM 125[ I ]  lodobolpyramlne
3. 0.08nM 125[ I ]  lodobolpyramlne
I t  1s Interesting to note that (-)dlmethlndene 1s much more potent than 
Its  (+) enantiomer, while there 1s not much stereoselective separation 
for the enantlomers of mebrophenhydramine (c f gut bath experiments).
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In-v1vo test methods
The most common 1n vivo assays of antihistamines are those In which 
the a b i l i t ie s  of test compounds to protect guinea pigs against lethal 
doses of 1.v. histamine or bronchospasm produced by Inhalation of a 
histamine aerosol are measured (Silva and Antonio, 1978).
The 1n vivo testing carried out by Janssen Pharmaceutlca on the 
resolved and synthesized compounds cited In this thesis Involved the use 
of compound 48/80 to In i t ia te  histamine release.
Compound 48/80 1s a mixture of oligomers obtained by condensation of 
I)-methoxy-N-methyl phenethylamlne and formaldehyde (Neimegeer et a l,  
1978). I t  1s recognised as a potent histamine releasing agent (Dews et 
a l,  1953; Paton, 1951; West, 1958). Compound 48/80 Is Injected at a 
challenge dose of 0.5mg/kg and the test compounds are administered s.e. 
at a dose of lOmg/kg. The test compounds are assumed to be active I f  the 
animals have a survival time of >240 minutes.
Table 6.16 shows the results of the 48/80 le tha lity  test for a 
selection of the tr ipro lid ine  analogues (Chapter 5) and Indicates the 
number of rats that survived. Each compound and dose of compound was 







E-trlprol1d1ne (23) 2 - 2 - 1
E-fi-ethyl analogue (37) 2 - - 1 -
E-£-bromo analogue (36) 2 0 0 - -
E-f)-chloro analogue (24) 2 1 0 - -
Z-£-chloro analogue (34) 0 - 0 - -
E-|>-methy 1 -3-py r 1 dy 1 
analogue (46) 2 2 1 - -
Z-phenyl-4-pyr1dyl
analogue (49) 1 - 0 - -
Table 6.16 Number of rats (out of 2 tested) that survived the 48/80 
le th a l i ty  test.
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6.5 Central Effects of Chiral Antihistamines
6.5.1 Study of the possible central nervous system (CNS) effects of 
( + 1  and ( - )  dlmethlndene In mice
In v i t ro  studies, on guinea pig Ileum, of dlmethldene have shown a 
potency ra t io  of >50 ( - ) : ( ♦ )  (Borchard et e l ,  1985; 6 .2 .6  of this  
thes is ).  Binding study results (6 .3 .2 )  show a 200 fold difference 1n 
potency of ( - )  against (+ ) .  Tests designed to establish any differences  
1 n the sedative properties of the two enantlomers were performed 1 n the 
mouse ( In  the Pharmacology Department of Smith Kline and French Research 
Lim ited).
The doses of test drug as ta r t ra te  salts ( ( - )  0 .5 , 5 and 50 mg/kg and 
(+) 50 mg/kg) and placebo were administered subcutaneously. The CNS 
effects were assessed by a number of d iffe ren t tests Involving 
behavioural studies and exploratory a v t lv l ty .  The results of this study 
were most disappointing and no s ign ificant difference was observed 
between the behavioural e ffects  of ( - )  and (♦) dlmethlndene.
6 .5 .2  Alertness and Performance 1n Han
Under the supervision of Group Captain A.N. Nicholson, at the Royal 
Air Force In s t i tu te  of Aviation Medicine, Farnborough, the Individual 
Isomers of chlorpheniramine and dlmethlndene, were administered to human 
volunteers and th e ir  effects on alertness and performance monitored by 
various tests and compared with a placebo and an active  control 
( t r ip r o l id in e ) .
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Doses of lOmg (+) and ( - )  chlorpheniramine maleate, 5mg (+) and 
( - )  dlmethlndene maleate, 5mg tr ip ro l id in e  hydrochloride and 2 
placebos were administered (o ra l ly ,  as a t r i tu r a te  with lactose 
and enclosed 1 n a gelatin capsule) on separate occasions to 6  
healthy volunteers. Tbree tests ( sleep latency, subjective 
sleepiness and d ig it  symbol substitution) were carried out 1 hour 
before and I ,  I I  and 3 hours a f te r  ingestion.
Differences between changes 1n measures for the tests from 
before to a f te r  Ingestion were analysed between enantiomers and 
between drugs and placebo. No differences were seen I  hour a f te r  
Ingestion. One and a half hours a f te r  ingestion reductions in 
sleep latencies were greater with (+) chlorpheniramine and ( - )  
dlmethlndene when compared to placebo. Increased subjective 
sleepiness was greater with (+) chlorpheniramine than with ( - )  
and placebo (a f te r  I I  and 3 hours) and with ( - )  dlmethlndene 
compared to the (+) isomer (3 hours a fte r  ingestion). (+) 
Chlorpheniramine also showed greater Impairment of performance 
than the ( - )  isomer ( I I  and 3 hours a fte r  ingestion).
The importance of these findings, that (+) chlorpheniramine and 
( - )  dlmethlndene (the active enantiomers in v itro  and in binding 
studies) show Increased drowsiness and impairment of performance 
over th e ir  inactive isomers 1 s that I t  provides a c lear  
indication that sedation arises from central preceptor  
blockade alone.
2 5 4
6 . 5 .  D i s c u s s i o n
The d a t a  on d i s s y m m e t r i c  a n t i h i s t a m i n e s  o f  b o t h  c h i r a l  and g e o m e t r i c a l
t y p e  p r e s e n t e d  I n  t h i s  c h a p t e r  and 1n t h e  I n t r o d u c t i o n  t o  t h i s  t h e s i s ,
p r o v i d e  e v i d e n c e  o f  t h e  s t e r e o s e l e c t i v e  n a t u r e  o f  H ^ - h l s t a m l n e
r e c e p t o r s  e s p e c i a l l y  w i t h  r e s p e c t  t o  l i g a n d s  t h a t  b l o c k  t h e s e  s i t e s .
T h i s  work has e s t a b l i s h e d  t h e  I m p o r t a n c e  o f  a c h i r a l  c e n t r e  c l o s e  t o  t h e
d l a r y l  u n i t  o f  t h e  s t r u c t u r e  as o p p o s e d  t o  f u r t h e r  removed c h i r a l
f e a t u r e s  as 1s t h e  c a s e  f o r  t h e  c l e m a s t l n e s  ( 1 2 ) ,  p h e n o t h l a z l n e s  and
1 s o t h 1 p e n d y l  ( 1 9 ) .
A l a r g e  number o f  p a i r s  o f  e n a n t i o m e r s  w i t h  c h e m i c a l l y  r e l a t e d  c h i r a l
c e n t r e s  have  now been e x a m i n e d ,  f o r  e x a m p l e  t h e  p h e n l r a m l n e s  ( 1 7 )  and t h e
d 1 p h e n h y d r a m 1 n e - t y p e s  ( 7 - 1 2 )  and t h e s e  r e s u l t s  d e m o n s t r a t e  t h a t  t h e
H r e c e p t o r  1s p r e f e r e n t i a l l y  b l o c k e d  by a l i g a n d  o f  t h e  g e n e r a l  
l
g e o m e t r y  ( 6 1 ) .  D e t a i l s  f o r  e v i d e n c e  o f  t h i s  a r e  sum m ar ize d  I n  T a b l e  6 . 1 5 .
Ph o r  2 - P y  ( 1 )
H
o r  Me 
( 3 )
4 - s u b s t 1 t u t e d  
p h e n y l  ( 2 )
a l k y l a m l n o  c h a i n  ( 4 )
( 61 )
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Name and Substituent about chiral centre References to
configuration of the Pharmacology
more potent enantiomer 1 2  3 4
R(+) neobenodine
Configuration:
Nauta and Rekker, 1978 
CO evidence (2.6.4)




S (-) carbinoxamine 2-Py 4-C1C5H4 H O C O y ^ Z
Configuration:
Barough et a l , 1971,
CO evidence (2.6.4)
Roszkowski and Govier, 
1959
Section 6 .2 .1 .
RR(+)clemastine
RS(-)diastereamer
Ph 4-ClC6H4 Me O -Q y
N
R Me
Ph 4 -0 1 ^ 4  Me O -O y
fN
S Me
Ebnother and Weber, 
1976
Nauta and Rekker, 
1978
Configuration:
Ebnother and Weber, 1976 
CO evidence (2.6.4)
R(-)mebrophenhydramine Ph 4-BrC^H4 Me O fa y p W ^  Sections 6 .2 .1 ., 6 .3.1
and 6 .4 .1 .
Configuration:
CO evidence (2.6.4)
S(+)pheniramine Py 4-XC6H4 H (Oy^NHEp Roth and Govier, 1958
and 4-Br and 4-C1 (X= H, B ritta in  et a l,  1959
analogues Br Nauta and Rekker, 1978
Cl) Sections 6.2.1 and
Configuration: 6.3.1
Shafi *ee and Hite, 1969
CO evidence (2.6 .3)
Table 6.17 Review of general geometry fo r H] antihistaminic a c tiv ity
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Receptor sens itiv ity  to the positioning of the two aryl groups 
around a benzyllc carbon 1 s also apparent 1 n antihistamines of 
the amlnopropene type e .g .t r lp ro H d ln e  (23 ). Isomers of the type 
(62) of the configuration E (fo r  the 2-pyr1dyl group) have much 
greater a f f in i t ie s  than th e ir  corresponding Z Isomer (Section
6.2.1 and 6.4.1 of this thesis; Adamson et a l ,  1951; Ison et a l ,  
1973). These receptor s tereose lectiv it ies  are maintained 1n the 
less potent 3-pyr1dyl analogues (Section 6 .4 .1 ; Hall and Ogren, 
1984).
I t  1s significant that chiral and geometrical configurational 
relationships correspond. For example, the enantiomeric 
phenlramlnes that correspond to the arrangement (A) of 
tr1prol1d1ne have the configuration (B) I . e .  S the (+) Isomer, 
while th e ir  mirror Images (C) are equivalent to the feebly active  



















From the study of the structural features of many 
receptor antagonists 1 t  Is evident that ligand receptor 
Interactions Involve both the aromatic and protonated amino 
features of the molecules. Of the two receptor sites which 
accommodate the aromatic groups, one prefers unsubstituted phenyl 
or 2-pyrldyl and the other a para-substituted group. I t  also 
follows that the anionic site of the receptor (which associates 
with the protonated amino feature (N*H) of the ligand) Is 
closer to the more extended aromatic recognition region (which 
associates with the para substituted group) I . e .  A and B of 
Scheme 1.
Isomeric potency and a f f in i ty  ratios
In the absence of Isomeric purity  I t  Is not advisable to 
attach too much significance to numerical differences between 
potency or a f f in i t y  ratios since false or misleading a c t iv ity  
values can result 1 f  the Isomeric sample 1 s contaminated even 
with only small amounts of the other Isomer. This Is most 
serious when the the less active form Is contaminated with the 
more active Isomer.
The optical purit ies  of most chira l antl-hlstamlnes examined, 
especially those prio r to 1980, are based on measurements of 
optical rotation (Chapter 2). As has already been shown In this  
thesis, this method of measuring optical purity Is not absolute 
and can therefore be misleading.
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More recently chromatographic (Souter, 1985; Lochmuller and 
Souter, 1975; Walner and Doyle, 1984; Karnes and Sarkar, 1987) 
and NHR methods (Casy and Mercer, 1988; Mercer, 1988) which 
quantitate each enantlomer separately are being used to measure 
optical purity  and as such a much greater degree of confidence 
can be placed on potency ratios of enantiomeric pairs analysed 1 n 
this way.
From Isomeric pairs prepared at Bath and analysed by HPLC and 
NMR procedures 1t was found that Isomeric a c t iv i ty  ratios for 
molecules that d i f fe r  1n 2-pyr1dyl and 4-subst1tuted phenyl 
orientation were substantially greater than those of molecules 
which Involve d ifferent dispositions of phenyl and 4-subst1tuted 
phenyl (Table 6 .15). For example the Isomeric ratios of ac tiv ity  
for brompheniramine at 30°C 1s 1524 whereas for mebrophenhydramlne 
1t 1s only 47. This trend 1s also seen 1n the case of analogues 
of t r 1 pro!1 d1 ne.
This result seems reasonable when one considers that receptor 
recognition and d iffe rentia tion  of two aromatic units must be the 
chief factor responsible for a f f in i ty  differences between isomers 
(many antihistamines e.g. diphenhydramine (7) the two aryl groups 
are Id e n t ic a l) .  The greater the difference 1n aromatic nature 
e.g. homo vs heteroaryl or homo vs homoaryl, the greater the 
degree of receptor discrimination between the two aromatic 
features to be expected.
Of the compounds tested those containing an ether link to the 
side chain showed lower stereospec1 f 1 c1 ty than those without such 
a linkage. For example, the Introduction of the ether linkage 
In to the chlorpheniramine structure I . e .  carblnoxamlne produced a 
reduction 1n the Isomeric potency ra tio  (a t  30°C) from 1683 to 65 
(Table 6.9) .
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The presence of the oxygen within the side chain generates a more 
f lex ib le  structure and therefore these compounds e.g. 
carblnoxamlne are more able to d is to rt  the ir  structure to be 
accomodated by the histamine receptor unlike the r ig id  
phenlramlnes. This f l e x ib i l i t y  factor may also be contributing  
to the large differences seen between brompheniramine and 
mebrophenhydramlne (as already discussed). In order to evaluate 
this e ffect fu l ly  a comparison should be made between for example 
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